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PREFACE: Outline of the Study 
OUTLINE OF THE STUDY 
Determination of the localization of sites of acute, subacute, and 
chronic infection and inflammation poses a common clinical problem. 
Accurate and quick localization of infectious and inflammatory lesions 
facilitates both elucidation of the cause of the disease as well as installation 
of a tailored therapeutic regimen. 
Over the last decades, numerous diagnostic procedures have been 
developed for establishing presence, localization and extent of infectious and 
inflammatory lesions. Besides physical examination, a variety of diagnostic 
techniques are available for detecting abnormalities, indicative for infection 
or inflammation or for identifying the etiology of the disease. Imaging 
modalities include scintigraphy, ultrasonography, radiographic techniques, 
such as X-ray computed tomography, and recently, magnetic resonance 
imaging. The revelation of abnormalities, using the latter three techniques, 
are mainly based on changes in structure, density and proton content in 
various tissues. Using these techniques, differentiation between active 
infection or inflammation and residual structural abnormalities after cure 
may be difficult. Nuclear medicine techniques are based on local 
concentration of radiolabeled compounds representing local physiochemical 
processes and changes therein, independent of structural changes in tissue 
composition. Furthermore, nuclear medicine offers an easy tool to perform 
whole body imaging. Especially when the site and source of suspected 
infection are unknown or the presence of additional foci is to be verified, 
whole body imaging is particularly advantageous. 
In the past twenty years, the utility of several radiopharmaceuticals has 
been investigated. So far, all currently available scintigraphic techniques 
have shown serious limitations. Therefore, research in this field of nuclear 
medicine is still in progress in order to develop more adequate and more 
convenient diagnostic procedures. 
In 1988, indium-Ill labeled human nonspecific polyclonal 
immunoglobulin G (In-111-IgG) was suggested as an agent to detect sites 
of infection. The first aim of the studies, presented in this thesis, was to 
investigate the diagnostic potential of this newly developed radiopharmaceu-
tical in various patient categories. The second objective was to contribute 
to the elucidation of the mechanism of accumulation in infectious foci. 
Thirdly, this new modality was to be put in perspective with at present 
commonly used techniques such as In-111 labeled leukocyte scintigraphy. 
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In chapter 1, an overview is given of the literature dealing with well-
established scintigraphic imaging modalities, such as gallium-67 citrate and 
radiolabeled white blood cells. First reports on other new developments, 
such as labeled antigranulocyte monoclonal antibodies and technetium-99m 
labeled human nonspecific immunoglobulin G, are discussed. 
Chapter 2 provides the results of studies in rats with artificially-
induced, focal infection. Several proteins, radiolabeled with different 
radionuclides were studied in order to identify the role of both the protein 
and the radionuclide in the accumulation of these agents in infectious foci 
and to study the distribution in the body. 
First results of In-111-IgG scintigraphy in patients with infectious bone 
and joint disease are presented in chapter 3, part A. Part В deals with the 
results of In-111-IgG scintigraphy in a group of over 100 patients, suspected 
of osteomyelitis, arthritis or prosthetic joint infection. An addendum to this 
chapter specifically deals with the role of In-111-IgG scintigraphy in the 
diagnosis of prosthetic joint infection. 
The issue of osteomyelitis of the foot in patients with diabetes mellitus 
is addressed in chapter 4. 
In chapter 5, In-111-IgG scintigraphy is used to study the hypothesis 
that excessive inflammation may play a role in the development of reflex 
sympathetic dystrophy after upper extremity injury. 
Granulocytopenia hampers the detection of infectious lesions. Chapter 
6 deals with the utility of In-111-IgG in this condition, both in a leukocyte-
depleted rat model and in a series of patients. 
The performance of In-111-IgG scintigraphy in a small series of 
patients with inflammatory bowel disease is studied in chapter 7. 
In chapter 8, the accuracy of In-111-IgG scintigraphy is compared to 
that of indium-Ill labeled leukocyte scintigraphy in patients, suspected of 
subacute infection. 
In chapter 9, the results of the presented studies are discussed and In-
111-IgG scintigraphy is put in perspective with other radiopharmaceuticals, 
at present applied to detect infectious and inflammatory lesions. 
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CHAPTER 1 
Scintigraphic imaging of inflammatory 
and infectious lesions: a survey 
Excerpts from: 
Indium-Ill labeled human nonspecific immunoglobulin G: a new radio-
pharmaceutical for imaging infectious and inflammatory foci. 
Wim J.G. Oyen, Roland A.M.J. Claessens, Jos W.M. van der Meer, 
Robert H. Rubin, H. William Strauss, Frans H.M. Corstens. 
Clin Infect Dis 1992; in press 
Permission to reprint excerpts from the article, 
granted by THE UNIVERSITY OF CHICAGO, 
is gratefully acknowledged. 
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INTRODUCTION 
In various clinical conditions, such as systemic bacterial or fungal 
infection or fever of unknown origin, clinicians would like to have a reliable 
method to delineate foci of infection or noninfectious inflammation at their 
disposal. In the last two decades, several scintigraphic techniques have been 
proposed to localize infectious and inflammatory foci scintigraphically. 
Three-phase technetium-99m methylene diphosphonate (Tc-99m-MDP) bone 
scintigraphy shows excellent sensitivity for diagnosing bone and joint 
infection. However, specificity for infection and inflammation is extremely 
low (1). In 1971, Lavender et al. and Ito et al. presented first clinical data 
on the utility of gallium-67 citrate (Ga-67) scintigraphy for imaging 
inflammatory lesions (2,3). In 1976, McAfee and Thakur reported the 
labeling of autologous leukocytes with indium-Ill (In-111) oxine (4). Both 
Ga-67 and In-111 labeled autologous leukocyte scintigraphy have found 
their way into routine clinical practice. In 1986, Peters et al. reported the 
use of Tc-99m-hexamethylpropyleneamine oxime (HMPAO) labeled 
leukocytes (5). In literature, the utility of Tc-99m nanocolloid scintigraphy 
has been reported, especially for delineating infection of the locomotor 
system (6). 
Besides In-111 labeled human nonspecific immunoglobulin G (IgG), 
various other new radiopharmaceuticals, such as Tc-99m labeled IgG and 
radiolabeled murine monoclonal antigranulocyte antibodies, are currently 
under investigation. 
In the following paragraphs, a description of current techniques as well 
as new modalities, currently under investigation, will be presented. 
GALLIUM-67 CITRATE 
Ga-67 citrate is used for imaging inflammation and infection, 
lymphoma, and sarcoidosis. Imaging infection with Ga-67 citrate was 
proposed in 1971 (2,3). In humans, Ga-67 has especially been proven to 
be useful in detecting and delineating chest infection and infections of the 
locomotor system (7,8,9). 
In infections of the locomotor system, some authors report a high 
accuracy of combined Tc-99m diphosphonate bone scintigraphy and Ga-67 
scintigraphy, especially if serial Ga-67 studies were obtained (10). 
Rosenthall et al. have reported 100% accuracy if both procedures are 
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negative, 100% accuracy if incongruent and 94% accuracy if congruent 
(11). Seabold et al. could not reproduce these results with such high 
accuracy (12). They reported that 11 of 21 congruent Tc-99m/Ga-67 images 
at fracture nonunion sites proved to be infected, the remainder being 
noninfected. Tumeh et al. observed that the characteristic pattern for 
infection (the Ga-67 uptake being relatively higher than the Tc-99m 
diphosphonate uptake) was only present in a minority (15%) of patients 
(13). Merkel et al. reported a sensitivity of only 50% and a specificity of 
78% (14). 
In the evaluation of abdominal infection, the utility of Ga-67 
scintigraphy appears limited, since large quantities of Ga-67 are excreted 
into the bowel (15,16). Another disadvantage of Ga-67 are the physical 
characteristics of the radionuclide: multipeak, high-energy photons impair 
image quality. Moreover, specificity for infection is limited due to avid 
accumulation in malignancies such as lymphoma (15,17,18). 
INDIUM-111 LABELED 
AUTOLOGOUS LEUKOCYTES 
The possibility to isolate and label autologous leukocytes with In-111 
oxine was a major step forward for scintigraphic imaging of infection (4). 
In acute infection, superior images of infectious foci can be obtained 
(15,19). Froelich et al. reported a correlation between the degree of 
inflammation and In-Ill leukocyte accumulation (15). In chronic infection, 
limited sensitivity of labeled leukocyte scintigraphy has been reported, 
explained by the absence of granulocyte influx in this type of infection 
(20,21). The leukocyte count appears not to serve as a predictive factor for 
the outcome of leukocyte scintigraphy (21). Moreover, labeled autologous 
leukocyte scintigraphy is of course not possible in granulocytopenic patients. 
The need to draw blood and to isolate and label leukocytes makes this 
technique relatively time-consuming, complicated and costly. It takes at least 
three hours to prepare the radiopharmaceutical. Moreover, not every nuclear 
medicine department has the facilities to label leukocytes. Two major 
concerns are the handling of blood and the possibility of administering the 
cells to the wrong patient. These problems require meticulous care by the 
staff (22,23). An additional difficulty of performing autologous leukocyte 
scans in children is the need to draw a relatively large volume of blood in 
order to obtain sufficient leukocytes. 
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TECHNETIUM-99m-HMPAO 
LABELED LEUKOCYTES 
A more recent development is the labeling of autologous leukocytes 
with Tc-99m HMPAO (5). With this labeling technique, the radiolabel is 
readily available. Another advantage of using Tc-99m is the improvement 
of image quality due to a relatively higher photon flux with a relatively 
lower radiation burden. The 140 keV gamma emissions of Tc-99m are also 
better suited for scintigraphy, using general all purpose gamma cameras, 
than the 173 and 247 keV gamma emissions of In-Ill. However, whether 
24 hour imaging is sufficient to delineate chronic, low-grade or even 
subacute infections remains to be established (24). The results of Moragas 
et al. in a series of 50 patients indicated that Tc-99m HMPAO labeled 
leukocyte scintigraphy was reasonably sensitive (80.9%) and specific 
(93.7%) (25). They note however that visualization of pathological uptake 
in areas with a high bone marrow content is difficult. This is a common 
problem in bone infection with low leukocyte infiltration. 
Excretion in the bowel after approximately three hours seems an 
inconvenience of Tc-99m-HMPAO labeled leukocytes, although pathological 
accumulation of the labeled leukocytes in the abdomen may be seen within 
30 to 60 minutes postinjection (26,27). In a group of patients with 
abdominal infection, Lantto et al. reported an accuracy as high as 77 
percent only two minutes after injection (28). The accuracy in their study 
increased to over 90 percent after 2 and 4 hours. 
Nevertheless, cell labeling facilities are still required and the risks of 
handling potentially infectious blood apply to this labeling procedure as they 
do to labeling leukocytes with In-Ill. 
TECHNETIUM-99m LABELED NANOCOLLOIDS 
Tc-99m labeled nanocolloid scintigraphy is an imaging modality that 
has predominantly been used in infectious bone and joint disease. As for 
all Tc-99m labeled kits, an advantage of this technique is the ready 
availability of the agent. Winker et al. reported a sensitivity of 82% and 
a specificity of 100% in a group of 60 patients (29). They noted 
false-negative results mainly in patients with (sub)acute infection. In some, 
the false-negative results may have been caused by increased pressure due 
to empyema in joints. Gericke et al. noted a sensitivity of 93.4% and a 
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specificity of 88.5% of nanocolloid scintigraphy in 276 patients suspected 
of infectious bone and joint disease (6). In acute infection, excellent results 
were obtained. In chronic infection, such as infectious loosening of joint 
prostheses, their results were less encouraging (a sensitivity of 62%). As 
also observed for Ga-67 and labeled leukocyte scintigraphy, they reported 
that with nanocolloid scintigraphy sterile inflammation could not be 
differentiated from infection. 
DOSIMETRIC CONSIDERATIONS 
The effective dose equivalent after injection of 25 MBq In-111 labeled 
leukocytes is approximately 15 mSv (30). After injection of 370 MBq 
Tc-99m labeled leukocytes, it will be 5 to 10 mSv (31). For imaging of 
inflammatory disease, doses of up to 220 MBq Ga-67 citrate were advised, 
resulting in an effective dose equivalent of up to 27 mSv (8,32). After a 
dose of 740 MBq Tc-99m nanocolloid, the effective dose equivalent will 
be approximately 10 mSv (33). 
NEW RADIOPHARMACEUTICALS UNDER 
CLINICAL INVESTIGATION 
I. LABELED MONOCLONAL 
ANTIGRANULOCYTE ANTIBODIES 
In search of in vivo labeling of granulocytes, several murine 
monoclonal antibodies against antigens located on the membrane of human 
granulocytes have been developed. With the BW 250/183, a monoclonal 
antibody which binds to the NCA-95 epitope on human granulocytes, ample 
experience has been achieved in humans. Several investigators reported the 
utility of Tc-99m-labeled BW 250/183 for the detection of infectious and 
inflammatory disease (34,35,36,37). However, the utility to detect infection 
in the axial skeleton seems limited, since infectious lesions appear as 
photopenic areas (38). This was explained by the relatively high physiologic 
uptake of the radiopharmaceutical in normal bone marrow, while in the 
chronic infectious focus normal bone marrow was destroyed, thereby 
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masking specific accumulation in the lesion. The avidity of the 
radiopharmaceutical for bone marrow makes it probably suitable for bone 
marrow scintigraphy (39). 
In 33 patients with inflammatory bowel disease, Segarra et al. found 
scintigraphy with BW 250/183 useful for diagnosis and localization. 
However, immunoscintigraphy was less accurate than In-111 labeled 
autologous leucocyte scintigraphy (37). Perkins et al. reported good 
concordance between the immunoscintigraphy and conventional 
examinations in sixteen patients with inflammatory bowel disease (40). 
These authors made the interesting additional observation that less than 
twenty percent of the activity in blood was granulocyte associated, 
suggesting that accumulation of this antibody is at least in part 
granulocyte-independent. 
A major disadvantage of using murine monoclonal antibodies is the 
possible development of human anti-mouse antibodies (HAMA), which can 
result in allergic reactions, increased liver uptake and interference with 
radioimmunoassays (41,42). The induction of H AM A may interfere with 
the potential therapeutic utility of murine monoclonal antibodies, both 
radiolabeled and unlabeled (43). We feel that a murine monoclonal 
antigranulocyte antibody should have higher uptake in infectious foci and 
more favorable biodistribution, compared to the labeled human polyclonal 
IgG, to justify the disadvantages of possible HAM A development in patients 
with benign disease. 
II. LABELED IgG 
In 1988, Rubin, Strauss et al. at the Massachusetts General Hospital 
in Boston, USA, suggested In-111-IgG for scintigraphic imaging of 
infectious and inflammatory foci. In rats with an artificial Pseudomonas 
aeruginosa infection of the thigh, they observed similar accumulation of 
In-111 labeled nonspecific IgG and a radiolabeled specific anti-Pseudomonas 
monoclonal antibody in the first 48 hours after injection of the radiopharma-
ceuticals (44). Shortly thereafter, further studies with In-111-IgG 
scintigraphy were initiated both at the Massachusetts General Hospital and 
at the University Hospital Nijmegen (45,46). The results of the studies, 
performed in the latter institution, will be presented in this thesis. 
As mentioned above, Tc-99m has both physical (better photon flux, 
lower radiation burden) and logistic (continuous availability) advantages 
over In-I l l . For these reasons, first results of studies with In-111-IgG 
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encouraged other investigators to explore the potential of Tc-99m-IgG. 
Buscombe et al. found high concordance of Tc-99m-IgG with In-111 labeled 
autologous leukocyte scintigraphy (47). Further studies by this group in 
HIV-positive patients revealed better results with Tc-99m-IgG compared to 
Ga-67 (18). However, Ga-67 scintigraphy was superior to Tc-99m-IgG in 
depicting infections in the chest area, mainly due to persisting Tc-99m 
activity in the blood (18). Since relatively high blood pool activity is present 
throughout the study, it is questionable whether Tc-99m-IgG is suited for 
the detection of chronic low-grade infections, since imaging up to 48 hours 
is not possible with Tc-99m-IgG, due to the six hours physical half life of 
the radionuclide. However, first results in twenty patients with chronic 
osteomyelitis showed that Tc-99m-IgG might be useful (38). Other studies, 
both in an animal model and in a small number of patients, demonstrated 
that Tc-99m-IgG might be useful to detect and objectively measure 
inflammatory activity in patients with rheumatoid arthritis (48,49). 
SUMMARY 
In literature, favorable results of gaHium-67 citrate scintigraphy were 
reported, especially in infections in the chest and the locomotor system. 
However,accumulation in lymphoma and in noninfected areas with increased 
bone turn-over, and physiological bowel excretion limit specificity, while 
physical properties result in relatively poor quality images and high 
radiation burden to the patient. 
Labeled leukocyte scintigraphy shows excellent results in acute 
infection. In subacute and chronic infection, however, sensitivity is 
decreased. The time-consuming and relatively complicated cell labeling as 
well as the handling of patients' blood, constitute limitations of this 
technique. 
Tc-99m nanocolloids appear useful for the evaluation of infection of 
the locomotor system. However, normal bone marrow uptake may hamper 
image interpretation. The role of this radiopharmaceutical in diagnosing 
other types of infection remains to be established. 
In view of possible HAMA development, the prospects for murine 
monoclonal antigranulocyte antibodies will depend on the degree of 
immunogenicity and on the performance in comparison with human IgG, 
the latter having an excellent safety record since many years (50). 
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First clinical results with the newly developed agent In-111-IgG, justify 
further investigations in various patient categories. Results of these studies 
are included in the following chapters. 
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INTRODUCTION 
Several reports suggest the utility of scintigraphy with indium-Ill 
labeled nonspecific polyclonal human immunoglobulin G (In-111-IgG) for 
the detection of various types of focal infection in humans (1,2,3,4). 
However, the mechanism of In-111-IgG accumulation in infectious and 
noninfectious inflammatory foci is not fully understood. Both specific 
receptor interaction and nonspecific macromolecular entrapment have been 
proposed (5,6,7,8). To evaluate the role of the type of protein in the 
mechanism of accumulation of In-111-IgG in infectious foci, In-111-IgG 
was compared to In-111 labeled human serum albumin (HSA), and In-111 
labeled human immunoglobulin A (IgA); also I-123-IgG was compared to 
I-131-HSA. To elucidate the role of the radionuclide and corresponding 
labeling method, IgG was labeled with In-111, 1-123, and Tc-99m and 
HS A was radiolabeled with In-111 and 1-131. 
MATERIALS AND METHODS 
Radiopharmaceuticals 
The biodistribution and kinetics of six radiolabeled proteins were 
studied. 
In-111-IgG. (IgG: Sandoglobulin, Sandoz AG, Nurenberg, FRG). 
Diethylenetriaminepentaacetic bicyclic anhydride (bicyclic DTPA) was 
conjugated to the protein according to Hnatowich and colleagues (9). The 
number of DTPA ligands, conjugated to one protein molecule was 
determined by the method described by Hnatowich et al. (9). The purified 
DTPA-conjugated protein was diluted to 2 mg/ml with 0.15 M acetate 
(pH = 6.5) and sterilized by membrane filtration. Aliquote of 0.5 ml of the 
conjugate were radiolabeled with In-111 (Indium chloride, Amersham 
International Ltd., Buckinghamshire, UK) via citrate transchelation. The 
radiochemical purity of all radiopharmaceuticals was determined by instant 
thin layer chromatography (ITLC) on Gelman ITLC-SG strips (Gelman 
Laboratories, Ann Arbor, MI) with 0.1 M citrate (pH=5) as solvent. 
Batchwise, the labeling efficiency was checked by HPLC on a 1125 size 
exclusion column (Waters-Millipore) with a 0.1 M acetate buffer (pH = 6) 
as solvent. A dose of 10 μg labeled with 2 MBq In-111 was injected i.v. 
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I-123-IgG. (IgG: Sandoglobulin, Sandoz AG, Nurenberg, FRG). IgG 
was labeled with 1-123 by means of the Iodo-gen method (Iodo-gen, 28600, 
Pierce, Rockford, II, USA) (10). Unbound iodine was removed with 
Sephadex 25. A dose of 10 /xg IgG labeled with 3 MBq 1-123 was i.v. 
injected. 
Tc-99m-IgG. Kits for labeling IgG with Tc-99m (Technescan-HIG) 
were kindly provided by Mallinckrodt Diagnostica Holland, Petten, The 
Netherlands. A kit, containing 1 mg of 2-iminothiolane-derivatized IgG 
(obtained from the Central Laboratory of the Bloodtransfiision Service of 
The Netherlands Red Cross, Amsterdam, The Netherlands) and stannous 
chloride, was radiolabeled with 500 MBq Tc-99m eluate. In vitro stability 
was tested by HPLC analysis after in vitro storage of Tc-99m-IgG at 37° С 
for 24 hours. A dose of 10 μg labeled with 4 MBq Tc-99m was injected 
i.v. 
Іп-111-HSA. (Human Albumin 20%, Central Laboratory of the 
Bloodtransfiision Service of The Netherlands Red Cross, Amsterdam, The 
Netherlands). DTPA-conjugation and In-111 labeling were accomplished 
as described above. A dose of 10 μg labeled with 2 MBq In-Ill was 
injected i.v. 
I-131-HSA. (Medgenix Diagnostics, Fleurus, Belgium). The radio­
pharmaceutical was obtained commercially. The protein bound 1-131 
activity was 96%. A dose of 40 μg labeled with 0.5 MBq 1-131 was i.v. 
administered. 
In-111-IgA. (Human IgA, 11010, Sigma Chemical Company, St. 
Louis, USA). DTPA-conjugation and In-111 labeling were accomplished 
as described above. The activity of IgA was determined before and after 
conjugation with DTPA by immuno-electrophoresis. Non-IgA bound In-111 
was removed with Sephadex PD 10. A dose of 10 μg labeled with 2 MBq 
In-111 was injected i.v. 
Animals and study design 
In young, male, randomly bred Wistar rats (weight 200-220 g), a calf 
muscle abscess was induced after ether anaesthesia with approximately 2 
χ 108 colony forming units of Staphylococcus aureus in 0.1 ml 50:50% 
suspension of autologous blood and normal saline. The animals were 
randomly divided in groups. 
Twenty four hours after the inoculation of Staphylococcus aureus in 
the muscle, when swelling of the muscle was apparent, the respective 
radiopharmaceuticals were injected in the tail vein. 
To collect tissues, rats were killed with 30 mg intraperitoneally 
injected phénobarbital, followed by cervical dislocation at two, six, 24 and 
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Figure 1. Activity uptake in abscess and muscle, expressed as % of the dose per gram 
(the errorbars indicate SEM). 
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48 hours after injection. For Tc-99m-IgG, tissues were obtained up to 24 
hours p.i. Each peptide was evaluated in six animals at each time point. 
Samples of bone marrow (taken from the right femur), blood and urine 
were collected. The infected left calf muscle, the right calf muscle, the 
liver, the spleen, the kidneys, and the right femur were collected and 
blotted dry. The activity in the tissues and samples was measured in a 
shielded well type gamma counter. The excreted activity in faeces and 
urine of each peptide at each time point between injection of the radiophar­
maceutical and killing of the animals was also measured in the well 
counter. To correct for radioactive decay and permit calculation of the 
uptake of the radiopharmaceuticals in each organ as fraction of the injected 
dose, aliquots of the respective doses were counted simultaneously. The 
measured activity in tissues and samples was expressed as percentage of 
injected dose per gram, the excreted activity per animal as percentage of 
total dose administered. 
For calculation of background activity, we used a combination of 
normal muscle activity and blood activity. Since the blood volume of rats 
approximates 60 ml per kg bodyweight (6%), 94% χ the activity per gram 
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in muscle plus 6% χ the activity per gram in blood was adopted as the 
value for background activity (11). Abscess to background ratios were 
calculated. 
Statistical Analysis 
All mean values are given ± SEM. Statistical analysis was performed 
using Tukey's analysis of variance. The level of significance was set at 
0.05. 
RESULTS 
Labeling efficiency and characterization of the proteins 
Conjugation of DTPA to proteins resulted in two to three DTPA 
ligands per protein molecule. For In-111 -IgG, labeling efficiency was 95 %. 
Results of ITLC and HPLC analysis were similar. In patients, all In-111 
activity in blood samples was still protein-bound at 48 hours p.i. No cell 
binding of In-Ill could be detected. 
For I-123-IgG, radiochemical purity was 98% after removing unbound 
iodine. 
For Tc-99m-IgG, labeling efficiency was 99%. HPLC analysis showed 
that approximately 75 % of the original Tc-99m activity was still protein-
bound after 24 hours in vitro. 
For In-111-HSA and I-131-HSA, the protein bound activity was 99% 
and 96%, respectively. 
The activity of Ig A after conjugation with DTPA was 89% of the 
original activity. Labeling efficiency of In-lll-IgA was 96% after 
purification. 
Role of the protein 
Comparison ofln-lll-IgG, In-lll-HSA and In-lll-IgA 
Figure 1 shows that all radiopharmaceuticals had a higher accumu­
lation in the infectious focus than in the contralateral normal muscle at all 
sampling times. The In-111-IgG uptake in the abscesses remained at a 
constant, high level. Although not significant, both In-lll-HSA and 
In-lll-IgA showed a tendency to decrease over time. The uptake of 
In-111-IgG and In-lll-HSA in the abscess revealed no significant 
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differences. The In-111-IgA uptake was significantly lower at all points in 
time (p<0.05). However, abscess to background ratios of all In-111 
labeled proteins, as shown in figure 2, did not differ significantly. 
Figure 2. Abscess to background ratios (the errorbars indicate SEM). 
ln-111-lgG l-123-lgG Tc-99m-lgG ln-111-HSA l-131-HSA ln-111-lgA 
After six hours, the In-111-IgG cleared significantly slower from the 
blood than In-111-HSA, ρ<0.05 (figure 3). The blood concentration of 
In-111-IgA was significantly lower than that of In-111-IgG and In-111-
HSA at each time point (p<0.05). 
The table and figure 4 show the distribution in various organs. 
In-111-IgA showed marked accumulation in kidneys, liver and spleen. The 
uptake of In-111-IgG and In-111-HSA in the liver and the spleen did not 
differ significantly. However, renal uptake of In-111-IgG was significantly 
higher compared to In-111-HSA (p<0.05). 
Excretion of In-111-IgG and In-111-HSA were also similar (figure 5). 
The excretion of In-111-IgA was slightly higher. 
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Comparison ofI-123-IgG and I-131-HSA 
At 24 and 48 hours, both I-123-IgG and I-131-HSA revealed signi­
ficant wash-out from the abscess, ρ < 0.05 (figure 1). The absolute abscess 
uptake of I-123-IgG was significantly higher than the corresponding uptake 
of I-131-HSA at 24 and 48 hours, since the wash-out of I-123-IgG was 
slower than that of I-131-HSA (p<0.05). This also applied for the absolute 
muscle uptake. For this reason, the abscess to background ratios of the two 
iodinated proteins did not differ (figure 2). 
The blood clearance and excretion rate of I-123-IgG were significantly 
slower than clearance and excretion rate of I-131-HSA, p<0.05 (figures 
3 and 5). The accumulation in organs was significantly lower for 1-131-
HSA than for I-123-IgG, p<0.05 (table and figure 4). 
Role of the radionuclide 
Comparison ofln-lll-IgG, I-123-IgG, and Tc-99m-IgG 
As shown in figure 1, the absolute abscess uptake over time showed 
different patterns for these labels: In-111-IgG was relatively high and 
constant from six hours p.i. onwards; I-123-IgG was also high at six hours 
Figure 3. Blood activity, expressed as % of the dose per gram (the errorbars indicate 
SEM). 
TIME p.i. (hours) 
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Table. Biodistribution, expressed as percentage of administered dose per gram 
(mean values + SEM). 
Organ 
Liver 
Spleen 
Kidneys 
Bone marrow 
Bone 
Time 
2 
6 
24 
48 
2 
6 
24 
48 
2 
6 
24 
48 
2 
6 
24 
48 
2 
6 
24 
48 
In-lll-IgG 
1.14±0.03 
1.32±0.07 
1.37±0.09 
1.49±0.04 
1.09±0.04 
1.43+0.10 
1.61+0.09 
1.81±0.11 
4.18+0.22 
5.45 ±0.49 
5.38±0.46 
5.36±0.61 
1.01±0.10 
1.45±0.08 
1.40+0.08 
1.40±0.08 
0.25+0.02 
0.23±0.02 
0.28±0.02 
0.34±0.05 
H23-IgG 
0.92±.011 
0.66±0.10 
0.26±0.02 
0.29±0.03 
0.90+0.10 
0.72+0.08 
0.36±0.02 
0.28±0.02 
1.47+0.14 
1.15+0.08 
0.56±0.03 
0.45 ±0.03 
1.30±0.10 
0.99±0.11 
0.40±0.03 
0.39 ±0.02 
0.27±0.02 
0.23 ±0.02 
0.11 ±0.01 
0.10±0.01 
Tc-99m-IgG 
0.88±0.03 
0.77±0.07 
0.38±0.08 
— 
0.88±0.08 
0.77±0.08 
0.40±0.02 
— 
9.41 ±0.84 
11.10±0.96 
10.15±0.81 
— 
1.27±0.28 
0.78±0.09 
0.27±0.01 
— 
0.22+0.03 
0.16±0.01 
0.08±0.00 
— 
p.i., but decreased afterwards; Tc-99m-IgG was relatively low and 
decreased between six and 24 hours p.i. The uptake of In-lll-IgG in the 
abscess was significantly higher than that of Tc-99m-IgG at 24 hours 
(p<0.05). Also at 48 hours, there was more In-lll-IgG than I-123-IgG 
activity in the abscess (p<0.05). The abscess uptake of I-123-IgG was 
initially significantly higher than that of Tc-99m-IgG (p <0.05), but did not 
differ significantly at 24 hours p.i. With regard to the abscess to back-
ground ratios (figure 2), only the higher ratio at 48 hours p.i. of In-111-
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Table, (continued) 
In-111-HSA 
1.07±0.16 
1.39±0.19 
1.29±0.19 
1.47±0.21 
1.12±0.13 
1.68±0.15 
1.90±0.31 
2.14±0.19 
1.57±0.17 
1.62±0.15 
1.74±0.18 
2.50±0.31 
1.19 ±0.07 
1.13±0.18 
1.24±0.02 
1.07±0.10 
0.28±0.04 
0.37±0.04 
0.39±0.05 
0.47±0.09 
M31-HSA 
0.54+0.04 
0.42+0.02 
0.12±0.00 
0.05+0.01 
0.58±0.05 
0.44±0.03 
0.12+0.01 
0.05 ±0.00 
0.93±0.09 
0.70±0.03 
0.21±0.01 
0.09±0.01 
0.90±0.17 
0.68±0.05 
0.20±0.05 
0.06±0.01 
0.24±0.02 
0.18±0.03 
0.10±0.01 
0.08±0.00 
In-111-IgA 
6.25±0.12 
6.94±0.34 
5.94±0.19 
4.85±0.33 
4.77±0.59 
3.70±0.36 
4.41 ±0.60 
3.15±0.48 
7.64±0.20 
7.88±0.13 
8.27±0.14 
7.81 ±0.25 
1.14±0.08 
0.99±0.06 
0.89 ±0.07 
0.79 ±0.09 
0.18±0.02 
0.14±0.01 
0.16±0.02 
0.11 ±0.01 
Time 
2 
6 
24 
48 
2 
6 
24 
48 
2 
6 
24 
48 
2 
6 
24 
48 
2 
6 
24 
48 
Organ 
Liver 
Spleen 
Kidneys 
Bone marrow 
Bone 
IgG compared to that ratio of I-123-IgG reached the level of significance 
(p<0.05). 
As shown in figure 3, significant differences could be noted in blood 
clearance: Tc-99m-IgG showed the fastest clearance (p<0.05) and 
I-123-IgG the slowest (p<0.05). 
The accumulation of the three IgG preparations in the kidneys varied 
significantly : I-123-IgG had the lowest (p<0.05) and Tc-99m-IgG the 
highest uptake (p<0.05) (table and figure 4). In liver, spleen, bone and 
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bone marrow, the In-111-IgG uptake significantly exceeded the uptake of 
I-123-IgG and Tc-99m-IgG (p<0.05). In-111-IgG showed stable or over 
time increasing activity in liver, spleen, kidneys, bone marrow and bone, 
I-123-IgG activity decreased these organs, while Tc-99m-IgG activity also 
decreased in these organs with the exception of the kidneys, whose activity 
remained relatively stable. Typically, the bone marrow uptake exceeded the 
bone uptake by a factor four to five for all preparations. 
As shown in figure 5, approximately 20% of the administered 
In-111-IgG was excreted in faeces and urine within 48 hours, excretion of 
I-123-IgG was higher (approximately 30%). After administration of 
Tc-99m-IgG, approximately 60% of the radiopharmaceutical was excreted 
within 24 hours. 
Comparison of In-Ill-HSA and I-131-HSA 
Similar differences as noted between In-111-IgG and I-123-IgG were 
found between In-111-HSA and I-131-HSA: retention in the abscess, 
constant abscess to background ratios over time, significant accumulation 
in organs, and low excretion rate of In-111-HSA versus wash-out from the 
abscess, over time decreasing abscess to background ratios, low organ 
uptake, and high excretion rate of I-131-HSA. 
DISCUSSION 
The similar abscess uptake and abscess to background ratios of 
In-111-IgG and In-111-HSA at various time points indicate that specific 
receptor binding of labeled IgG in an infectious focus, if at all present, is 
not the major factor in accumulation of labeled IgG in such a focus, since 
HSA lacks this receptor affinity. These findings are in concert with the 
autoradiographic studies by Morrei et al. and our own experience in 
neutropenic patients (7,8). 
IgA is an immunoglobulin without Fc-7 receptor affinity. On 
inflammatory cells few Fc-a receptors are present (12). However, target 
to background ratios of In-111-IgA in infections in extremities do not differ 
from those after In-111-IgG injection, thus confirming that Fc-γ receptor 
interaction is not a major factor in the accumulation of In-111-IgG in 
infectious foci. The different uptake in liver, spleen and kidney of In-111-
IgG and In-111-IgA revealed that the protein is a major factor in biodistri­
bution. Since hepatocytes of rats are equipped with IgA-receptors, the high 
liver uptake of In-111-IgA in our experiment is not surprising (13). 
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Figure 4. Biodistribution in liver, kidney and spleen. 
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The initially high and persistent organ uptake of In-111-IgA is in accor-
dance with fast clearance from the blood to the organs. Hepatic, renal and 
splenic uptake of In-111-IgA are so high, that, at least in rats, this agent 
is not suited for imaging infectious foci in these areas. The differences, 
observed between In-111-IgG and In-111-IgA confirm the results of 
Fischman et al., who noted that physical chemical differences between 
In-111 labeled Fab- and Fc-fragments of IgG might account for differences 
in abscess localization and biodistribution (14). 
More striking differences were observed with regard to the biological 
behaviour when IgG was labeled to either In-Ill, 1-123 or Tc-99m. 
In-111-IgG was retained in the abscess, while I-123-IgG and Tc-99m-IgG 
showed wash-out. The physiological uptake in organs of In-111-IgG, the 
radiopharmaceutical thus far most frequently used in patient studies, is 
relatively high for most organs, compared to I-123-IgG and - except for the 
kidney uptake - Tc-99m-IgG. 
The relatively slow blood clearance of I-123-IgG might appear 
disadvantageous in detection of infectious foci, because of persistingly high 
background activity. The most probable explanation for this persisting 
blood activity is dehalogenation of the protein in organs and subsequent 
wash-in of iodine and iodinated fragments into the circulation. A labeling 
procedure with more stable halogenation could overcome this problem and 
also the wash-out of iodinated IgG from the infectious focus over time. 
Then, the low physiological uptake in organs of I-123-IgG could be useful 
for the evaluation of infectious foci in parenchymatous organs. Clinical 
studies with In-111-IgG showed disappointing results for the detection of 
infectious foci in these organs (4,8). Additional advantages of 1-123 are the 
physical properties: a half life of thirteen hours, permitting imaging up to 
48 hours after administration, a relatively low radiation burden per unit 
activity compared to In-111, thus allowing a higher dose to administer, 
leading to high quality imaging with reasonable imaging times. A somatic 
dose equivalent of 15 mSv after injection of 75 MBq In-111-IgG necessi-
tates reluctancy in the use of this radiopharmaceutical in paediatric patients 
(15). The more favorable distribution of I-123-IgG in this animal study 
compared to In-111-IgG might bring IgG scintigraphy in scope for imaging 
of infection in children. Major drawbacks for widespread use of I-123-IgG 
are of course the limited availability and its high cost. 
Tc-99m-IgG performs well up to six hours p.i. Although the abscess 
to background ratio remained at the same high level after 24 hours p.i., a 
rapid decrease of abscess activity was apparent. This decrease - in 
combination with the physical half life of six hours - is a major impediment 
for good quality images after 24 hours. One might wonder whether or not 
this decrease makes Tc-99m-IgG scintigraphy less suited for the detection 
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of subacute and low-grade infections in humans, in whom 48 hour images 
are often necessary to achieve good sensitivity (3). The high renal uptake 
and the excretion of Tc-99m-lg,G, which was also observed by Rubin et al. 
for Tc-99m-HSA, may interfere with abdominal imaging (16). Never­
theless, first results in humans with Tc-99m-IgG, using the type of kit as 
in the present study, were encouraging (17). However, the design of the 
study of Buscombe was not ideal because of coinjection of Tc-99m-IgG and 
In-111 leukocytes, leading to possible interference of In-111 photons in the 
late Tc-99m images. Moreover, the In-111 leukocyte scintigraphy was used 
as the golden standard. In a recent comparative study between In-111-IgG 
and In-111 labeled leukocyte scintigraphy, we found that in certain types 
of infection In-111 labeled leukocyte scintigraphy was not suited as the 
golden standard (4). Recently, Abrams et al. reported a new Tc-99m 
labeling method of proteins, using nicotinyl hydrazine derivative IgG (18). 
These investigators observed equivalent biodistribution of the Tc-99m 
labeled IgG preparation and In-111-IgG. The fact that Tc-99m labeled 
nicotinyl hydrazine derivative IgG showed no wash-out from the abscess, 
is of major importance for adequate imaging of acute infection with 
Tc-99m-IgG. Further studies are needed to establish whether or not 
imaging up to 24 hours is sufficient to reveal subacute and low-grade 
infection in humans adequately. 
Both the present study and data in literature stress the relevance of the 
radiolabel on the dynamic distribution of the protein. In the present study, 
great similarity was observed between In-111-IgG and In-111-HSA. 
Although wash-out of I-123-IgG from the abscess was slower than that of 
I-131-HSA, both iodinated proteins showed similar trends with regard to 
the uptake and retention the abscess and the organs and the abscess to 
background ratios and distribution. In contrast, Calarne et al. observed 
lower abscess to background ratios for Tc-99m-HSA than for Tc-99m-IgG 
(19). However, their experimental model differed from ours with regard 
to the animal, the strain of bacteria and amount of bacteria injected. 
In conclusion, both the radionuclide and the protein are important in 
the biodistribution and kinetics of radiolabeled proteins used for detection 
of infectious foci. For the accumulation in infectious foci, the radionuclide 
appears to be the major determinant. Specific Fc-γ receptor binding is 
probably of minor, if any, importance in the uptake of radiolabeled 
proteins in infectious foci. Most probably the accumulation in these areas 
is caused by increased vascular permeability initially and retention with 
time by macromolecular entrapment. The protein defines the blood 
clearance and the distribution in organs of radiolabeled proteins, thus 
determining the amount of labeled protein that is available for delivery to 
an infectious focus. 
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Given the similarity of In-111-IgG and In-111-HSA in this animal 
model, further studies in humans with In-111-HSA would be useful. 
Despite economic and logistic disadvantages, I-123-IgG also merits further 
investigation. The present study warrants further studies to develop a 
radiolabeled protein with persistingly high abscess uptake, low background 
activity, fast blood clearance and low physiological organ uptake (20). 
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INTRODUCTION 
Infections of bone and adjacent tissues often present a diagnostic and 
therapeutic problem, making the management of the disease difficult. The 
available scintigraphic imaging techniques show limitations in diagnosing 
these infections. This applies especially to patients who have undergone 
multiple revision operations for chronic osteomyelitis. Technetium-99m 
methylene diphosphonate (Tc-99m-MDP) bone imaging is nonspecific and 
not suitable to demonstrate the extent of the lesion accurately (1,2,3). 
Gallium-67 (Ga-67) may accumulate in areas of increased bone turn-over 
and shows modest accumulation compared to indium-Ill (In-111) labeled 
nonspecific polyclonal human immunoglobulin G (In-111-IgG) (2,4,5). 
Some authors reported a low sensitivity of In-111 labeled white blood cells 
(WBC) scintigraphy to detect low-grade infection (2,6). The utility of Tc-
99m-WBC to detect chronic osteomyelitis has not been established. Above 
this, time-consuming techniques are required for every WBC labeling 
method (7,8). Labeling of leucocytes in full blood with Tc-99m colloid has 
not been sufficiently validated yet (9,10,11). 
Recently, several reports have appeared suggesting the potential utility 
of In-111-IgG as an imaging agent for detecting focal inflammation. These 
studies, both in animals and humans have been primarily concerned with 
soft-tissue, intraabdominal and vascular infection (4,12,13,14). Because of 
the need for better techniques for imaging bone and joint infection, we 
initiated a study to evaluate the safety and accuracy of IgG scintigraphy in 
patients with infections of bone and adjacent tissue. 
PATIENTS AND METHODS 
Radiopharmaceuticals and imaging procedures 
In all patients, routine three-phase skeletal scintigraphy was performed 
after i.v. injection of 600 MBq Tc-99m-MDP. 
Diethylenetriaminepentaacetic bicyclic anhydride (bicyclic DTPA) was 
conjugated to human, nonspecific, polyclonal IgG (Sandoglobulin, Sandoz 
AG, Nurenberg, FRG) according to Hnatowich and colleagues (15). The 
purified DTPA-conjugated IgG was diluted to 5 mg/ml with 0.15 M acetate 
(pH = 6.5) and sterilized by membrane filtration. Aliquote of 0.5 ml of the 
conjugate were radiolabeled with In-111 (Indium chloride, Amersham 
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International Ltd., Buckinghamshire, UK) via citrate transchelation. The 
radiochemical purity was determined by 1TLC-SG chromatography (Gelman 
Laboratories, Ann Arbor, MI) with 0.1 M citrate (pH=5) as the solvent. 
The labeling efficiency was always higher than 97 %. A dose of 
approximately 1 mg of IgG labeled with 75 MBq In-111 was injected 
intravenously either between two and seven days after the Tc-99m-MDP 
skeletal scintigraphy had been completed, or after the second phase images 
of Tc-99m-MDP scintigraphy were obtained. The latter procedure was 
followed when operation was scheduled within 72 hours after the patient 
had been referred to the nuclear medicine department. Scintigraphic images 
were obtained with a Siemens Orbiter gamma camera connected to a 
Scintiview image processor (Siemens Inc., Des Plaines, II, USA). All 
images were collected in digital format in a 256 χ 256 matrix. Bone images 
were always obtained with a low-energy parallel-hole collimator (140 keV 
photopeak, 15% symmetric window). However, when In-111-IgG was 
injected after the second phase of the skeletal scintigraphy, the delayed bone 
images were obtained with a medium-energy parallel-hole collimator (140 
keV photopeak, 15% symmetric window). In-111-IgG images were acquired 
at 4, 18-24 and 42-48 hours postinjection for a preset time of 5, 7.5, and 
10 minutes, respectively. Approximately 1000-1500 kcounts for the trunk 
region, 600-750 kcounts for the pelvic region and 80-120 kcounts for the 
lower limb were collected. A medium-energy parallel-hole collimator (173 
keV peak, 15% symmetric window; 247 keV peak, 15% symmetric 
window) was used. When injected after the second phase of the bone scan, 
the 173 keV In-111 peak was not used for imaging In-111-IgG 4 and 18-24 
hours postinjection. 
All images were interpreted by three observers. The observers were 
not blinded for clinical information or radiographic images, when available. 
A definite judgement of the scintigraphic images was reached before any 
of the verification procedures were performed. The In-111-IgG images were 
interpreted with the corresponding bone scintigraphy. An In-111-IgG scan 
was interpreted as positive, if focal increasing accumulation could be noted 
over time. Nonvisualization of the lesion detected by bone scan and/or plain 
radiograph, or failure to show increasing accumulation was considered to 
be a negative In-111-IgG scintigraphy. 
Patients 
Patients suspected of acute (evidence of infection since one or several 
days) or chronic (evidence of infection for weeks, months or even years) 
osteomyelitis or infectious arthritis in whom a Tc-99m-MDP bone scan was 
indicated and in whom proof of the infection was likely to be obtained, 
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were eligible for the study. In 22 out of 25 patients suspected of infection, 
cultures from the focus were obtained within two days after completion of 
the imaging procedures, either during operation or by needle aspiration. 
Furthermore, a small number of patients with noninfectious bone disease 
were studied to get an impression of the specificity of In-Ill-IgG 
scintigraphy. One patient with clinically-cured sternal osteomyelitis was 
studied. If the attending physician agreed to perform an In-111-IgG 
scintigraphy, patients were informed about the experimental nature of the 
imaging procedure. Pregnant and lactating females were excluded from the 
study. No patient had a history suggestive of IgA- or IgG-deficiency or 
adverse reaction to previous IgG administration. Consent was obtained. The 
study was approved by the local ethical committee. 
Other procedures 
Blood samples were taken from all patients immediately before and if 
possible 2-3 weeks after the In-111-IgG injection for extensive hematologi-
cal (full blood cell count and WBC differentiation) and biochemical 
(minerals, liver- and kidney function, glucose, cholesterol, protein 
spectrum) assessment. Also qualitative urinalysis was performed. Vital signs 
were monitored up to 45 minutes after injection. 
In five patients, suspected of infectious bone disease, the relative 
uptake of In-111-IgG in the focus compared to the uptake in the 
contralateral limb was estimated after drawing variable size regions of 
interest (ROI) on the 42-48 hours images. Similar regions were then drawn 
over the corresponding areas on the 4 and 18-24 hours images. Before 
calculating the ratios on the consecutive images, the regions were 
normalized for slight differences in size of the two regions. 
The same procedure was followed for calculating the ratios in five 
patients suffering from noninfectious bone disease. In case of non-
visualization of a lesion by In-111-IgG, the placement of the region was 
guided by the area of increased uptake on the skeletal scintigraphy. 
In three patients, a series of blood samples was taken after In-111-IgG 
injection in order to estimate the blood clearance of In-111-IgG. 
RESULTS 
Thirty two patients (16 males, 16 females; mean age 52.7 years, range 
23 - 87 years) were investigated. Twenty five patients were suspected of 
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Table 1. Clinical characteristics, results of the In-111-IgG scintigraphy, verification procedures 
and cultures of the patients suspected of chronic osteomyelitis. 
Patient 
(sex.age) History 
IgG- Verification 
imaging procedure Culture* 
1 (F,38) Low-grade infection after osteosynthesis for femoral 
fracture 
2 (M,30) Low-grade infection after complicated tibial fracture 
3 (M,81) Painful loosening total hip prosthesis 
4 (F,23) Complicated crural fracture at the age of 6; infec-
tion since elongation procedure lower limb 1 yr 
prior to scintigraphy 
5 (M,29) Osteotomy femur, painful hip 
6 (F,27) Low-grade infection after osteosynthesis for tibia 
plateau fracture 
7 (M,61) Recurrent low-grade osteomyelitis distal femur 
8 (M,79) Painful loosening total knee prosthesis 
9 (M,63) Painful loosening total hip prosthesis, fistula 
10 (F,63) Painful loosening total knee prosthesis 
11 (M,S8) Chronic osteomyelitis after osteosynthesis for 
traumatic pelvic fracture 
12 (M,40) Chronic osteomyelitis upper arm with fistula after 
chemotherapy for testiscarcinoma 
13 (F,28) Postoperative chronic osteomyelitis ankle 
14 (F,85) Postoperative chronic osteomyelitis knee 
15 (F,75) Chronic osteomyelitis humerus 
16 (M,39) Posttraumatic low-grade tibial infection 
17 (F,38) Postoperative recurrent, low-grade infection hip 
18 (M,32) Chronic osteomyelitis after complicated femoral 
fracture 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
operation 
fístula 
fistula 
fístula 
SA,B,P, 
PA.HS 
Ρ,ΡΑ,Ε 
SA.SE.PA 
SA,D,HS 
SA 
SA.SE 
SA 
Ρ 
SA 
D 
SA 
SA 
SA,A 
SA 
SA 
not done 
not done 
not done 
The patients are categorized on the basis of the clinical data available to the observers at the time 
of imaging. The patients were not using antibiotics unless stated. 
A = Alcalignes species, В = Bacteroides species, D = Diphteroid rods, E = Enterococcus, 
HS = Hemolytic streptococcus, M = Mycobacterium tuberculosis, Ρ = Peptostreptococcus, 
PA = Pseudomonas aeruginosa, SA = Staphylococcus aureus, SE = Staphylococcus 
epidermidis. 
bone and joint infections in 29 lesions. Seven patients were suffering from 
noninfectious bone and adjacent tissue disease. 
The clinical characteristics of the investigated patients, the results of 
the In-111-IgG scintigraphy, the verification procedure and the results of 
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the microorganism cultures are summarized in tables 1-4. The patients are 
categorized on the basis of the clinical data available to the observers at the 
time of imaging. Sinus tract cultures are not included in table 1 because 
they may not reflect the causative microorganism involved (16). 
Clinical or biochemical side effects of the In-111-IgG administration 
were not encountered. 
In all 32 patients, the Tc-99m-MDP skeletal scintigraphy was positive, 
indicating the site of the skeletal lesions. On the basis of the clinical 
features, the three-phase bone scan and the plain radiographs, it was 
possible to make the diagnosis of acute osteomyelitis or infectious arthritis 
with sufficient confidence. However, in case of chronic osteomyelitis, bone 
scan and radiographs could not identify the presence, the degree and the 
extent of infection. 
In-111-IgG identified the 29 sites of inflammation in all 25 patients, 
suspected of having an infection. Moreover, with In-111-IgG scintigraphy 
we were able to discriminate between osseous and joint infection. The 
involvement of the adjacent soft-tissues could be delineated accurately with 
help of the Tc-99m-MDP images. The figures 1, 2, 3, and 4 show the 
images obtained with Tc-99m-MDP and In-111-IgG in four patients. In 
Table 2. Clinical characteristics, results of the In-111-IgG scintigraphy, verification procedures 
and cultures of the patients suspected of acute osteomyelitis / spondylodiscitis. 
Patient 
(sex.age) History 
IgG- Verification 
imaging procedure Culture' 
19 (M,58) 
20 (M,43) 
21 (F,66) 
22 (F,79) 
Recurrent staphylococcal bacteraemia, spondylodis-
citis thoracic spine. For 1 week flucloxacillin 3 g 
and gentamycin 160 mg daily 
Possible osteomyelitis after biopsy ilium for 
chondrosarcoma 
Acute spondylodiscitis thoracic spine, painful hip 
Acute spondylodiscitis lumbar spine, painful knee 
and shoulder. For 1 mo: isoniazide 2S0 mg, 
rifampicin 400 mg and pyrazinamide 1500 mg daily 
+ 
+ 
autopsy' SA 
operation negative 
open biopsy HS 
needle M 
aspiration 
The patients are categorized on the basis of the clinical data available to the observers at the time 
of imaging. The patients were not using antibiotics unless stated. 
See table 1 for definitions. 
* Patient 19 died of cardiorespiratory failure due to a pre-existing heart condition. 
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Figure 1. Patient 4 (23 years old fe­
male). Complicated, left 
crural fracture at age of 6, elongation 
procedure lower leg at age of 19 (fi­
bular transplant), noncomplicated re-
fracture at age of 21, osteomyelitis 
since osteosynthesis. Surgery con­
firmed chronic osteomyelitis. Cultures 
showed growth of Staphylococcus 
aureus and epidermidis and /î-hemo-
lytic Streptococcus. Tc-99m-MDP 3 
hours postinjection (A) and In-111-
IgG 4 (B), 24 (C), 48 (D) hours post-
injection and plain radiograph (E). 
The arrows indicate corresponding 
areas. 
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Figure 2. Patient 5 (29 years old 
male). Femoral fracture at 
age of 15, elongation osteotomy at age 
of 23, infection at age of 25, and re­
cently progressively painful hip. At 
operation, a soft-tissue infection and 
a chronic osteomyelitis of the right 
femur were found. Cultures showed 
growth of Staphylococcus aureus. Tc-
99m-MDP 3 hours postinjection (A) 
and In-111-IgG 4 (B), 24 (C), 48 (D) 
hours postinjection and plain radio­
graph (E). The arrows indicate cor­
responding areas. 
figure 1 and 2, plain radiographs are also presented. In case of inflam-
mation, in the first 48 hours a relative increase of In-111-IgG activity was 
noted at the affected site compared to the same region in the contralateral 
limb. Figure 5 shows the increasing ratio of activity over time in five 
individual patients with infection. 
In 22 out of 25 patients suspected of infection, cultures from the focus 
were obtained two days after completion of the imaging procedures. In 20 
out of these 22 patients (nos. 1-15, 19, 21-24), a positive culture was 
obtained, proving the infectious etiology of their disease (15 patients with 
chronic osteomyelitis, two with acute spondylodiscitis and arthritis, one with 
acute spondylodiscitis, two with acute arthritis). 
In two patients (nos. 20 and 25) with positive In-111-IgG scans, the 
cultures were negative. Patient 20 showed clinical evidence of infection 
after a biopsy, taken from the right ilium because of a chondrosarcoma. The 
In-111-IgG scintigraphy showed increased activity near the site of the 
biopsy. At surgery, a large hematoma was found near the biopsy site. 
Cultures taken at surgery remained sterile. The location of the hematoma 
matched with the site of the In-111-IgG accumulation. In patient 25 with 
In-111-IgG accumulation in the left knee, joint fluid cultures remained 
sterile. The Gram-stain however showed marked leukocytosis. The patient 
was diagnosed as having a sterile synovitis of the left knee and recovered 
without further therapy. 
At surgery, it appeared that In-111-IgG correctly identified the 
presence and localization of the site of inflammation. The impression at 
operation was, that bone, articular and soft-tissue involvement was predicted 
correctly by the In-111-IgG scintigraphy. 
In three out of 25 patients, clinically suspected of having chronic 
infectious bone disease (nos. 16, 17, and 18), no cultures were obtained. 
These patients had a recent history of recurrent fistulae, thus proving the 
infectious etiology of the bone disease. In all three patients, In-111-IgG 
correctly localized the lesion and demonstrated the soft-tissue involvement 
in the region of the fistula. 
In addition to the 25 cases stated above, we also studied seven patients 
not suffering from bone and joint infection. Figure 6 shows the ratio 
between the In-111-IgG uptake in the lesion and the corresponding area in 
the contralateral limb in five of these patients without evidence of infection. 
Patients 26 and 27 with recent tibial fractures (ten days and three weeks old, 
respectively) showed both positive skeletal and In-111-IgG scintigraphies. 
Patients 28 and 29 with both approximately six months old fractures had 
a positive Tc-99m-MDP bone scan. In these 2 patients, the In-111-IgG did 
not show the lesion, resulting in a ratio of approximately 1. Patient 30 
showed evidence of a well-perfused soft-tissue tumor without osseous invol-
si 
Table 3. Clinical characteristics, results of the In-111-IgG scintigraphy, verification procedures 
and cultures of the patients suspected of infectious arthritis. 
Patient 
(sex.age) History 
IgG- Verification 
imaging procedure Culture* 
+ 
+ 
open biopsy HS 
needle M 
aspiration 
operation SA 
21 (F,66)' Acute spondylodiscitis thoracic spine, painful hip 
22 (F,79)' Acute spondylodiscitis lumbar spine, painful knee 
and shoulder. For 1 mo: isoniazide 250 mg, 
rifampicin 400 mg and pyrazinamide 1500 mg daily 
23 (M,60) Staphylococcal bacteraemia, painful shoulder and 
upper part of leg. For 2 wk flucloxacillin 12 g i.v. 
daily 
24 (F,27) Progressively painful shoulder 
25 (F,87) Painful knee, possible arthritis 
The patients are categorized on the basis of the clinical data available to the observers at the time 
of imaging. The patients were not using antibiotics unless stated. 
See table 1 for definitions. 
* Patients 21 and 22 were also listed in table 2. 
Table 4. Clinical characteristics, results of the In-lll-IgG scintigraphy, verification procedures 
and cultures of the patients suspected of noninfectious bone disease. 
+ 
+ 
operation 
needle 
aspiration 
SA 
negative 
Patient 
(sex, age) History 
IgG- Verification 
imaging procedure Culture 
26 (M,62) Silent rheumatoid arthritis, sudden onset pain tibia 
three weeks ago, stressfracture 
27 (M,23) Recent (10 days) traumatic noncomplicated tibial 
fracture 
28 (F,57) Approximately 6 months old fracture pubic bone 
29 (F,84) Approximately 6 months old fracture around 
femoral component total hip prosthesis 
30 (M,36) Soft-tissue tumor upper leg (haemangioma) 
31 (F,51) Postmediastinoscopy sternal osteomyelitis, clinically 
cured for 3 mo 
32 (F,64) Total hip prosthesis both hips, pain right hip region 
since 6 mo, loosening, no evidence of infection 
+ 
+ 
— 
— 
— 
— 
open biopsy negative 
no surgery 
no surgery 
no surgery 
operation negative 
no surgery 
operation negative 
The patients are categorized on the basis of the clinical data available to the observers at the time 
of imaging. The patients were not using antibiotics unless stated. 
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Figure 3. Patient 6 (27 years old female). Low-grade osteomyelitis after osteosynthesis 
for left tibial plateau fracture at age of 25. At surgery, the diagnosis chronic 
osteomyelitis was confirmed. Cultures showed growth of Staphylococcus aureus and epi-
dermidis. Tc-99m-MDP 3 hours postinjection (A) and In-111-IgG 4 (B), 24 (C) and 48 
(D) hours postinjection. The arrows indicate corresponding areas. 
vement just above the knee. Initially the tumor was well visualized by In-
111-IgG, but over time no increasing In-111-IgG accumulation in the tumor 
could be noted. Histologic examination showed a haemangioma. 
Patient 31 with clinically-cured sternal osteomyelitis, still showed a hot 
spot in the sternum at scintigraphy with Tc-99m-MDP. In-111-IgG scinti-
graphy did not reveal the lesion. 
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Figure 4. Patient 22 (79 years old female). Progressive pain lumbar spine, right shoul-
der, and right knee for two months. Cultures taken by needle aspiration 
showed growth of Mycobacterium tuberculosis. Knee region: Tc-99m-MDP 3 hours 
postinjection (A) and In-111-IgG 4 (B), 24 (C) and 48 (D) hours postinjection. The 
arrows indicate corresponding areas. 
Figure 7 shows the scintigraphic images of patient 32. This patient 
showed evidence of loosening of the right total hip prosthesis. There was 
no evidence of septic loosening. The bone scintigram shows increased 
uptake in the right acetabular region. The In-111-IgG around the prosthesis 
was normal. Cultures taken at surgery showed no bacterial growth. 
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A relatively high intravascular activity of In-111-IgG can be noted up 
to 48 hours. Figure 8 demonstrates the blood clearance in three patients. 
The slow clearance of In-111-IgG resulted in a relatively high background 
activity at scintigraphy. 
DISCUSSION 
Our results indicate that In-111-IgG is able to identify the location and 
the extent of infectious bone and joint disease. This is especially valuable 
in low-grade, chronic osteomyelitis. 
Although Tc-99m-MDP skeletal scintigraphy is indispensable for rapid 
localization of the site of the lesion and visualization of the osseous 
structures, little information can be obtained about soft-tissue involvement 
and the actual extent and nature of the lesion, since it lacks specificity to 
discriminate between reactive increased bone turn-over (i.e. bone 
remodelling) and actual inflammation (1,3,17,18). 
In the literature, no definitive view has been reached on the value of 
Ga-67 scintigraphy and In-111-WBC imaging in patients with bone 
infections. Some authors reported about the usefulness of Ga-67 
scintigraphy in chronic infectious bone disease (1,19). Others found a higher 
sensitivity of In-111-WBC scintigraphy compared to Ga-67 imaging 
(2,17,20). It has been noted that Ga-67 may accumulate in areas of 
increased bone turn-over, decreasing the specificity for infection (2,21,22). 
In rats with artificial muscle infection, the degree of Ga-67 accumulation 
appeared to be modest compared to that of In-111-IgG (4,5). In our limited 
experience, In-111-IgG did not accumulate locally in the remodelling phase 
of six months old fractures and in an aseptic loosening of a total hip 
prosthesis. 
While In-111-WBC scintigraphy has proven to have a high diagnostic 
accuracy in acute infections, there is no consensus on the sensitivity of In-
111-WBC imaging in patients, suffering from chronic osteomyelitis (2,3,6, 
19,20,23,24,25). In our study, In-111-IgG identified all patients suffering 
from chronic osteomyelitis. 
A major advantage of In-111-IgG is the relatively easy and quick 
preparation of the radiopharmaceutical, when compared to In-111 or Tc-
99m-HMPAO-WBC. When using WBC, 40 to 50 ml of blood has to be 
drawn carefully in order to obtain sufficient undamaged leukocytes. Time-
consuming, complex and costly isolation- and labeling techniques are requi-
red (7,8). Whereas the preparation of In-111-WBC in our department requi-
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Figure 5. The ratio between the In-lll-IgG uptake in the infection focus and in the 
corresponding area in the contralateral limb in five patients. 
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Figure 6. The ratio between the In-111-IgG uptake in the lesion and the corresponding 
area in the contralateral limb in five patients, suffenng from noninfectious 
bone disease. 
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Figure 7. Normal In-111-IgG scintigraphy. Patient 32 (64 years old female). Total hip 
prosthesis both hips. Pain right hip region for 6 months. At surgery, loose-
ning of the acetabular component of the right total hip prosthesis was found. Bacterial 
cultures remained sterile. Tc-99m-MDP 3 hours postinjection (A) and In-111-IgG 4 (B), 
24 (C) and 48 (D) hours postinjection. The arrows indicate corresponding areas. 
res at least 2.5 hours, labeling of the IgG-DTPA conjugate with In-Ill 
takes only 10 minutes. In addition, a constant quality of In-111-IgG is 
guaranteed. Whereas many smaller nuclear medicine departments have 
problems with the proper labeling of leukocytes with In-Ill, every 
department should be able to prepare In-111-IgG when the IgG-DTPA 
conjugate is available on the shelf. In view of the recent discussion between 
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Figure 8. The blood clearance of In-111-IgG in three patients. The activity in the blood 
sample taken after 2 minutes is denominated as 100%. 
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Mock et al. and Hanna et al., the utility of labeling WBC with Tc-99m 
colloid in filli blood remains to be established (9,10,11). 
Since oxine is a cytotoxic agent and In-111 may cause radiation 
damage to long-living T-lymphocytes, the In-111-oxine dose in labeling 
WBC is limited (26). As a consequence, relatively long imaging times are 
necessary to obtain adequate images. In dogs, In-111-WBC and Tc-99m-
HMPAO-WBC identified recent, artificially inflicted osteomyelitis in the 
appendicular skeleton equally well. Whether infection in the axial skeleton 
can be adequately detected remains to be established (27). Furthermore, it 
needs to be clarified whether a time span of 24 hours is sufficient to detect 
low-grade osteomyelitis with Tc-99m labeled WBC scintigraphy. 
One advantage of In-111-WBC over In-111-IgG is the relatively fast 
blood clearance of In-111-WBC, resulting in a low background activity. 
This leads to a relatively good target to background ratio when In-111-WBC 
accumulation is present. However, the relatively high background activity 
of In-111-IgG, even after 24 and 48 hours, does not significantly interfere 
with image interpretation. In the majority of patients, the best quality 
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images were obtained 48 hours postinjection. However, the focus of 
infection could very well be delineated after 24 hours. The images obtained 
48 hours postinjection, were necessary in some cases to establish the 
diagnosis of low-grade osteomyelitis and helped to discriminate between 
hypervascular status and accumulation of In-111-IgG. This differentiation 
is not relevant in most patients. Imaging up to 24 hours postinjection is in 
most cases sufficient. Thus, with regard to the half life of the radionuclide, 
IgG imaging with Tc-99m would be possible. 
We are currently comparing the utility of In-111-WBC and In-111-IgG. 
Results in the first sixteen patients, who were investigated with both 
techniques, suggest that In-111-IgG is at least as potent as In-111-WBC in 
revealing an inflammatory lesion. However, compared to In-111-WBC a 
higher degree of uptake in a lesion can be noted when using In-111-IgG. 
Since many patients in the study also received an injection of Tc-99m-
MDP shortly before the In-111-IgG administration, high standard dosimetry 
was not possible. Preliminary data suggest that the radiation burden to any 
organ after the administration of 75 MBq In-111-IgG is far less than 50 
mGy (5 rad). This is in agreement with other reports (13). Further studies 
are in progress. Intravenous IgG preparations in gram doses have been a 
safe therapeutic agent for years. The injection of 1 mg of radiolabeled IgG 
did not produce any clinical or biochemical side effects. For these reasons, 
In-111-IgG can be regarded as a safe radiopharmaceutical (13,28). 
The mechanism of IgG uptake at the inflammation site has not been 
fully elucidated yet. On the basis of experiments, using Fab, F(ab)2 and Fc 
fragments of the complete IgG molecule, it has been suggested that the Fc-
portion of IgG is responsible for the concentration at the inflammation site 
(4,12). Recently, enhanced vascular permeability followed by 
macromolecular entrapment in the connective tissues was reported as a 
possible explanation for IgG accumulation (29). 
With In-111-IgG no definite discrimination is possible between 
infectious and sterile inflammation. In our study, this is demonstrated by 
the positive In-111-IgG scintigraphy in patients with a hematoma, sterile 
arthritis and recent fractures. This also applies to In-111-WBC scintigraphy 
(3,24,30,31,32). In case of chronic osteomyelitis, this is of minor import-
ance, since a sterile inflammatory process seems unlikely in an area with 
recurrent infections. Of major importance is differentiation between 
increased bone turn-over (due to repair process) and persisting infection. 
Only 3 out of 32 patients were using antibiotics at the time of imaging. 
Therefore, no conclusions can be drawn regarding the effect of antibiotics 
on the outcome of In-111-IgG scintigraphy. Data in the literature suggest 
little influence of an antibiotic regimen on the outcome of IgG scintigraphy 
(4). 
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Fischman et al. reported the usefulness of serial In-111-IgG 
scintigraphy in for example inflammatory bowel disease to assess the cure 
of the infection (4,13). Whether this holds true for the assessment of cure 
of infections of bone and joint will be the object of further studies. In our 
study, a patient with cured sternal osteomyelitis showed a negative In-111-
IgG scintigraphy. Also the specificity of In-111-IgG imaging in skeletal 
infections has to be determined. 
We conclude that with In-111-IgG a safe, easily prepared 
radiopharmaceutical has become available. We have obtained promising 
results with regard to the capability of In-111-IgG scintigraphy to localize 
infectious bone and joint disease. This property is especially valuable for 
the investigation of low-grade, chronic osteomyelitis. 
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INTRODUCTION 
Accurate noninvasive diagnosis of infection in bones, joints and joint 
prostheses remains a vexing clinical problem. All widely used radiographic 
and scintigraphic techniques have limitations. Radiography has poor results 
in assessment of disease activity in osteomyelitis (1). Technetium-99m 
methylene diphosphonate (Tc-99m-MDP) studies show excellent results in 
ruling out infection, but specificity is low (2,3). Reports on the use of 
gallium-67 (Ga-67) scintigraphy are variable, but it appears that it is less 
well suited for imaging infection, because of its accumulation in areas of 
bone remodelling and physiological excretion in the intestines (4). In 
chronic low-grade infections, decreased sensitivity of labeled white blood 
cell (WBC) scintigraphy has been reported (5). Initial results of a study on 
the usefulness of scintigraphy performed after administration of indium-111 
labeled human nonspecific polyclonal immunoglobulin G (In-111-IgG) 
indicated the possibilities of a new, convenient technique for imaging 
infection (6). In our study, we assessed the results of In-111-IgG 
scintigraphy in patients with infections of bones, joints, joint prostheses and 
soft-tissues of the locomotor system. 
MATERIALS AND METHODS 
Radiopharmaceutical doses 
Human nonspecific polyclonal immunoglobulin G, sterile and 
pyrogen-free monomeric IgG (Sandoglobulin, Sandoz AG, Nurenberg, 
FRG), was conjugated to diethylenetriaminepentaacetic bicyclic anhydride 
(bicyclic DTPA) according to the method described by Hnatowich et al. and 
labeled with In-Ill (Indium chloride, Amersham International Ltd., 
Buckinghamshire, UK) (7). The labeling efficiency was always higher than 
95 %. A dose of approximately 1 mg of IgG labeled with 75 MBq In-111 
was administered intravenously by means of bolus injection. 
For therapeutic purposes, nonlabeled IgG has been used in gram doses 
for more than twenty years with an excellent safety record. In more than 
800 patient studies, both in our department and in the Massachusetts 
General Hospital in Boston, no adverse reactions after injection of 1 mg IgG 
radiolabeled with 75 MBq In-111 were observed (6, W.J.G.O.-unpublished 
data). 
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Imaging procedures 
One hundred and twenty foci of suspected infection were studied in 
113 patients, who also underwent a standard three-phase scintigraphy, 
performed after injection of Tc-99m-MDP. In-111-IgG was injected either 
between two and seven days after the Tc-99m-MDP skeletal scintigraphy 
had been completed, or after the second phase Tc-99m-MDP scintigrams 
were obtained. Scintigrams were obtained with an Orbiter gamma camera 
connected to a Scintiview image processor (Siemens Gammasonics Inc., 
Hoffman Estate, II, USA). 
At 4, 18-24 and 42-48 hours after injection of In-111-IgG, gamma 
camera images were obtained for a preset time of 5, 7.5, and 10 minutes, 
respectively, with a medium-energy collimator. In most cases, the gamma 
camera was set for both the 173 and the 247 keV photopeak with symmetric 
15% windows. Typical count rates in the trunk region ranged from one to 
1.5 miHion counts, in the pelvic region from 600,000 to 750,000 counts and 
in the lower limb from 80,000 to 150,000 counts. 
When In-111-IgG was injected shortly after the second phase of the 
bone scan, only the 247 keV peak was used to acquire In-111-IgG images 
4 and 18-24 hours after injection to avoid scatter of Tc-99m-MDP on the 
gamma camera images obtained with In-111-IgG. No significant scatter of 
In-Ill was observed in the Tc-99m-MDP scintigrams. 
Image interpretation 
All images were interpreted by three observers (W.J.G.O., 
R.A.M.J.C., F.H.M.C), blinded to the results of the verification 
procedures. The images obtained with In-111-IgG were interpreted with the 
corresponding bone scintigram. The Tc-99m-MDP scintigrams were used 
to localize osseous structures and/orjoint prostheses. However, the presence 
or absence of infection was estimated with In-111-IgG scintigraphy only. 
A scan obtained with In-111-IgG was considered positive, if focal increasing 
accumulation was noted over time. Nonvisualization of a suspected lesion 
or failure to show increasing accumulation on the scan was considered a 
negative finding. 
Patient categories and verification procedures 
The patients were categorized on the basis of the nature of the 
suspected infectious focus: chronic osteomyelitis, infection of total hip 
prosthesis, infection of total knee prosthesis, acute osteomyelitis or 
spondylodiscitis, arthritis, and soft-tissue infection. For example, if a patient 
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had chronic osteomyelitis with soft-tissue extension, this patient's case was 
categorized as chronic osteomyelitis. Whenever evidence of infection 
persisted for less than two weeks, we regarded an infection as being acute. 
Whenever clinical signs, radiographic and laboratory findings suggested 
persistence of infection for many weeks, months or even years, the 
infection was regarded as chronic. Several patients had more than one joint 
prosthesis. Only the results of the In-111-IgG scintigraphy of prostheses, 
suspected of being infected, are included in the table. 
In 51 patients (45%), the results of scintigraphy were verified by 
intraoperative cultures and in 21 patients (19%) by needle aspiration with 
subsequent Gram stains and cultures. In 26 patients (23%), the majority of 
whom had negative findings on the scintigrams obtained with In-111-IgG, 
verification was obtained with serial radiographic evaluation and long-term 
clinical follow-up of at least 6 months. In 15 patients (13%), a productive 
fistula was considered evidence of chronic osteomyelitis. 
Initial results of scintigraphy performed after administration of 
In-111-IgG in 32 patients which were reported previously are included in 
this study (8). 
RESULTS 
All patients had increased uptake of Tc-99m-MDP on the bone 
scintigrams. All infections of joint prostheses were chronic. Non-
symptomatic prostheses with a normal appearance on radiographs never 
showed increased uptake of In-111-IgG. 
The table shows the overall results of In-111-IgG scintigraphy in the 
various categories, based on the results of the verification procedures. Two 
uninfected total hip prostheses showing normal distribution of In-111-IgG 
were uncemented, all other prostheses were cemented. 
Most culture-proven infectious lesions were caused by Staphylococcus 
species (n = 30, 60%), Streptococci (n = 8, 16%), Pseudomonas aeruginosa 
(n=5, 10%), and Mycobacterium tuberculosis (n=3, 6%). In four of the 
culture-proven infectious lesions (8%), other causative microorganisms or 
a mixed flora were cultured. 
Seven studies showed accumulation of In-111-IgG in lesions that 
proved to be noninfected (table, "FP" column). In two of these patients, 
In-111-IgG had accumulated near the neck of femoral component of a 
cemented total hip prosthesis: in one patient, noninfected, necrotic, fibrinoid 
tissue was removed at surgery; in the other patient, active periarticular ossi-
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Table. Overall results of In-111-IgG scintigraphy in bone, joint, and soft-tissue 
infection. 
Findings 
Condition 
Chronic osteomyelitis 
Infection of total hip prosthesis 
Infection of total knee prosthesis 
Acute osteomyelitis or spondylodiscitis 
Infectious arthritis 
Soft-tissue infection 
Total 
η 
52 
31 
6 
8 
15 
8 
120 
TP 
37 
7 
4 
4 
11 
7 
70 
TN 
14 
21 
1 
3 
2 
0 
41 
η = number of lesions; TP = true-positive for infection; TN = true-negative for 
infection; FP = false-positive for infection; FN = false-negative for infection 
fications accounted for the false-positive findings at scintigraphy with 
In-111-IgG. A hemorrhage in the total knee prosthesis of a patient with 
hemophilia and a hematoma after biopsy for chondrosarcoma in another 
patient caused uptake of In-111-IgG. In two patients with suspected 
infectious arthritis of the knee, findings on scintigrams with In-111-IgG 
were positive, while an infectious origin could not be proved: one patient 
had severe, rapidly progressive degenerative osteoarthritis, and the other 
patient sterile synovitis. The seventh patient with false-positive scintigrams 
obtained with In-111-IgG showed increased uptake at the ventral side of a 
total knee prosthesis. At surgery, a prepatellar bursitis was found. The 
bursa was removed. Subsequent cultures remained negative. The prosthesis 
itself appeared normal on the scintigrams. This study was considered false-
positive for soft-tissue infection. 
Only two culture-proven infections were missed: one case of low-grade 
hematogenous osteomyelitis in the intertrochanteric region and one infected 
cemented total hip prosthesis (table, "FN" column). In both patients, the 
intraoperative cultures revealed growth of Staphylococcus aureus in low 
counts. 
In this group of 120 suspected infectious foci with a prevalence of 
infection of 59 %, the sensitivity for the detection of infection was 97 %, and 
the specificity for infection 85%, with a positive predictive value of 88% 
67 
Figure 1. Right total hip prosthesis, infected with Staphylococcus aureus in a man aged 
81 years. (A) Scintigram obtained with In-111-IgG (posterior view, obtained 
48 hours postinjection, with a preset time of 10 minutes; 600,000 counts acquired) shows 
increased uptake of In-111-IgG around the prosthesis with soft-tissue extension (arrow). 
(B) Plain radiograph shows nonspecific osteolysis of a bone graft at the lateral margin 
of acetabular component, but no evidence of infection, such as femoral osteolysis. 
and a negative predictive value of 95%. 
The figures 1, 2 and 3 are typical examples of scintigrams obtained 
with In-111-IgG. Figure 1 shows the scintigram and radiograph from a 
patient with an infected total hip prosthesis with extension of the infection 
in the soft-tissue near the neck of the femoral component of the prosthesis. 
Figure 2 shows a scintigram and radiograph of a patient with chronic osteo-
myelitis of the femur. Figure 3 shows the scintigrams of a large soft-tissue 
abscess of the upper leg. 
Four patients with a suspected infectious focus and three other patients 
also had abnormalities of noninfectious origin (lesions not tabulated in the 
table). Four recent noninfected fractures up to four weeks old without 
complications were positive on scintigrams obtained with In-111-IgG. In 
contrast, two noninfected fractures four to six months old, without 
complications, that were clearly visible on the Tc-99m-MDP images, 
showed no accumulation of In-111-IgG. A hemangioma showed some 
uptake of In-111-IgG on the images obtained four hours after injection, but 
was considered negative for inflammation, since In-111-IgG did not further 
accumulate in the lesion on the subsequent images. 
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Figure 2. Chronic recurrent osteo-
myelitis of the left distal 
femur, caused by Staphylococcus 
aureus, in a man aged 58 years. (A) 
Scintigram obtained with In-111-IgG 
(anterior view, obtained 48 hours 
postinjection, with a preset time of 10 
minutes; 150,000 counts acquired) 
shows increased uptake of In-111-IgG 
in the left distal femur (arrow). (B) 
Plain radiograph shows two years old 
beads containing gentamycin in the 
left distal femur. No definite radiogra-
phic evidence of active infection is 
seen. 
DISCUSSION 
Our results indicate a high sensitivity of scintigraphy, performed after 
injection of In-111-IgG, for the detection of infections in bones, joints and 
joint prostheses. In our study, only two low-grade Staphylococcus aureus 
infections were missed. Specificity for infection was lower than sensitivity: 
85%. This is not surprising, because labeled IgG is a nonspecific radio-
pharmaceutical, that accumulates not only in infection, but also in various 
other types of inflammatory processes (6,8,9). In our study, this is illus-
trated by the images categorized as false-positive. In all seven of these 
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Figure 3. Soft-tissue abscess, caused by Staphylococcus aureus, in the flexor muscles 
of the right upper leg of a woman, aged 60 years. (A) Scintigram obtained, 
like (B), with In-111-IgG (posterior view, obtained 48 hours postinjection, with a preset 
time of 10 minutes; 300,000 counts acquired) shows increased uptake of In-111-IgG in 
a large area in the upper right leg (arrows). (B) Scintigram (lateral view, obtained 48 
hours postinjection, with a preset time of 10 minutes; 250,000 counts acquired) shows 
the focus of infection (arrows). 
cases, an inflammatory component could be identified. In some patients with 
joint prostheses, wear of the prosthesis components may cause a foreign-
body reaction, that causes granulation tissue (10). If this sterile inflamma­
tory reaction is substantial, it could cause false-positive findings on 
scintigrams obtained with In-111-IgG. In general, aseptic loosening of a 
prosthesis resulted in positive Tc-99m-MDP bone scans, but the images 
obtained with In-111-IgG were unremarkable. Findings on scintigrams 
obtained with In-111-IgG were positive in four recent noninfected fractures. 
Accumulation in sterile inflammatory lesions has also been reported 
after administration of other radiopharmaceuticals, such as Ga-67 and 
labeled WBC (11-13). 
No consensus exists in radiology literature on the utility of Ga-67 in 
infectious bone and joint disease. Some authors presented rather poor results 
due to Ga-67 accumulation in noninfected areas with increased bone 
turnover (14,15). Accuracy might improve with use of sequential 
Tc-99m-MDP and Ga-67 scintigraphy (16, 17). The characteristics of Ga-67 
have additional disadvantages: multipeak, high-energy photon emission, 
which is less suited for imaging, and physiological intestinal excretion (9). 
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This excretion does of course not interfere with image quality in the limbs, 
but it may obscure mild uptake in the lumbar and lower thoracic spine. 
A relatively new radiopharmaceutical for evaluation of musculoskeletal 
infection is Tc-99m labeled nanocolloid. Although good results were 
obtained in acute infection, Tc-99m labeled nanocolloid appears to be of 
limited value in the evaluation of the prosthetic joint (18). 
The results of scintigraphy performed after administration of In-Ill 
labeled WBC in chronic infection are also variable. Some authors report 
excellent results (13,19,20). Others find relatively low sensitivity in 
low-grade infection (5,15). Initial results of Buscombe et al. indicate a 
similarity in performance between In-111 labeled WBC and Tc-99m labeled 
IgG scintigraphy in sixteen patients with osseous infection (9). In a 
comparative study of In-111-WBC and In-111-IgG, we found a significantly 
better performance of In-111-IgG (21). Recently, Palestro et al. reported 
the efficacy of In-111-WBC and Tc-99m-sulfur colloid in sequential imaging 
of bone marrow to detect infection of total hip prosthesis (22). The 
usefulness of Tc-99m-hexamethylpropyleneamine oxime labeled WBC in 
scintigraphy of infectious bone and joint disease is not well established, but 
it is likely that the performance is similar to that of WBC labeled with In-
111. In a small group of patients, Roddie et al. reported good results with 
Tc-99m-WBC scintigraphy (23). WBC scintigraphy shows high sensitivity 
and specificity in acute infection, especially when the patient's WBC count 
is elevated (5). Our study indicates that scintigraphy performed with 
In-111-IgG also yields good results in low-grade infection when the 48 
hours imaging protocol is used. In acute infection, accurate imaging is 
possible within 24 hours, whenever images are obtained 4 and 24 hours 
after injection. 
In addition to low sensitivity in low-grade infection, the need for cell 
labeling facilities is another drawback for the widespread use of labeled 
leukocyte scintigraphy. Moreover, WBC isolation and labeling is time-
consuming and expensive and thus makes instantaneous preparation impos-
sible. IgG-DTPA conjugate is readily available as a sterile, pyrogen-free 
kit for rapid labeling without the need to handle blood of patients. This is 
especially valuable in acute infection when results of scintigraphy should 
be available in the shortest possible time. In acute infection, it is possible 
to make an accurate diagnosis with In-111-IgG scintigraphy within 24 hours 
after referral to the nuclear medicine department. 
Evaluation of chronic osteomyelitis with radiographs is difficult due 
to lack of accuracy (1,16). Magnetic resonance imaging could be an 
important technique for obtaining additional information in this group of 
patients (16). 
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Although the exact mechanism of accumulation of In-111-IgG in 
infectious foci remains to be elucidated, we conclude that scintigraphy 
performed with In-111-IgG is a valuable technique for the evaluation of 
infection in bones, joints and joint prostheses. Because infection of the spine 
was studied in only a few patients, further studies are needed to fully 
elucidate the role of scintigraphy performed with In-111-IgG in infections 
of the axial skeleton. 
One has to consider that In-111-IgG, like all other radiopharmaceuticals 
used for imaging infection, accumulates in any inflammatory focus, 
regardless of whether the focus is infectious or sterile. However, in chronic 
recurrent low-grade infection, one of the major indications for scintigraphy 
with In-111-IgG, this distinction is of minor importance, because a sterile 
inflammation in these areas is less likely to occur. In our experience, uptake 
of In-111-IgG due to sterile inflammation such as repair after recent fracture 
and wound healing after surgical procedures disappears after four to six 
months. Until then, prudent interpretation of scintigrams obtained with 
In-111-IgG is necessary to avoid false-positive results. 
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TO THE EDITOR: We have read Dr. Alazraki's interesting editorial on 
diagnosing prosthetic joint infections (1). We share Dr. Alazraki's view that 
some serious difficulties are related to the use of In-111 labeled leukocytes 
for the diagnosis of prosthetic joint infections. In a recent paper, we 
reported our first experience with indium-Ill labeled human nonspecific 
immunoglobulin G (In-111-IgG) scintigraphy in patients with bone and joint 
infections (2). Five patients with prosthetic joints were included in this 
study. Since that time, scintigraphy with In-111-IgG was performed in an 
additional 35 patients with prosthetic joints. 
Of the total of 40 patients studied, 34 had total hip arthroplasty, six 
had total knee prosthesis. All patients had clinical signs of loosening and/or 
chronic infection. A conventional technetium-99m methylene diphosphonate 
skeletal scintigraphy was abnormal in all patients. All patients also 
underwent scintigraphic imaging after intravenous injection of 1 mg IgG 
(Sandoglobulin, Sandoz AG, Nurenberg, FRG), radiolabeled with 75 MBq 
In-Ill (Indium-Ill chloride, Amersham International Ltd., Buckingham­
shire, UK) at 4, 24 and 48 hours (2). Scintigraphic results were evaluated 
by bacterial cultures obtained at surgery in 25 patients and by clinical 
follow-up and serial radiography in twelve patients. Three patients had 
productive fistulae. 
Figure 1 is a typical example of an In-111-IgG scintigram of an 
infected total hip arthroplasty with increased uptake in the right acetabular 
region with extension in the surrounding soft-tissue (Fig 1A-B) and 
increased uptake around the tip of the femoral component of the prosthesis 
(Fig 1С). 
Fourteen patient studies were categorized as true-positive, 22 as true-
negative, three as false-positive and one as false-negative. In all false-
positive studies, a sterile inflammatory process could be identified: active 
periarticular ossifications, necrotic tissue around the neck of a femoral 
component of a total hip prosthesis, and a hemorrhage in the total knee 
prosthesis in a hemophilic patient. In the one patient with a false-negative 
In-111-IgG scintigraphy, a single culture revealed growth of Staphylococcus 
aureus in low counts. 
In this group of patients, sensitivity of In-111-IgG scintigraphy was 
93%, specificity for infection 88%, specificity for inflammation 100%, 
positive predictive value for infection 82%, positive predictive value for 
inflammation 100%, and negative predictive value for infection and/or 
inflammation 96%. 
In our opinion, In-111-IgG scintigraphy overcomes most of the 
difficulties with In-111 labeled leukocytes addressed by Dr. Alazraki (1). 
Using the physiological activity uptake is in the soft-tissues around bone and 
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Figure 1. In-111-IgG images (48 
hours p.i.) of an infected 
right total hip arthroplasty. (A) 
Anterior view of the pelvis: increased 
uptake in the acetabular region with 
soft-tissue extension (arrow). (B) Pos-
terior view of the pelvis: increased 
uptake in the acetabular region with 
soft-tissue extension (arrow). (C) An-
terior view of the upper legs: in-
creased uptake around the tip of the 
femoral component (arrow). 
prosthesis as a landmark, it is possible to discriminate pathological In-111-
IgG accumulation in bone from soft-tissue uptake. Comparing the marrow 
uptake per pixel per MBq in the iliac crest, the uptake of In-111 leukocytes 
typically exceeded the In-111-IgG uptake by 50%. In this series of patients, 
In-111-IgG uptake in bone marrow did not interfere with image 
interpretation. Our results indicate that In-111-IgG scintigraphy has no 
decreased sensitivity in chronic infection. 
Like all radiopharmaceuticals used for imaging infection, In-111-IgG 
accumulates not only in infectious foci, but also in sterile inflammatory 
processes. In our study, this is demonstrated by the three patients that were 
categorized as false-positive, among them a patient with heterotopic bone 
formation. 
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The very important concern about the handling of whole blood for In-
111 leukocyte scintigraphy and the possibility of iatrogenic errors does not 
apply to In-111-IgG (1,3). The IgG-DTPA conjugate is readily available 
as a sterile, pyrogen-free kit. Additional advantages of In-111-IgG are the 
rapid labeling procedure and the constant, high quality of the radiophar­
maceutical. 
In conclusion, we feel that In-111-IgG scintigraphy is an excellent 
method for imaging infection, especially in the notoriously difficult field 
of chronic low-grade bone and prosthetic joint infections. 
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INTRODUCTION 
Infection of the foot is a serious complication of long-existing diabetes 
mellitus, increasing patient morbidity and mortality considerably. Clinical 
assessment of the extent of infection is difficult, because of concomitant 
neuropathic and angiopathic changes. Radiographic findings are nonspecific 
(1). Bone scintigraphy using technetium-99m methylene diphosphonate 
(Tc-99m-MDP) is highly sensitive, but lacks sufficient specificity (2,3). 
Gallium-67 (Ga-67) scintigraphy provides disappointing results, mainly due 
to accumulation in areas of increased bone turn-over which are not infected 
(4,5). Better results have been reported, using labeled leukocytes (WBC) 
scintigraphy (6,7). The time-consuming and relatively difficult preparation 
of labeled WBC is a major drawback for widespread use of this technique. 
Recently, the potential of indium-Ill labeled human nonspecific 
immunoglobulin G (In-111-IgG) scintigraphy for diagnosing infectious bone 
and joint disease was reported (8,9,10). 
The aim of this study was to evaluate the utility of In-111-IgG 
scintigraphy in diabetic patients, suspected of osteomyelitis of the foot. 
PATIENTS AND METHODS 
Patients 
Sixteen patients (eight male, eight female) with diabetes mellitus (13 
type II and 3 type I) were studied. Mean age was 62.1 years (range 41 to 
83 years). Mean duration of the diabetes was 21.3 years (range 5 to 42 
years). 
All patients suffered from ulcers, gangrene or a painful Charcot joint. 
The latter was defined according to Levin: a deformed foot (particulary of 
the tarsal and metatarsal bones), increased temperature and erythema (11). 
Patients with severe foot infection, requiring immediate surgical 
intervention, were excluded. Since Tc-99m-MDP bone scintigraphy has an 
excellent sensitivity for the detection of osteomyelitis, patients with normal 
bone scans were also excluded. No patient had a history, suggestive of 
severe systemic reaction after prior IgG administration or of IgG or IgA 
deficiency. 
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Clinical assessment. 
Inspection and soft-tissue cultures 
The location of ulcers and gangrene was noted. To obtain material for 
cultures, a tissue curettage from the base and edges of all ulcers and 
gangrenous lesions was performed according to the method described by 
Lipski et al. (12). The material was placed in a sterile container and 
immediately transported to the laboratory of clinical microbiology. 
Angiopathy 
ín patients complaining of intermitted claudication, the maximum 
painfree walking distance was recorded. Pedal pulses were palpated. 
Systolic blood pressure was measured in the dorsal pedal and posterior tibial 
arteries, using a conventional 10 MHz Doppler ultrasound probe (Stopler, 
Parks Electronics Lab, USA) and an occluding leg cuff. Measurements were 
made until three reproducible values were obtained (within a range of 10 
mm Hg). The mean of these readings was calculated. The brachial systolic 
blood pressure was measured in the same way using an arm cuff. The 
ankle/brachial pressure index ( = A/B index) was calculated (13,14). Since 
mediacalcification may cause falsely elevated blood pressure measurements, 
presence or absence thereof was noted on radiographs of the feet (15). 
Neuropathy 
Neuropathic symptoms had to be present for at least 6 months. The 
vibration sense was tested with a 128 Hz tuning fork on the first metatarsal 
and lateral ankle of both feet. This test was performed three times on both 
locations. Results were categorized as (a) normal, (b) diminished on the toes 
only, (c) absent on the toes and diminished on the ankle, (d) absent on both 
the toes and the ankle. Knee and ankle reflexes were categorized as either 
normal or absent/diminished. 
Radiopharmaceutical 
Human nonspecific polyclonal immunoglobulin G (Sandoglobulin, 
Sandoz AG, Nurenberg, FRG) was conjugated to diethylenetriaminepen-
taacetic bicyclic anhydride (bicyclic DTPA) according to the method 
described by Hnatowich et al. and labeled with In-Ill (Indium chloride, 
Amersham International Ltd., Buckinghamshire, UK) (16). Labeling 
efficiency was always higher than 95 %. A dose of approximately 1 mg of 
IgG labeled with 75 MBq In-Ill was injected intravenously. 
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Imaging protocol 
Plain radiographs of the feet were made in all patients. 
All scintigraphic images were obtained with a Siemens Orbiter gamma 
camera connected to a Scintiview image processor (Siemens Inc., Hoffman 
Estate, II, USA), equipped with a low-energy all-purpose collimator for the 
Tc-99m-MDP bone scintigraphy or a medium-energy parallel-hole 
collimator for the In-111-IgG scintigraphy. 
A four-phase bone scintigraphy was performed using 600 MBq 
Tc-99m-MDP. Immediately after injection, dynamic images of the feet 
(three seconds per image) were obtained for one minute. Five minutes 
postinjection (p.i.) a so-called blood-pool image (350 kcounts) was made. 
After three hours, delayed images of the feet (anterior, plantar, lateral, and 
medial view) were made with a preset time of 5 minutes each. An additional 
plantar image for a preset time of 15 minutes was obtained 24 hours p.i. 
in order to obtain optimal bone delineation. 
In-111-IgG was injected immediately after the 24 hours p.i. bone scan 
image was recorded. In-111-IgG images were made four, 24, and 48 hours 
p.i. At all time points, images of the feet were obtained from four angles. 
All images were collected for a preset time of 10 minutes. The four hours 
images were recorded using only the 247 keV photopeak with a 15% 
symmetrical window in order to avoid Tc-99m scatter in areas with 
significant Tc-99m-MDP retention. Both the 173 and the 247 keV peak of 
In-Ill with a 15% symmetrical window were used to record the images at 
24 and 48 hours p.i. 
Image interpretation and verification 
The conventional radiographs of the feet were reviewed by an 
experienced radiologist, who was unaware of the clinical and scintigraphic 
findings. The radiographs were assessed for osteomyelitis, using criteria as 
given by Resnick (soft-tissue swelling, osteoporosis, osteolysis, cortical or 
medullary destruction and sequestration) (17). The diagnosis was settled as 
positive, negative or equivocal. 
All scintigraphic images were interpreted by three observers, unaware 
of the results of clinical and radiographic findings. An In-111-IgG 
scintigraphy was considered positive when focal, with time increasing 
accumulation was observed. Using the bone scintigraphy as a landmark, 
increased In-111-IgG uptake was attributed to either bone or soft-tissue. The 
bone scan by itself did not contribute to the diagnosis of osteomyelitis. 
Patients, not responding to antibiotic medication and local treatment 
within two to three weeks, underwent surgery. In these patients, material 
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was collected for histologic examination. Leukocyte and bacterial infiltration 
of bone tissue was considered to be histologic proof of osteomyelitis. In 
patients, who responded well to antibiotic medication and local treatment, 
the data obtained during follow-up of at least six months were used to judge 
the results of the radiographs and the scintigraphic images. 
RESULTS 
Table 1 shows the individual clinical data of the patients and a 
description of condition of the foot problem. Only the A/B index of the 
diseased foot is included in the table. All patients had evidence of 
neuropathy, six patients also showed signs and symptoms of angiopathy. 
Table 2 shows the results of the radiographs and scintigraphic images with 
regard to osseous involvement, and the results of the verification procedures 
in the individual patients. 
Tc-99m-MDP Bone Scan 
As indicated in tables 1 and 2, in all 22 localizations, clinically suspect 
for osteomyelitis, increased Tc-99m-MDP uptake was observed. The bone 
scan revealed four additional possible osteomyelitic foci. All seven proven 
osteomyelitic lesions could be identified with the bone scan. The remaining 
nineteen areas of increased uptake were not due to osteomyelitis, but were 
caused by neuropathic osteopathy, Charcot joints, degenerative 
osteoarthritis, uninfected pressure points and soft-tissue involvement with 
local hyperperfusion. 
In-111-IgG Scintigraphy 
Using the bone scan as a landmark for the osseous structures, the 
In-111-IgG scintigraphy identified six of seven proven osteomyelitis foci. 
Figure 1 shows scintigraphic images from patient 7 with histologically 
proven osteomyelitis. In two cases (no. 14 and 15), abnormal In-111-IgG 
accumulation was attributed to the calcaneus, while only a deep soft-tissue 
infection was present. Figure 2 shows the scintigraphic images of patient 
14. 
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Table 1. Clinical characteristics, duration of the diabetes mellitus, signs and symptoms of diabetic 
neuropathy and angiopathy, localization of the ulcer or necrosis, and results of soft-tissue 
cultures. 
Patient 
(sex/age) 
duration 
1 (M/65); 
13 yr 
2 (F/76); 
8yr 
3 (F756); 
7yr 
4 (M/83); 
32 yr 
5 (F/81); 
20 yr 
6 (F/77); 
25 yr 
7 (F/55); 
42 yr 
8 (F/63); 
17 yr 
9 (F/59); 
32 yr 
Neuropathy 
numbness toes; absent 
VS (toes); absent KR 
and AR 
numbness feet; absent 
VS; absent KR and 
AR 
numbness toes; absent 
VS (toes); normal KR; 
absent AR 
numbness feet; absent 
VS; absent KR and 
AR 
numbness feet; absent 
VS; absent KR and 
AR 
numbness lower legs; 
absent VS; absent KR 
and AR 
numbness toes; absent 
VS; absent KR and 
AR 
numbness lower legs; 
absent VS; absent KR 
and AR 
numbness feet; pain; 
absent VS; absent KR 
and AR 
(Continued on next page) 
Angiopathy 
no claudication; normal 
pulsations; A/B index 1.08 
no claudication; normal 
pulsations; A/B index 0.59; 
no claudication; normal 
pulsations; A/B index 0.98 
claudication (1000m); absent 
pulsations; A/B index 0.47 
no claudication; normal 
pulsations; mediacalcifi-
cation, A/B index 1.10 
no claudication; absent 
pulsations; A/B index 0.44 
no claudication; normal 
pulsations; A/B index 0.92 
claudication (100m); absent 
pulsations; mediacalcifi-
cation; A/B index 0.53 (R) 
and 0.74 (L) 
no claudication; normal 
pulsations; mediacalcifi-
cation, A/B index 0.93 (R) 
and 0.87 (L) 
Localization (clinical) 
(soft-tissue culture) 
ulcer first toe L; 
(culture negative) 
ulcer midfoot R; 
(culture: /3-hemolytic Strep-
tococcus, Proteus) 
ulcer heel L 
(culture: Staphylococcus 
epidermidis) 
ulcer second toe R; 
(culture: /3-hemolytic Strep-
tococcus) 
gangrene second toe R; 
(culture: mixed flora inclu-
ding anaerobic baaeria); 
ulcer hindfoot R; Charcot 
joint L and R 
ulcer first toe R; 
(culture: Staphylococcus 
aureus and ß-hemolytic Strep-
tococcus) 
ulcer second toe R; 
(culture: Staphylococcus 
aureus) 
ulcer midfoot L and R; 
(culture: Staphylococcus 
aureus and Enterobacter 
species) 
Charcot joints L and R; 
(culture not done) 
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Table 1. (Continued) 
Patient 
(sex/age) 
duration 
10 (M/45); 
20 уг 
11 (M/63); 
21 уг 
12 (M/58); 
5уг 
13 (F/72); 
14 уг 
14 (M/55); 
26 уг 
15 (M/44); 
34 уг 
16 (M/41); 
25 уг 
L = Left; R 
А/В = Ankle 
Neuropathy 
numbness feet; pain; 
absent VS (ankle); 
normal KR; absent 
AR 
paresthesia; absent 
VS; absent KR and 
AR 
numbness feet; absent 
VS; normal KR; 
absent AR 
absent VS (toes); 
normal KR and AR 
numbness feet; absent 
VS; absent KR and 
AR 
numbness feet; absent 
VS (toes); normal KR; 
absent AR 
numbness lower legs; 
absent VS (toes); 
normal KR; absent 
AR 
= Right; VS = Vibration 
s/branchial blood pressure 
Angiopathy 
no claudication; normal 
pulsations; mediacalcifi-
cation, A/B index 1.87 
claudication (500m); absent 
pulsations; A/B index 0.39 
claudication (10m); absent 
pulsations; A/B index 0.39 
claudication (50m); absent 
pulsations; mediacalcifi-
cation, A/B index 0.52 
no claudication; normal 
pulsations; A/B index 1.21 
no claudication; normal 
pulsations; mediacalcifi-
cation; A/B index 0.77 
no claudication; normal 
pulsations; mediacalcifi-
cation; A/B index 1.08 
ι sense; KR = Knee reflex; AR 
index 
Localization (clinical) 
(soft-tissue culture) 
Charcot joint L; 
(culture not done) 
ulcer midfoot L 
(culture: Morganelli morgan-
ni) 
gangrene fourth, fifth toe R; 
(culture: Staphylococcus 
aureus) 
ulcer first toe L 
(culture negative) 
ulcer heel R; 
(culture: Staphylococcus 
aureus and epidermidis) 
ulcer heel L; 
(culture: Staphylococcus 
aureus and Proteus vulgaris) 
amputation of all toes, ulcers 
lateral and medial side of 
midfoot R; (culture: Staphylo­
coccus aureus); clinically 
unremarkable Charcot joint R 
= Ankle reflex; 
Four patients had Charcot joints, two of them bilaterally. In those 
patients (no. 5,9, and 16), in whom this condition already existed for many 
months or even years, the In-111-IgG scintigraphy was negative. In patient 
no. 16, having a clinically unremarkable Charcot joint, the bone scan was 
also negative. In the fourth patient (no. 10), having sustained fractures only 
four weeks prior to scintigraphy, the In-111-IgG scintigraphy showed 
accumulation in the osseous structures of the midfoot (see figure 3). This 
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Table 2. Suspected osteomyelitis on the plain radiographs (X-ray), bone scan (MDP), and 
In-111-IgG scintigraphy (IgG) and the final diagnoses. 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
No. 
L = 
Localization 
First toe L 
Midfoot R 
Calcaneus L 
Second toe R 
Midfoot R 
First toe L 
Second toe R 
Calcaneus R 
Midfoot L 
Midfoot R 
MTP 1,R 
Metatarsal 2,R 
Metatarsal 1,L 
Metatarsal 1,R 
Metatarsal 2/3,L 
MTP 2,R 
Metatarsals L 
Midfoot L 
Metatarsal 5,L 
Metatarsal 5,R 
Fourth/fifth toe R 
First toe L 
Calcaneus R 
Calcaneus L 
Metatarsal LR 
Metatarsal 5,R 
= Patient number 
Left; R = Right; MTP 
X-ray 
— 
— 
+ 
— 
+ 
± 
± 
+ 
+ 
+ 
— 
— 
— 
+ 
MDP 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
IgG 
— 
— 
+ 
+ 
+ 
+ 
— 
+ 
+ 
— 
— 
+ 
+ 
+ + + 
+ + — 
= Metatarsophalangeal jo 
Verification 
Healing of ulcer 
Healing of ulcer 
Healing of ulcer 
Histology (surgical specimen) : osteomyelitis 
No evidence of infection (F) 
No evidence of infection (F) 
Histology (surgical specimen) : osteomyelitis 
Superficial ulcer, no bone involvement 
Charcot joint, no evidence of infection (F) 
Charcot joint, no evidence of infection (F) 
Histology (surgical specimen) : osteomyelitis 
Histology (surgical specimen) : osteomyelitis 
Pressure point, no infection (F) 
Histology (surgical specimens both lesions): 
no osteomyelitis, soft-tissue involvement only 
Charcot joint, no evidence of infection (F) 
Charcot joint, no evidence of infection (F) 
Charcot joint, no evidence of infection (F) 
Histology (surgical specimen) : osteomyelitis 
Pressure point, no infection (F) 
Histology (surgical specimen) : no osteo-
myelitis 
Histology (surgical specimen) : osteomyelitis 
Healing of ulcer 
Histology (surgical specimen) : no osteo-
myelitis 
Evident osteomyelitis,patient refused surgery 
Healing of ulcer 
Charcot joint: normal MDP and IgG studies) 
int; F = Long-term clinical follow-up 
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patient was categorized as false-positive for osteomyelitis. Only one 
false-negative In-111-IgG scan was observed (patient no. 13). This patient 
had severe arterial angiopathy and histologically proven osteomyelitis of the 
first toe. 
Plain Radiograph 
Plain radiographs identified four of seven osteomyelitic foci. Falsely 
negative results were obtained in two patients (no. 5 and 13 ) with osteo­
myelitis of a toe and in patient 7 with osteomyelitis of a metatarsal. 
Osteomyelitis was correctly ruled out in 15 of 19 lesions. The 
radiographic findings of three lesions were equivocal for osteomyelitis: 
osteomyelitis of bilateral Charcot joints could not be ruled out in patient 9, 
and in patient 15 focal demineralization of the calcaneus indicated possible 
osteomyelitis. In patient 16, the radiograph indicated involvement of the 
fifth metatarsal, while osteomyelitis could not be established. 
Figure 1. Plantar views of the Tc-99m-MDP bone scintigraphy 24 hours p.i. (A) and 
the In-111-IgG scintigraphy 48 hours p.i. (B) of patient? (female, 55 years, 
diabetes mellitus since 42 years). She had an ulcer at the base of second toe of the right 
foot, that developed after amputation of the toe. Soft-tissue cultures showed growth of 
Staphylococcus aureus. She also had a pressure point on the base phalanx of the first 
toe of the left foot, that developed after resection of the distal phalanx. 
The bone scan shows increased activity at the site of both the ulcer (large arrow) and 
the pressure point (small arrow). The In-111-IgG scintigraphy correctly identified histo-
logically-proven osteomyelitis in the second metatarsal of the left foot (large arrow) and 
correctly ruled out infection at the pressure point on the right foot (small arrow). 
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Figure 2. Lateral views of the right foot of the Tc-99m-MDP bone scintigraphy 3 
hours p.i. (A) and the In-111-IgG scintigraphy 48 hours p.i. (B) of patient 
14 (male, 55 years, diabetes mellitus since 26 years). He had a deeply penetrating, soft-
tissue ulcer of the right heel (soft-tissue culture: Staphylococcus aureus and epidermidis). 
Both the bone scan and the In-111-IgG scintigraphy show intensely increased activity 
in the right calcaneus (arrows). The ulcer responded well to antibiotic medication and 
local treatment and healed without complications in the course of several weeks. There-
fore, both studies were categorized as falsely positive for osteomyelitis. 
Soft-Tissue Culture 
In 14 of 16 patients, soft-tissue cultures were obtained. In twelve 
patients, the cultures showed bacterial growth. Six of these patients had 
osteomyelitis. In the other six, osteomyelitis could not be proven. Of the 
two patients with negative cultures, one had osteomyelitis. 
Overall sensitivity, specificity, and predictive values for osteomyelitis 
of the diagnostic procedures are summarized in table 3. 
DISCUSSION 
The present study indicates that In-111-IgG scintigraphy is a useful 
method for evaluation of possible osteomyelitis of the diabetic foot. 
Recently, Wegener et al. also indicated the possible use of In-111-IgG 
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Table 3. Summary of the performance of the various techniques for detection of osteomyelitis. 
Soñ-tissue culture 
Plain radiograph 
Tc-99m-MDP 
In-111-IgG 
η = Number of lesions; TP 
FP = False-positive; PPV = 
η 
14 
26 
26 
26 
TP 
6 
4 
7 
6 
TN 
1 
15 
0 
16 
FN 
1 
3 
0 
1 
FP 
6 
4 
19 
3 
Sensitivity 
86% 
57% 
100% 
86% 
= True-positive; TN = True-negative; FN = 
Positive predictive value; NPV = Negative 
Specificity 
14% 
79% 
0% 
84% 
False-negative; 
predictive value 
PPV 
50% 
50% 
27% 
67% 
NPV 
50% 
84% 
— 
94% 
scintigraphy in the diabetic foot: in three patients they observed that this 
technique adequately localized the osteomyelitic focus (18). 
Using the bone scan as a landmark for the osseous structures, it is in 
most cases possible to discriminate osteomyelitis from mere soft-tissue 
involvement. However, this discrimination is hardly possible on an 
In-111-IgG scintigraphy alone. When patients suffer from deep soft-tissue 
ulcers, differentiation between bone and soft-tissue involvement remains 
difficult, as indicated by patients no. 14 and 15, who had penetrating 
hindfoot ulcers. In our study, the In-111-IgG scintigraphy of only one 
patient (no. 13) was categorized as falsely negative for osteomyelitis. The 
severe arterial angiopathy of this patient may have hampered supply of 
In-111-IgG to the infectious lesion. As reported earlier, recent fractures are 
pitfalls in the interpretation of In-111-IgG images (9,10). This was 
exemplified by the patient with a recent Charcot joint. However, several 
months old fractures pose no problem in the interpretation of the In-111-IgG 
scan (9,10). These findings imply that In-111-IgG scintigraphy appears to 
be of limited value for the detection of infectious lesions in Charcot joints 
with recent fractures. This not only applies to In-111-IgG scintigraphy, but 
to all scintigraphic techniques currently used for imaging infectious bone 
and joint disease, such as Ga-67 and labeled autologous WBC scintigraphy 
(2,5). 
The performance of bone scintigraphy in the present study is in 
agreement with reports in literature (1,2,3,4,5,19,20). We also observed 
superb sensitivity. Specificity was extremely low in our study, since all 
clinically suspect osteomyelitic foci showed increased Tc-99m-MDP uptake. 
The accuracy of plain radiographs also confirms previous reports (1,4, 
7,19,20). Initially a plain radiograph may show only soft-tissue swelling, 
periosteal reaction, or cortical irregularities, but these findings are non-
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Figure 3. Plantar views of the Tc-99m-MDP bone scintigraphy 24 hours p.i. (A) and 
the In-111-IgG scintigraphy 48 hours p.i. (B) of patient 10 (male, 45 years, 
diabetes mellitus since 20 years). He had a painful Charcot joint of the left foot. He 
sustained spontaneous fractures in the left foot four weeks prior to scintigraphy. Both 
the bone scan and the In-111-IgG scintigraphy show intensely increased activity in the 
left midfoot (arrows). With specially designed shoes, the patients complaints dis­
appeared. This study is an example of recent fractures, inducing falsely positive bone 
scan and In-111-IgG studies. 
specific. Diagnostic findings only become apparent after a certain degree 
of bone loss. Diabetic osteopathy may significantly interfere with 
interpretation of the radiographs. 
With regard to other scintigraphic techniques for imaging infection, 
Ga-67 is the least suited in this group of patients, mainly due to 
accumulation in areas of increased bone turn-over, resulting in a relatively 
low specificity (2,4,5). 
Several authors reported very good results, using In-111 labeled WBC 
(2,6,7,21). Maurer et al. observed a clearly increased specificity of In-Ill 
labeled WBC scintigraphy compared to the bone scan (21). Schauwecker 
et al. indicated the usefulness of dual isotope imaging, using a Tc-99m 
labeled bone scanning agent and In-Ill labeled WBC (6). They were able 
to discriminate bone from soft-tissue infection in 89% of their patients. In 
a series of 77 patients, Keenan et al. observed 100% sensitivity and 79% 
specificity for osteomyelitis (7). In contrast to Schauwecker et al., they felt 
that little benefit was obtained from bone scans (6,7). Compared to 
In-111-IgG preparation, the main drawback for widespread use of labeled 
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WBC is the relatively complicated and time-consuming cell labeling. 
Isolating and labeling leukocytes takes at least three hours. Moreover, very 
careful handling of the potentially infectious blood is necessary to avoid 
infection of both the staff and other patients. In contrast, the IgG-DTPA is 
readily available as a sterile, pyrogen-free kit for convenient one step 
labeling. In-111-IgG is ready for injection within half an hour. 
To our knowledge, scarce data are available, dealing with diabetic foot 
infections, using other new scintigraphic techniques such as Tc-99m labeled 
IgG and labeled monoclonal antigranulocyte antibodies. Weidlich et al. 
observed 90% sensitivity and 90% specificity for osteomyelitis in a group 
of 20 diabetic patients, using the murine monoclonal antigranulocyte 
antibody BW 250/183 (22). 
Magnetic resonance imaging (MRI) could lead to improvement in the 
management of diabetic foot complications. First reports indicate excellent 
sensitivity. Yuh et al. observed 100% sensitivity and only two false-positive 
results in a group of 24 patients (20). However, it appears that MRI also 
shows false-positive results in osteoarthropathy of recent onset (2). Seabold 
et al. found similar sensitivity of MRI and In-111 labeled WBC imaging 
in diabetic feet (2). 
It is not possible to estimate the probability of osteomyelitis on the 
basis of culturing soft-tissue specimens. Our results revealed that 50% of 
the patients with positive soft-tissue cultures actually had osteomyelitis. 
Moreover, one of the two patients with negative soft-tissue cultures had 
osteomyelitis. 
In conclusion, it is shown that In-111-IgG scintigraphy can contribute 
significantly to the evaluation of suspected diabetic foot infections. The 
presence and the extent of possible bone involvement can reliably be 
assessed. Ulcera, penetrating deeply in the soft-tissues, but not in bone, may 
cause falsely positive results for osteomyelitis. Although the conventional 
bone scan is of little or no value for determining bone infection, it is 
essential for localizing the osseous structures of the foot, whereas a normal 
bone scan virtually rules out osteomyelitis. 
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Reflex sympathetic dystrophy of the hand: 
an excessive inflammatory response ? 
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INTRODUCTION 
Reflex sympathetic dystrophy (RSD) is a disabling complication that 
may occur after extremity injury and in the course of myocardial infarction, 
neurologic and rheumatologic diseases (1,2,3). RSD can be induced by 
fracture, surgery or even minimal trauma to an extremity, such as a sprain 
or a contusion. In some patients, no cause can be identified. Although RSD 
may resolve without special treatment, therapy-resistant pain and severely 
limited function of the affected extremity may ensue. 
In the literature, there is no consensus on the pathophysiologic 
mechanism of RSD. It has been postulated that RSD is a disorder of the 
sympathetic nervous system, a vascular tone abnormality or that it is of 
psychogenic origin (4,5). Recently, Hannington-Kiff hypothesized that failed 
natural opioid modulation in regional sympathetic ganglia may cause RSD 
(6). Sudeck's original theory that RSD is an excessive inflammatory reaction 
found little support (7,8). However, in the acute phase of RSD, all classical 
signs and symptoms of inflammation - rubor, calor, dolor, tumor and 
fiinctio laesa of the affected extremity - are present (9). 
In previous studies, it has been reported that indium-111 labeled human 
nonspecific polyclonal immunoglobulin G (In-111-IgG) accumulates in 
infectious and inflammatory lesions (10,11,12,13,14,15,16). Accumulation 
of In-111-IgG has been shown to result from increased vascular 
permeability in these foci (17,18). In RSD, it has been suggested that toxic 
oxygen radicals cause an inflammatory reaction (9). The aim of this study 
was to evaluate such a possible inflammatory component in RSD in patients 
with clinical evidence of early RSD of the upper limb using this new 
scintigraphic technique rather than to establish the diagnostic value of this 
method. 
PATIENTS AND METHODS 
Clinical assessment 
Since there is no clear definition for the clinical assessment of RSD, 
patients were scored for signs and symptoms indicative for RSD. Of the 
following six symptoms, at least five should be present in an area larger 
than the primary injury: unexplained diffuse pain, abnormal skin 
temperature, abnormal skin color, diffuse edema, unexplained limitation of 
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the range of motion, and increase of these signs and symptoms after 
exercise (2). 
The duration of RSD was classified according to the phases identified 
by Démangeât et al.: stage I from 0 to 5 months after onset and stage II 
from 5 to 14 months after onset. (19). 
Patients 
Twenty three patients were studied (7 male, 16 female; mean age 46.9 
years, range 20 to 71 years). In five patients, RSD was the consequence 
of a Colles' fracture, in five of a fracture of one or more of the 
metacarpals, in six of finger tendon or carpal tunnel surgery, and in five 
of distorsion or contusion of the hand. In two patients, no cause for the 
development of RSD could be identified. One of them suffered from 
bilateral RSD of unknown origin.The mean duration of RSD when 
In-111-IgG scintigraphy was performed was 2.6 months (range 0.5 to 6 
months). Seventeen patients were classified as stage I, six as stage II. 
Radiopharmaceutical 
Human nonspecific polyclonal immunoglobulin G (Sandoglobulin, 
Sandoz AG, Nurenberg, FRG) was conjugated to diethylenetriaminepen-
taacetic bicyclic anhydride (bicyclic DTPA) according to the method 
described by Hnatowich et al. and labeled with In-111 (Indium chloride, 
Amersham International Ltd., Buckinghamshire, UK) (20). Labeling 
efficiency was always higher than 95 percent. A dose of approximately 1 
mg of IgG labeled with 75 MBq In-Ill was administered intravenously as 
a bolus injection in the cubital vein of the nonaffected arm. 
Imaging protocol 
Both hands were placed with the palms down on the gamma camera 
(Siemens Orbiter connected to a Scintiview image processor, Siemens Inc., 
Hoffman Estate, II, USA), equipped with a medium-energy collimator. 
After intravenous administration of In-111-IgG, dynamic images were 
obtained (12 images, 5 seconds per image). Thereafter, static images of the 
hands were made 5 minutes, 20 minutes, and 4, 24 and 48 hours 
postinjection (p.i.). The images 5 minutes p.i. were acquired for a preset 
time of 5 minutes, all other images for a preset time of 10 minutes. 
Since exercise is known to trigger or aggravate the signs and symptoms 
of RSD, the patients were asked to inflate a blood pressure manometer ten 
times to 200 mm Hg after the 5 minutes p.i. image was obtained. The 
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affected hand was stressed first, followed by the normal hand. When 
maximal exertion could not be achieved with the affected hand, patients 
were encouraged to stress the hand as much as possible. 
Image interpretation 
Quantitative analysis of the images was performed using the regions 
of interest (ROI) technique. ROI were drawn over the affected and the 
normal hand. On the dynamic images the ROI was drawn over the whole 
of both the affected and the nonaffected hand. The ratio of activity uptake 
of the affected and the normal hand (target to background = T/B) ratio was 
calculated for the arterial phase (0 to 20 seconds p.i.) and the venous phase 
(20 to 60 seconds p.i.) 
For the static images, a ROI was drawn on the 48 hour image over the 
area with increased uptake in the affected hand and over the corresponding 
area in the contralateral hand. This region was then projected on the static 
images obtained at earlier time points. T/B ratios were calculated for each 
time point. The image obtained 5 minutes p.i. was considered to be the 
"baseline" for the T/B ratios. An In-111-IgG scintigraphy was interpreted 
as positive, if on the static images focal accumulation of activity in the 
affected hand increased with time (13). When no increasing activity over 
time was noted on the static images, the In-111-IgG scintigraphy was 
considered to be negative. For the patient with bilateral RSD, of course T/B 
ratios could not be calculated. 
Four patterns, describing the evolution of T/B ratios over time in 
individual patients, could be distinguished: 
* Pattern A: Increased activity in the flow phase, a slightly elevated 
T/B ratio at the early static images, followed by a steady increase 
of the T/B ratio up to 48 hours. 
* Pattern B: Increased activity in the flow phase, a slightly elevated 
T/B ratio at the early static images, not followed by an increase 
of the T/B ratio at the later images. 
* Pattern C: Decreased activity in the flow phase, followed by a 
steady increase to a maximum T/B ratio at 48 hours. 
* Pattern D: decreased activity in the flow phase, followed by 
symmetrical uptake on the static images. 
Statistical analysis 
All mean values are expressed + SD. The results of scintigraphy were 
analyzed using the χ2 - test, Spearman's rank correlation test, Student's 
t-test and Wilcoxon's signed rank test. 
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RESULTS 
In the table, the T/B ratios of the individual patients are given. 
Dynamic images 
Nineteen patients showed an increased flow in the affected hand (mean 
T/B ratio 1.64 ± 0.63). In three patients, the flow was decreased (mean 
T/B ratio 0.70 ± 0.10). For the patients with a decreased arterial flow, the 
T/B in the venous phase was 0.79 ± 0.14, for the other patients 1.23 ± 
0.16. 
Static images 
Figure 1 is a typical example of the static In-111-IgG images obtained 
in a patient with RSD. 
Visually, eight patients had a negative In-111-IgG scintigraphy. In 
these patients, T/B ratios after 48 hours were 1.20 or less with no or only 
minimal relative increase over time. In fourteen patients, a focal and with 
time increasing accumulation was noted in the affected hand (positive 
In-111-IgG scintigraphy). These fourteen patients had a T/B ratio after 48 
hours ranging from 1.28 to 1.87. On the static images, no patient had an 
activity uptake that decreased with time. The patient with bilateral RSD 
showed an elevated, over time increasing activity in both hands on the 
scintigraphic images. Two of the three patients with diminished activity in 
the flow phases had a positive In-111-IgG scintigraphy (T/B ratios after 48 
hours 1.35 and 1.73, respectively), the other patient showed symmetrical 
activity uptake after 48 hours. 
Although exercise provoked aggravation of symptoms in all patients, 
the T/B ratios did not change from the 5 minutes image to the 20 minutes 
image (Wilcoxon's signed rank test, ρ >0.10). 
The T/B ratios after 24 and 48 hours were not significantly correlated 
with the arterial and venous phase T/B ratios (Spearman's rank correlation 
test, ρ >0.10). 
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Table. Target to nontarget ratios of the individual patients at the various time 
points. 
No. 
Stage I 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
Stagen 18 
19 
20 
21 
22 
23 
0-20 
sec 
0.79 
1.13 
inc. 
0.59 
n.d. 
1.34 
1.54 
2.00 
3.26 
1.67 
1.83 
1.11 
1.24 
2.60 
1.14 
2.47 
1.11 
1.33 
1.68 
1.24 
1.10 
0.73 
20-60 
sec 
0.95 
1.14 
inc. 
0.71 
n.d. 
1.33 
1.29 
1.25 
1.61 
1.22 
1.43 
1.09 
1.14 
1.18 
1.11 
1.53 
1.05 
1.13 
1.25 
1.15 
1.03 
0.71 
Time 
5 
min 
1.12 
1.34 
1.00 
1.23 
n.d. 
1.26 
1.27 
1.12 
1.46 
1.06 
1.37 
postinjection 
20 
min 
1.09 
1.35 
0.93 
1.23 
n.d. 
1.28 
1.23 
1.15 
1.42 
1.07 
1.40 
4 
hr 
1.24 
1.41 
1.03 
1.32 
1.21 
1.50 
1.25 
1.07 
1.50 
1.05 
1.48 
Bilateral abnormalities. 
1.37 
1.07 
1.09 
1.19 
1.24 
1.00 
1.10 
1.05 
1.11 
1.00 
0.92 
1.31 
1.07 
1.06 
1.16 
1.29 
0.95 
1.09 
1.05 
1.12 
0.97 
0.86 
1.44 
1.24 
0.97 
1.15 
1.43 
1.05 
1.14 
1.08 
1.19 
0.99 
0.96 
24 
hr 
1.26 
1.50 
1.04 
1.66 
1.44 
1.60 
1.63 
1.25 
1.79 
1.13 
1.78 
1.80 
1.31 
1.12 
1.26 
1.64 
1.07 
1.13 
1.08 
1.24 
1.02 
0.95 
48 
hr 
1.35 
1.59 
1.04 
1.73 
1.44 
1.71 
1.70 
1.28 
1.82 
1.20 
1.87 
1.77 
1.37 
1.12 
1.35 
1.76 
1.11 
1.12 
1.06 
1.26 
1.06 
0.99 
no. = patient number; 
inc. = increased, no exact data available; 
n.d. = not done. 
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T/B patterns 
In eleven stage I patients and one stage II patient, pattern A was 
observed. Three stage I patients and four stage II patients showed pattern 
B. In only three patients, the flow to affected hand was relatively lower than 
the flow to normal hand. Of these three patients, two patients (both stage 
I) showed pattern С and one patient (stage II) showed pattern D. 
Correlation with duration of RSI) 
The arterial and venous phase T/B ratios were not significantly 
different for stage I and II RSD. The arterial phase T/B ratios were 1.61 
± 0.75 (range 0.59 to 3.26) and 1.20 ± 0.31 (range 0.73 to 1.68), 
respectively (Student's t-test, ρ >0.05). The venous phase T/B ratios were 
20 min. 4 h. 24 h. 48 h. 
Figure 1. In-Ul-IgG scintigraphy of a 34 years old female patient (no. 11 in the 
table), who sustained fractures of metacarpals II to IV of the right hand two 
months prior to scintigraphy. She developed a painful, swollen right hand with loss of 
function. Maximal exercise of the right hand: 5 times inflation of the manometer to 150 
mm Hg. 
From left to right: images and T/B ratios after 20 minutes, 4, 24, and 48 hours. 
Note the relative increase of activity over time in the affected right hand. 
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1.22 ± 0.24 (range 0.71 to 1.61) and 1.05 ± 0.19 (range 0.71 to 1.25), 
respectively (Student's t-test, ρ>0.05). 
The T/B ratios after 48 hours for stage I RSD were significantly higher 
for stage I compared to those of stage II RSD: 1.51 ± 0.26 and 1.09 ± 
0.09 for stage I and stage II, respectively (Student's t-test, ρ < 0.05). Figure 
2 represents the T/B ratio after 48 hours correlated with the duration of 
RSD. 
Of the seventeen patients with stage I RSD (including the patient with 
bilateral RSD), fourteen showed an over time increasing activity uptake in 
the affected hand, while only one of six patients with stage II RSD had a 
positive In-111-IgG scintigraphy (χ2 = 8.44, p<0.005). 
Figure 2. Correlation between the T/B ratio after 48 hours and the duration of RSD. 
Stage I Stage II 
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DISCUSSION 
In this study, we have found evidence of extravasation of In-111-IgG 
in early RSD. This extravasation increased with time. We and others have 
demonstrated previously that In-111-IgG accumulates with time in infectious 
and noninfectious inflammatory foci (10,11,12,13,14,15,16). This 
accumulation is most probably due to increased permeability for 
macromolecules (17,18). The steadily increasing activity of In-111-IgG over 
48 hours in fifteen of our patients therefore strongly suggests an 
inflammatory reaction in early RSD. It can not be explained by either 
increased activity of the sympathetic nervous system, abnormalities in 
vasomotor activity or psychogenic disorders. 
Since the flow phase T/B ratios - when In-111-IgG was in the 
intravascular space - and the T/B ratios after 24 and 48 hours - when a 
portion of the In-111-IgG was in the extravascular space - were not 
correlated, it appears that two separate mechanisms are involved in RSD: 
firstly, an abnormality in the blood flow of the affected hand and secondly, 
increased permeability for large proteins, sucn as In-111-IgG. The presence 
of two mechanisms was further exemplified by the two patients with a 
diminished flow that clearly showed increasing activity in the affected hand 
on the late static images. 
All patients showed abnormalities in the arterial or venous phase of 
the In-111-IgG scintigraphy. Increased flow has also been noted by other 
authors, who used the bone scanning agent technetium-99m (Tc-99m) 
diphosphonate (1,3,19,21,22). This has been explained by altered 
sympathetic nervous activity, resulting in abnormalities of the vasomotor 
tone. Blockx et al. imaged patients up to 20 minutes, using Tc-99m labeled 
human serum albumin (HSA) (23). In the majority of patients with early 
RSD, an increased flow was found, followed by a decrease of T/B ratios. 
This pattern was very similar to the pattern observed for the flow phases 
and early images of In-111-IgG: increased flow, followed by a decrease of 
the T/B ratios (In-111-IgG patterns A and B). Blockx et al. hypothesized 
that the relative decrease in the first 20 minutes was caused by a fall in 
vascular resistance due to opening of arteriovenous shunts. They considered 
the images after 10 minutes p.i. to be a steady state. Unfortunately, they 
did not perform imaging beyond 20 minutes, so evidence of extravasation 
of Tc-99m-HSA beyond these relatively early images was not available. 
Greyson et al. found in 8 of 21 patients with early RSD after a 
cerebrovascular accident decreased flow with increased uptake on the late 
diphosphonate bone scan images (1). They speculated that this was due to 
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a decreased flow to the soft-tissues, while bone blood flow was relatively 
increased. Their data were confirmed by the results of Démangeât et al., 
who found decreased arterial flow in 8 percent of their cases (19). An 
inflammatory response could also explain the scintigraphic, findings after 
administration of a bone scanning agent in RSD patients. On top of 
increased uptake in bone due to increased flow, an even larger portion of 
the Tc-99m-diphosphonate dose would be available for binding to bone 
when vascular permeability is increased. 
Despite persisting abnormalities in the arterial and venous phase, five 
out of six patients with stage II RSD had a negative In-111-IgG scintigraphy 
with regard to the static images. This indicates that the increased 
permeability for macromolecules decreases after approximately five months. 
This suggests, that the inflammatory response subsides with time. 
Démangeât et al. observed normalization of the bone scan pattern in stage 
II in 32 percent of their patients (18). 
The scarce histological findings in the literature are in agreement with 
our findings. Kozin et al. noted inflammatory changes in two patients with 
early RSD (4). Two other patients, who showed no histologic evidence of 
inflammation, had RSD for as long as one year. Since two out of four 
patients had late RSD, the time point for demonstrating inflammation in 
RSD might have been less optimal in their small group of patients. 
Therefore, one might question the validity of their conclusion that 
histologically no frank inflammation is involved in RSD. In skeletal muscle 
biopsies, taken from patients with RSD, evidence of pathologic muscle 
alterations due to oxidative stress was observed (24). Our present data are 
also in agreement with previous clinical studies that suggested the tissue 
damage in RSD was due to an inflammatory response, caused by free 
oxygen radicals (2,9). 
In conclusion, the present data support the hypothesis that a 
flow-independent, inflammatory component is present in RSD. It can be 
observed especially in early RSD and may subside in the course of the 
disease. Our findings do not support the current consensus that altered 
sympathetic activity and subsequent vasomotor tone changes are the sole 
somatic factors responsible for the development of RSD. 
From a pathophysiologic point of view, a multi-phase In-111-IgG 
scintigraphy appears to be better suited for the assessment of RSD than 
conventional three-phase bone scintigraphy, since both flow phenomena and 
late, flow-independent In-111-IgG accumulation can be evaluated. The 
evolution of the scintigraphic pattern after therapy and a possible correlation 
between scintigraphy and the outcome of therapy will be the object of 
further studies. 
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INTRODUCTION 
Fever poses a major diagnostic and therapeutic problem in patients with 
severe granulocytopenia. Approximately 70% of these patients experience 
one or more febrile episodes (1). In granulocytopenic patients, clinical signs 
of infection are often scarce and in 50 to 70% of the patients, no cause of 
the fever can be detected (2,3,4,5). Some authors estimate that 20 to 40% 
of febrile patients do not have an infection, and that the fever is of para-
neoplastic origin or caused by drugs (6). When a focus is found, the identi-
fication of the causative microorganism and installation of adequate therapy 
is facilitated. 
Recently, the utility of indium-ill-labeled human nonspecific poly-
clonal immunoglobulin G (In-111-IgG) scintigraphy to detect focal infection 
has been reported (7,8). All patients in these studies had either normal or 
elevated white blood cell counts. In this study, we addressed the issue 
whether In-111-IgG scintigraphy could be helpful in delineating infection 
in febrile granulocytopenic patients. Since Fc-7 receptors of phagocytic cells 
could be important for this imaging technique, we decided to perform an 
animal experiment in granulocytopenic rats to determine, if In-111-IgG 
showed any accumulation in infectious foci, while granulocyte counts were 
low. Stimulated by the positive outcome of the animal experiment, we 
studied a group of granulocytopenic patients to assess the potential of 
In-111-IgG scintigraphy in localizing focal infection in such patients. 
MATERIALS AND METHODS 
Radiopharmaceutical 
Human, nonspecific, polyclonal IgG (Sandoglobulin, Sandoz AG, 
Nurenberg, FRG) was conjugated to diethylenetriaminepentaacetic bicyclic 
anhydride (bicyclic DTPA) and radiolabeled with In-111 (Indium chloride, 
Amersham International Ltd., Buckinghamshire, UK) via citrate trans-
chelation (9). The labeling efficiency was always higher than 95 %. 
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Imaging Procedures 
Scintigraphic images were obtained with a Siemens Orbiter gamma 
camera connected to a Scintiview image processor (Siemens Inc., Hoffman 
Estate, II). All images were collected in a digital format with a 256 χ 256 
matrix. A medium-energy parallel-hole collimator was installed. Imaging 
was performed using both In-Ill photopeaks (173 keV peak, 15% sym­
metric window; 247 keV peak, 15% symmetric window). 
Animal Study 
In four young, randomly bred, male Wistar rats (weight 200-220 g), 
severe granulocytopenia was induced with intraperitoneally injected cyclo­
phosphamide. On Days 1, 3, and 6, a dose of 200, 100, and 100 mg cyclo­
phosphamide per kg of body weight was injected respectively. The 
granulocyte count was monitored by daily blood samples obtained by orbital 
puncture. After severe granulocytopenia had been established, an infection 
was induced on Day 6 by inoculating approximately 108 colony-forming 
units of Staphylococcus aureus in the left calf muscle. One day later, when 
gross swelling was apparent, 6 MBq of In-111 labeled to 100 /tg IgG-DTPA 
conjugate was injected in the tail vein. Scintigraphic images were recorded 
4, 24, and 48 hours postinjection (p.i.). Regions of interest with a fixed size 
were drawn over the infectious focus and the contralateral calf muscle. 
Ratios of In-111-IgG uptake in the infectious foci to that in the contralateral 
muscle were calculated. All mean values are given ± SEM. 
Patient Study 
Patients with fever and a granulocyte count below 2.0 χ 109/1 were 
eligible for the study. The criteria for fever were: oral temperature 
>38.5°С on one occasion or >38°С on two or more occasions during a 
12-hour period as described by the Consensus Panel of the Immunocompro­
mised Host Society (10). Antibiotic treatment was not stopped or altered 
during the study. The experimental nature of the imaging procedure was 
explained to the patients. Informed consent was obtained. No patient had 
a history suggestive of IgA- or IgG-deficiency or adverse reaction to 
previous IgG administration. Pregnant and lactating females were excluded 
from the study. The study was approved by the Institutional Research 
Review Board. 
Patients received an intravenous dose of approximately 1 mg of IgG 
labeled with 75 MBq In-Ill. One patient, a 15-years old female, received 
only 55 MBq of In-111-IgG for dosimetric reasons. The effective dose equi-
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valent after i.v. administration of 75 MBq In-111-IgG was calculated to be 
15 mSv and was similar to that of leukocyte scintigraphy (18 mSv after i.v. 
injection of 30 MBq In-Ill labeled leukocytes) (11,12). 
In-111-IgG images were obtained at 4, 24, and 48 hours p.i. for a 
preset time of 5, 7.5, and 10 minutes respectively. Spot views of the total 
body were obtained at least once 24 hours p.i. 
Images were interpreted independently by three observers blinded to 
the results of the verification procedures. An In-111-IgG scan was inter­
preted as positive if focally increasing accumulation of activity could be 
noted over time. 
In-111-IgG scintigraphy results were verified by clinical, roentgeno­
logical, ultrasonographical, and microbiological methods. All mean values 
are given ± SEM. 
RESULTS 
Animal Study 
On Day 6, when calf muscle infection was induced, all animals had 
severe granulocytopenia. The mean granulocyte count was 0.1 ± 0.02 χ 
lO'/l. At all times, infectious foci showed a high degree of In-111-IgG 
uptake. The ratios of In-111-IgG uptake in the focus relative to that in the 
noninfected contralateral muscle steadily increased from 2.6 ± 0.3 (4 hours 
p.i.) to 6.0 ± 0.4 (24 hours p.i.) and finally reached 12.3 ± 1.9 (48 hours 
p.i.). 
Patient Study 
Twenty patients were studied (13 males, 7 females; mean age 36.9 
years, range 15 to 63 years). Sixteen patients suffered from different types 
of leukemia, three had malignant lymphoma, one had aplastic anemia. Most 
patients were granulocytopenic due to remission induction chemotherapy 
or conditioning regimen prior to bone marrow transplantation. Patient 11 
had granulocytopenia of unknown origin. All patients were febrile for 
approximately one to two weeks. Individual hemato-oncological diagnoses, 
granulocyte cell counts, scintigraphic results and verification procedures are 
summarized in the table. All patients, except Patients 2 and 11, received 
antibiotic treatment. The mean granulocyte count was 0.4 ± 0.1 χ lO'/l, 
the median granulocyte count 0.2 χ 109/1. 
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Table. Clinical characteristics, 
verification procedures. 
granulocyte counts, results of In-111-IgG scintigraphy and 
Patient 
(sex/age) 
1 (M,39) 
2 (M,45) 
3 (M,58) 
4 (M,54) 
5 (F,43) 
6 (M,22) 
7 (F,41) 
8 (F,15) 
9 (F,44) 
10 (M,31) 
11 (M,63) 
Medical history 
ALL,BMT,GVHD 
Hairy cell leukemia 
B-CLL 
NHL stage IV-B 
AML, BMT, relapse 
AML 
Aplastic anemia 
AML 
Ileocecal NHL 
AML,BMT,GVHD 
Mediastinal NHL, 
stage I-A 
CLL 
Gran. 
(109/1) 
0.4 
1.0 
0.1 
1.3 
0.05 
0.1 
0.3 
1.7 
0.5 
0.6 
1.0 
IgG-scan 
Negative 
Negative 
Lungs 
Negative 
Mandibule 
Lungs 
Lungs 
Lungs 
Lungs 
Lungs 
Hip 
Thoracic wall 
Right lower 
abdomen 
Verification 
Thoracic wall infiltrate after Hick-
man catheter caused by SA 
No infection proven 
Pulmonary infection 
(BAL: SV, SA,HI) 
No infection (autopsy) 
Extraction of infected molar tooth 
AF infection of the lung, proven 
at autopsy 
Clinical and roentgenological 
diagnosis: Aspergillus infection 
Pulmonary infection 
(BAL: CF, HSV) 
Pulmonary infection (BAL: AF) 
Generalized toxoplasmosis infec-
tion (autopsy) 
Sterile femoral head necrosis after 
prednisone 
Thoracic wall ulcer after diagnos-
tic parasternal mediastinotomy 
Pleural effusion: photopenic on 
IgG, culture: no infection 
Surgery: perforated appendicitis 
12 (M,44) ALL, BMT 0.2 Wrist Septic arthritis with prompt 
recovery after Vancomycin 
13 (M,43) AML 
14 (F, 18) Relapse ALL 
0.2 Colon 
0.6 Negative 
15 (F,17) ALL,BMT,GVHD 0.1 Negative 
No infection proven 
No infection; skin lesions (IgG 
negative): allergic vasculitis 
No infection proven 
(Continued on next page) 
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Table. (Continued) 
Patient 
(sex/age) 
16(F,17) 
17 (M,20) 
18 (M,50) 
19 (1^,34) 
20 (М,40) 
Medical history 
AML 
ALL 
AML 
CML 
CML 
Gran. 
(109/1) 
0.06 
0.1 
0.01 
0.03 
0.05 
IgG-scan 
Right lower 
abdomen 
Negative 
Distal colon 
Lower left 
abdomen 
Oral cavity 
Negative 
Verification 
Pain and tenderness in the right 
side of the abdomen, disappeared 
in a few days, no microbiological 
confirmation 
No infection proven 
No infection proven 
Unverified (*) 
Fulminant oral mucositis. 
Shoulder (IgG negative):chloroma 
Gran. = Granulocyte count. 
ALL = Acute lymphatic leukemia; AML = Acute myelogenous leukemia; BAL = 
Bronchoalveolar lavage; BMT = Bone marrow transplant; CLL = Chronic lymphatic 
leukemia; CML = Chronic myelogenous leukemia; GVHD = Graft versus host disease; 
NHL = non-Hodgkin lymphoma. 
AF = Aspergillus fumigatus; CF = Citrobacter freundii; HI = Haemophilus influenzae; 
HSV = Herpes simplex virus; SA = Staphylococcus aureus; SV = Streptococcus viridans 
(*) Patient 19 died one week after scintigraphy. Permission for autopsy was not given. 
Patient Study: Typical Scintigraphic Findings (Figures 1-4) 
After remission reinduction therapy for relapse of acute myelogenous 
leukemia, Patient 5 developed a molar root infection, resulting in an 
infiltrate in the left mandibular region (Fig. 1A). This focus was thought 
to be the cause of her fever. Total-body imaging using In-111-IgG revealed 
a large zone with increased uptake in the area of the middle lobe of the 
right lung (Fig. IB). The chest X-ray, made a few days prior to scinti­
graphy, was normal (not shown). One week later, only mild abnormalities 
were seen on the chest X-ray (Fig. 1С). At that time, initial clinical 
symptoms of pulmonary infection were noted. A chest X-ray taken two 
weeks after scintigraphy showed a hyperdense area, matching the area of 
increased uptake on In-111-IgG scintigraphy (Fig. ID). One week later the 
patient died. Postmortem examination revealed a pulmonary infection caused 
112 
by Aspergillus fumigatus. In this case, In-111-IgG scintigraphy depicted a 
pulmonary infection, which preceded clinical symptoms and chest X-ray 
abnormalities by at least one week. 
Figure 1. Patients. (A) In-111-IgG image ofthe head (48 hours p.i.): increased uptake 
in the left mandibular region due to molar root infection (arrow). (B) Ante-
rior In-111-IgG image of the chest (48 hours p.i.): increased uptake in the middle lobe 
of the right lung (arrow). (C) Chest X-ray one week after scintigraphy: only mild abnor-
malities in the middle lobe of the right lung. (D) Chest X-ray two weeks after scinti-
graphy: large hyperdense area, matching the area of increased uptake on In-111-IgG 
scintigraphy. The patient died in shock one week later. Postmortem examination revealed 
pulmonary infection caused by Aspergillus fumigatus. In-111-IgG scintigraphy depicted 
pulmonary infection at least one week earlier than the chest X-ray. 
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Figure 2 shows the images of Patient 6, who had aplastic anemia. 
Despite antibiotic therapy he developed fever and symptoms of pulmonary 
infection. Scintigraphy showed multiple coin-shaped lesions in both lungs 
(Fig. 2A), which matched the lesions on the chest X-ray (Fig. 2B), but were 
more distinct. The clinical course was highly suspect for an Aspergillus 
infection. Cultural proof could not be obtained despite repeated broncho-
alveolar lavages. The patient died one month after scintigraphy due to 
progressive pulmonary infection. Permission for autopsy was not given. 
Figure 2. Patient 6. (A) Anterior In-111-IgG image of the chest (48 hours p.i.): 
multiple coin-shaped lesions in both lungs. (B) Chest X-ray: the abnorma-
lities match the lesions on In-111-IgG image, but are less distinct. The clinical course 
was highly suspect for an Aspergillus infection. 
Patient 11 with chronic lymphatic leukemia and high fever had no 
clinical signs of an infectious focus. On scintigraphy however, uptake of 
In-111-IgG was seen in the right lower abdomen (Fig. 3). One week later 
the patient developed abdominal pain, and a perforated appendix was 
surgically removed a few days later. 
The scintigraphic results for Patient 12, a bone marrow transplant 
recipient who developed fever and mild swelling of the wrist, depict high 
In-111-IgG uptake in the affected wrist (Fig. 4). Puncture did not yield 
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specimens for bacterial culture. After vancomycin had been added to the 
antibiotic regimen, the patient promptly recovered and the inflammation 
subsided. 
Figure 3. Patient 11. Anterior In-
Ul-IgG image of the ab-
domen (48 hours p.i.) : accumulation 
in the right lower abdomen (arrow). 
Approximately two weeks after scinti-
graphy a perforated appendix was 
removed. 
ili.. 
Figure 4. Patient 12. Image of hands 
and wrists (48 hours p.i.): 
high uptake in left wrist (arrow). 
Clinical diagnosis: septic arthritis with 
marked clinical improvement after 
antibiotic treatment. 
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Patient Study: Overall Results 
Proven Inflammatory and Infectious Foci Showing 
Increased In-111-IgG Uptake (True-Positive Studies) 
Pulmonary Lesions. Two Aspergillus fumigatus infections were proven 
by culture (Patients 5 and 8). In one patient (no. 6), the clinical and 
roentgenological course were compatible with Aspergillosis. Two patients 
(no. 3 and 7) had pulmonary infection caused by bacteria. Patient 9 had a 
toxoplasmosis infection. 
Bone and Joint Lesions. Septic arthritis showed increasing In-111-IgG 
accumulation (Patient 12). An aseptic prednisone-induced femoral head 
necrosis was also positive on In-111-IgG scintigraphy (Patient 9). 
Abdominal Lesions. An appendicular infiltrate, proven at surgery 
(Patient 11), and an infection in the right lower abdomen, suspected on 
clinical grounds (Patient 16), showed increased In-111-IgG uptake. 
Soft-tissue Lesions. A mandibular infiltrate due to a molar root 
infection (Patient 5), a postmediastinotomy thoracic wall ulcer (Patient 10) 
and a fulminant oral mucositis (Patient 19) were clearly visualized. 
No Infection, Normal In-III-IgG Scintigraphy 
(True-Negative Studies) 
A pleural effusion was photopenic on In-111-IgG scintigraphy, but 
repeated cultures remained sterile (Patient 10). Skin lesions showed no 
increased uptake and were diagnosed as allergic vasculitis and not as septic 
emboli (Patient 14). An infectious origin of a right shoulder swelling in 
Patient 20 could not be proven by cultures or roentgenological examination. 
At a later date, chloroma was proven by biopsy, histologic examination and 
subsequent response to irradiation. In five other patients with normal 
In-111-IgG scintigraphies, infection could not be proven. 
Noninfected Areas with Increased In-111-IgG Uptake 
(False-Positive Studies) 
In two cases (Patients 13 and 18), infection could not be established. 
Intense activity was seen in the large bowel. In both patients, no clinical 
or microbiological signs of abdominal infection were present. Patient 13 
remained febrile for approximately two weeks. During this period he was 
treated with Ceftazidime and Co-trimoxazole. Normalization of temperature 
coincided with an increase of the blood granulocyte count. After treatment 
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with Ciprofloxacin and Co-trimoxazole, Patient 18 became afebrile within 
two weeks after scintigraphy. 
Proven Focal Infections with no Increased In-111-IgG Uptake 
(False-Negative Studies) 
In Patient 1, a thoracic wall infiltrate caused by Staphylococcus aureus, 
showed no increased In-111-IgG uptake. During scintigraphy, however, the 
size of the infiltrate and the signs of inflammation had diminished. In the 
following weeks, an extensive Pseudomonas aeruginosa infection of the 
chest wall developed. 
For Patient 9 who had toxoplasmosis, proven infection of the heart, kidneys 
and liver showed no abnormal uptake. 
Unassessable Study 
In Patient 19, a focus in left lower abdomen could not be verified. The 
patient died one week after scintigraphy. Permission for autopsy was not 
given. 
Using the number of evaluated lesions (n=26) mentioned above, we 
calculated a sensitivity of 76%, a specificity of 78% and an accuracy of 
77% for In-111-IgG scintigraphy, with a positive predictive value of 87% 
and negative predictive value of 64%. 
DISCUSSION 
Results from the animal study showed high In-111-IgG uptake in the 
infected muscle. Although the number of animals was small and only 
Staphylococcus aureus infection was studied, the experiment showed that 
In-111-IgG accumulates in infectious foci, despite low granulocyte counts. 
In rats without granulocytopenia, the ratio of activity uptake appeared to 
be lower (between 2.3 and 3.4) (13). Higher uptake in granulocytopenic rats 
may be explained by greater outgrowth of bacteria in the absence of 
granulocytes. We chose Staphylococcus aureus infections for these experi-
ments because it is one of the few not rapidly fatal infections in 
granulocytopenic rats. Data in the literature suggest that the causative 
microorganism is not a determining factor for accumulation of radiolabeled 
IgG in infectious foci, even in immunocompromised animals (14,15,16). 
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Our results in humans indicate that In-111-IgG scintigraphy shows 
performance characteristics in granulocytopenic patients similar to those in 
patients with normal or elevated WBC (7,8). Pulmonary, abdominal, joint 
and soft-tissue infections were detected. In Patients 3 and 7, with positive 
In-111-IgG images of the lungs and clinical and roentgenological evidence 
of pulmonary infection, one has to consider the possibility that broncho-
alveolar lavage might not have recovered the actual pathogenic microbial 
flora, but resident oral contamination when the bronchoscope was passed 
through the nasopharynx. With In-111-IgG, not only bacterial, but also 
fungal infections were localized adequately and sometimes in early stages, 
as demonstrated by Patients 5 and 11. Since the diagnosis of infections 
(especially those caused by fungi) in granulocytopenic patients is notoriously 
difficult, the ability to detect such infections holds great promise, since it 
may lead to early microbiological diagnosis and specific treatment. Even 
when microbiological confirmation is not achieved, localization of a focus 
may give an indication of the causative pathogen (17). 
With regard to our false-positive studies, no infection could be proven 
in two patients showing marked In-111-IgG uptake in the large bowel. One 
reason for this accumulation might be significant mucosal barrier damage 
by cytosine-arabinoside, given two to three weeks before imaging. This 
drug is known to cause extensive desquamation of the intestinal mucosa with 
exudation and bleeding. Therefore, increased In-111-IgG uptake in the large 
bowel might have been due to increased protein leakage. Another possible 
explanation is that local bowel uptake occurred because of a chemotherapy-
induced break in mucosal integrity with local bacterial invasion but negative 
blood cultures while temperature normalized due to empiric antibiotic 
treatment. 
The number of false-negative studies was low. One focal lesion (a 
thoracic wall infiltrate) was missed. Temporary improvement of the 
infiltrate in the period of scintigraphic imaging may have accounted for the 
absence of In-111-IgG accumulation. In a patient with generalized toxoplas-
mosis, the lungs showed increased In-111-IgG uptake, whereas the heart, 
kidneys, and liver, containing multiple small lesions, appeared normal on 
scintigraphy. This is not surprising, since these organs show a relatively 
high physiological In-111-IgG uptake in all patients, thereby obscuring 
possible small lesions in these organs. 
If we assume that In-111-IgG scintigraphy is not appropriate for the 
detection of lesions in organs such as the liver, kidneys and heart because 
of high background activity, it is probably justified to delete the missed 
toxoplasmosis lesions from the calculations. This would lead to a sensitivity 
of 93%, a specificity of 78%, an accuracy of 87%, a positive predictive 
value of 87%, and a negative predictive value of 88%. 
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Until now, all investigations in febrile granulocytopenic patients 
showed low yield. Clinical signs of inflammation are often lacking (2). 
Chest X-rays may show a delay between the onset of infection and the 
appearance of abnormalities, as demonstrated in the present study by Patient 
5 (18,19). The same holds true for ultrasonography and X-ray CT scanning. 
Surveillance cultures are time-consuming, costly and have a low predictive 
value (20,21,22,23). Bronchoalveolar lavage also has a low yield, especially 
in pulmonary Aspergillosis (24). 
For scintigraphic delineation of infectious foci, several techniques are 
available. However, scarce data of scintigraphic imaging in granulocyto­
penic patients are reported. The utility of gallium-67 (Ga-67) scintigraphy 
in granulocytopenic patients is questionable, since lactoferrin from 
granulocytes is necessary for Ga-67 accumulation, resulting in frequent 
false-negative studies (25,26,27). Autologous leukocyte scintigraphy is not 
possible and anti-human granulocyte monoclonal antibody scintigraphy 
seems inappropriate in patients with low leukocyte counts. Moreover, 
human anti-mouse antibodies development poses a serious problem using 
the latter technique (28). Several reports document the utility of donor 
leukocyte scintigraphy (26,29). However, preparation of this radiophar­
maceutical is complicated, time-consuming, costly, and not free of side 
effects, such as transfusion reactions, HLA-immunization, graft versus host 
disease and the possibility of inducing viral infection (30,31,32,33,34). 
In-111-IgG on the other hand is pathogen free and readily available as a kit. 
No side effects have been seen after the administration of 1 mg dosages of 
radiolabeled IgG in more than 350 patients (7, 8, W.J.G.O.-unpublished 
data). In addition, the safety of intravenous IgG preparations has been 
established by long-term therapeutic administration in gram doses (35). 
In-111-IgG, like all scintigraphic imaging techniques used for detection 
of focal infection, does not discriminate between sterile inflammation and 
focal infection. In the present study, this is exemplified by In-111-IgG 
accumulation in a sterile femoral head necrosis. 
In one patient, an artefact was observed in the subcutaneously tunnelled 
part of the Hickman catheter due to injection of In-111-IgG through the 
catheter. Since Hickman catheters are known to be the site and source of 
infection, an optimal scintigraphic image of the tissue around the catheter 
should be obtained. Therefore, we recommend administering In-111-IgG 
through direct venipuncture in the contralateral arm. 
Despite the use of antibiotics in 18 patients, we obtained high quality 
images. Thus, it seems unnecessary to stop or alter antibiotic medication 
for imaging purposes. 
Both the animal and patient studies indicate that neutrophils are not a 
major factor in the uptake of In-111-IgG in infectious foci, making Fc-γ 
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receptor mediated accumulation an unlikely mechanism. This is in 
agreement with the hypothesis of Morrei et al., who suggest that In-111-IgG 
accumulation is caused by enhanced vascular permeability (36). 
Patients with clinically proven infectious foci represent, a population 
different from those with no clinically identifiable focus (e.g. with regard 
to the recommended antibiotic treatment, time course for treatment, and the 
outcome of the febrile episode (17). It appears, that In-111-IgG scintigraphy 
will become a valuable additional diagnostic tool for those febrile patients 
in whom no focus can be identified by conventional techniques or in whom 
an inflammatory component of known abnormalities is to be evaluated. 
Further studies are needed to establish whether In-111-IgG scintigraphy can 
contribute to the improvement of therapy in febrile granulocytopenic 
patients due to early localization of focal infection, especially in patients 
with fever of unknown origin that do not respond to antibiotic treatment. 
Furthermore, the utility of follow-up scans during or after adequate 
treatment of infection warrants further studies (7). 
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CHAPTER 7 
Evaluation of inflammatory bowel disease activity with 
indium-Ill labeled human nonspecific immunoglobulin G 
Wim J.G. Oyen, Ton HJ. Naber, Roland A.MJ. Claessens, 
Jos W.M. van der Meer, Frans H.M. Corstens 
INTRODUCTION 
Nowadays, several techniques are available to assess disease activity 
in patients with inflammatory bowel disease (IBD). These include radio-
graphic, ultrasonographical, endoscopic and scintigraphic methods. With 
regard to scintigraphic techniques, good results have been obtained using 
autologous white blood cells (WBC), labeled with either indium-Ill 
(In-111) oxine or technetium-99m-hexamethylpropyleneamine oxime 
(Tc-99m-HMPAO) (1,2). However, white blood cell labeling is rather 
complicated and time-consuming. Moreover, many nuclear medicine depart-
ments do not have facilities and sufficiently skilled staff to perform high 
quality cell labeling. Since first results with indium-Ill labeled human 
nonspecific immunoglobulin G (In-111-IgG) in patients with abdominal 
infectious foci were encouraging, we initiated a study to assess its 
usefulness to detect and localize inflammatory activity in patients with active 
IBD (3,4,5). 
PATIENTS AND METHODS 
Patients 
Four male and six female patients (mean age 40.6 years, range 25 to 
57 years) with clinically active Crohn's disease or ulcerative colitis were 
studied. Pregnant and lactating females were excluded. No patient had a 
history suggestive of severe systemic reaction after prior IgG administration 
and of IgG or Ig A deficiency. Informed consent was obtained. The study 
was approved by the Institutional Review Board of the University Hospital 
Nijmegen. 
Radiopharmaceutical 
Human nonspecific polyclonal immunoglobulin G (Sandoglobulin, 
Sandoz AG, Nurenberg, FRG) was conjugated to diethylenetriaminepen-
taacetic bicyclic anhydride (bicyclic DTPA) according to the method 
described by Hnatowich et al. and labeled with In-111 (Indium chloride, 
Amersham International Ltd., Buckinghamshire, UK) (6). Labeling 
efficiency was always higher than 95 %. A dose of approximately 1 mg of 
IgG labeled with 75 MBq In-111 was injected intravenously. 
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Imaging protocol 
Scintigraphic images were obtained with a Siemens Orbiter gamma 
camera connected to a Scintiview image processor (Siemens Inc., Hoffman 
Estate, II, USA), equipped with a medium-energy parallel-hole collimator. 
Both the 173 and the 247 keV peak of In-111 with symmetric 15% window 
were used. 
Anterior and posterior planar images of the abdomen and pelvis were 
recorded at 4, 24, and 48 hours postinjection (p.i.) for a preset time of 5, 
7.5 and 10 minutes, respectively. Typical count rates in the abdominal 
region ranged from one to 1.5 million counts, and in the pelvic region from 
600,000 to 750,000 counts. An additional image of the pelvis with the 
patient sitting above the camera surface leaning backwards, was also 
recorded at each time point. 
Single Photon Emission Computed Tomography (SPECT) was 
performed 24 hours p.i. using the same peak-energy and window settings 
as for planar imaging. Sixty four frames were recorded through 360 degrees 
with a recording time of 45 seconds per frame. Digital acquisition was 
recorded on a Microdelta computer system (Siemens Inc., Hoffman Estate, 
II, USA). Transverse, coronal and sagittal sections of 5.8 mm were 
reconstructed using a Generalized Hamming filter with a 1.0 Nyquist cut-off 
frequency and a 0.5 a weighing coefficient. 
Image interpretation and verification 
All images were interpreted by three observers, unaware of the results 
of the clinical, endoscopic, and radiographic findings. An In-111-IgG 
scintigraphy was considered positive when focal, over time increasing 
accumulation was observed. A SPECT study was considered positive when 
pathologic accumulation of activity was seen on at least two adjacent slices. 
The scintigraphic findings were compared with the results of contrast 
radiography and/or endoscopy, performed within two weeks of scintigraphic 
imaging, and - when available - the findings at surgery. 
RESULTS 
Table 1 represents the individual clinical characteristics of the patients. 
All patients with Crohn's disease had a history of partial bowel resection. 
None of the two patients with ulcerative colitis had undergone laparotomy. 
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Table 1. Clinical characteristics of the patients with inflammatory bowel disease. 
Patient 
(sex/age) History Present clinical status 
1 Crohn's disease since 5 years; 2 years ago: 
(F/25) partial colectomy and resection of distal 
ileum; ileosigmoidostomy 
2 Crohn's disease since 18 years; 16 years 
(F/51) ago: colectomy and resection of distal 
ileum; colostomy; thereafter, more than 
30 abdominal operations for relapse of 
Crohn's disease and ileus 
3 Crohn's disease since 15 years; 10 years 
(F/47) ago: partial jejunum resection, ileocecal 
resection; 8 years ago: surgery for perianal 
abscess and fistula 
4 Crohn's disease since 30 years; multiple 
(M/45) small bowel resections (remnant 145 cm) 
5 Crohn's disease since 40 years; 35 years 
(F/57) ago: ileocecal resection; thereafter: mul­
tiple small bowel resections 
6 Crohn's disease since 12 years; 12 years 
(F/38) ago: ileocecal resection and right-sided 
hemicolectomy; 2 years ago: resection 
distal ileum and ileotransversostomy; 
1 year ago: partial sigmoid resection 
7 Crohn's disease since 16 years; 10 years 
(M/30) ago: ileocecal resection 
8 Crohn's disease since 3 years; 2 years ago: 
(F/42) partial colectomy, colostomy 
9 Ulcerative colitis since 5 years 
(M/26) 
10 Ulcerative colitis since 11 years; frequent 
(M/45) relapses since 2 years 
Abdominal pain, ileus 
Severe abdominal pain 
and fever 
Diarrhoea 3-4 χ daily, 
pain in the left lower 
abdomen, fever and active 
perianal fístula 
Diarrhoea 1-7 χ daily, 
abdominal pain, mass in 
right lower abdomen 
Fever, abdominal pain, 
diarrhoea 3-4 χ daily 
Diarrhoea 7-15 χ daily, 
no fever, diffuse 
abdominal pain 
Pain right lower abdomen, 
abdominal mass, fever 
Abdominal pain and fever 
Diarrhoea 4 χ daily, mild 
abdominal pain, no fever 
Diarrhoea 10-15 χ daily, 
no pain, no fever 
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Table 2 shows the results of In-111-IgG scintigraphy and the final 
diagnosis, established at surgery, endoscopy, and/or contrast radiography. 
With In-111-IgG scintigraphy, presence and extent of small bowel 
involvement was detected in five patients, presence and extent of colon 
involvement in four patients, and perianal involvement in two patients. In 
two patients, abdominal abscesses were detected. Other imaging modalities 
did not identify additional areas of active inflammation. Figures 1 and 2 are 
typical examples of In-111-IgG images, obtained in patients with Crohn's 
disease. 
On the 4 hours p.i. images, accurate detection of disease activity was 
not possible. At 24 hours p.i., all inflammatory foci showed increased 
In-111-IgG uptake. However, definition of these lesions was better at 48 
hours p.i. compared to the 24 hours images, due to lower background 
activity and persistingly high In-111-IgG activity in the lesions. With 
SPECT, important additional information was obtained with regard to the 
localization of foci in three dimensions. Therefore, accurate assessment of 
the extent of active inflammation was only possible on the SPECT images. 
However, the appearance of accumulation in active bowel inflammation and 
Figure 1. In-111-IgG scintigraphy of patient 4 (male, 45 years) with Crohn's disease 
since 30 years. He complained of abdominal pain. In right lower abdomen, 
a mass was palpable. (A) Planar image of the pelvis, 24 hours p.i. Mild uptake in the 
right lower abdomen (arrow). (B) Coronal SPECT image. Large area of increased uptake 
in the right lower abdomen (arrow). This study shows the contribution of SPECT to ade-
quate detection of inflammatory activity. 
127 
in abscesses was indistinguishable both on the planar and the SPECT 
images. 
DISCUSSION 
In this group of patients, it was possible to adequately detect presence 
and extent of active IBD with In-111-IgG scintigraphy. Using this modality, 
all lesions, that were identified with other diagnostic techniques, were 
detected. In only one patient (no. 2), no definite proof of pathologic uptake 
of In-111-IgG could be obtained. The In-111-IgG images in this patient, 
who had clinical evidence of colon involvement, showed increased uptake 
in the colon. Colonoscopy or radiographic examination after a barium 
enema were not performed. 
Figure 2. In-111-IgG scintigraphy of patient 8 (female, 42 years) with Crohn's disease 
since 3 years. After partial colectomy 2 years ago, a colostomy was con-
structed. She had abdominal pain and fever. (A) Planar image of the pelvis, 24 hours 
p.i. Mild uptake in the right lower abdomen at the location colostomy (arrow). (B) 
Transverse SPECT image (the top of the image represents the ventral side of the 
patient). Activity uptake at the colostomy (arrow), extending dorsally in the colon 
remnant. This study shows that only with SPECT the extent of inflammatory activity 
can correctly be estimated. 
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Table 2. Areas of active inflammation identified with In-111-IgG scintigraphy and the 
correlation with other procedures. 
No. Scintigraphy Other procedures 
1 distal ileum, 
perianal region 
2 focus in lower 
abdomen 
3 distal ileum, 
whole colon, 
perianal region 
4 distal ileum 
5 small bowel 
activity in right 
middle abdomen 
6 distal ileum 
7 large focus in 
right lower 
abdomen 
8 colostomy and 
colon remnant 
9 whole colon 
10 whole colon 
E: swollen mucosa with multiple, deep ulcers in distal 
ileum and deep ulcers in mucosa of anal region; Histology: 
very active Crohn's disease of the ileum and anal mucosa 
Surgery: abscess, located ventrally of sacrum; BE (through 
colostomy): no abnormalities of colon remnant, no fistula 
SBS: inflammation of distal ileum (30 cm); clinical evi­
dence of colitis, no definite proof; productive perianal 
fistula 
SBS: stenosis distal ileum with prestenotic dilatation; US: 
thickening of bowel wall and fluid collection in right lower 
abdomen; Surgery: resection large mass right lower 
abdomen 
SBS: active inflammation in the jejunum, distal ileum 
normal; BE: no evident abnormalities (difficult reading due 
to faecal contamination); US: no evident bowel abnorma­
lities 
SBS: active inflammation distal ileum (30 cm); E: inflam­
mation of distal ileum with ulcers, Histology: active 
Crohn's disease of the ileum; 
CT: no evidence of fistulae of abscesses 
US: abdominal mass in right lower abdomen (size 4 x 7 
cm); SBS: active Crohn's disease distal ileum with abscess 
and fistula; Surgery: abscess in right lower abdomen 
BE: active Crohn's disease colon remnant; E: inflammation 
of colon remnant with ulcers; Surgery: abscess in margin of 
colostomy 
Clinically mild colitis; BE: no definite signs of active colitis 
Clinically moderately severe colitis; E: erythematous, 
swollen mucosa of the whole colon with ulcers; Histology: 
active inflammation with ulcers 
No. = Patient number. 
SBS = Barium contrast X-ray series of the small bowel; BE = Barium enema 
with X-ray series of the colon; СГ = X-ray computed tomography; US = Ultra­
sonography; E = Endoscopy. 
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At 24 hours p.i., it was possible to obtain high quality SPECT images. 
The use of this modality was obligatory for adequate delineation of the 
extent of the inflammatory activity. With In-111-IgG scintigraphy, adequate 
noninvasive imaging of the whole abdomen without discomfort or hazards 
to patient is possible. However, contrast radiography and endoscopy are the 
procedures of choice for diagnosing structural abnormalities such as stenosis 
and fistula. Moreover, with the latter technique, the mucosa can be visua-
lized directly and biopsy specimens can be obtained. 
With gallium-67 scintigraphy, some studies reported acceptable results 
in patients with abdominal inflammatory foci (7). However, nonspecific 
bowel uptake of this radiopharmaceutical may significantly interfere with 
image interpretation (8). In our experience in over 500 patients, some 
physiological In-111-IgG uptake can be encountered in the area of the large 
bowel (5). However, this faint uptake can easily be distinguished from 
pathologic In-111-IgG accumulation (4). The physical characteristics of 
Ga-67 are also not very favorable: the multipeak high-energy photons are 
not particularly suited for scintigraphic imaging with general all-purpose 
gamma cameras. Moreover, the radiation burden of Ga-67 is relatively high 
(9). 
In many clinical studies, high accuracy of labeled WBC scintigraphy 
was observed. First studies were performed using In-111 labeled WBC (1, 
10,11,12,13). Segarra et al. observed a 94 percent accuracy in a group of 
33 patients. Saverymuttu et al. and Ybern et al. also observed excellent 
correlation of In-111-WBC scintigraphy with radiographic and endoscopic 
results (11,12). Crama et al. reported 85 percent accuracy of In-111-WBC 
scintigraphy in 26 patients with active Crohn's disease of the small intestine, 
and 91 percent accuracy in 32 patients with colonic disease (13). Froelich 
et al. reported that late imaging - beyond four to six hours postinjection -
may result in false-positive images, due to leukocyte transmigration into the 
luminal contents (1). Ingested labeled leukocytes in the course of 
concomitant pulmonary infection may be another source of false-positive 
results (14). 
The development of Tc-99m-HMPAO labeling of WBC was a major 
step forward for imaging acute infection (15). However, approximately 3 
hours after injection, nonspecific biliary excretion of the radiophar-
maceutical may cause confusion in image interpretation (16). However, 
several reports indicated high accuracy within one hour after injection of 
Tc-99m-HMPAO-WBC (2,17). Lantto et al. reported an accuracy of 77% 
as early as 2 minutes after injection of the labeled WBC (18). The accuracy 
increased with time, finally reaching 95% at 4 hours p.i. Being a Tc-99m 
labeled radiopharmaceutical, both the availability and the radiation burden 
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per unit of radioactivity administered are favorable, compared to In-111 
labeled products. 
The main disadvantages of in vitro WBC labeling techniques are the 
time-consuming and rather complicated preparation. While IgG-DTPA is 
readily available as a sterile kit for rapid labeling, it takes more than two 
hours to isolate and label the WBC. However, since areas of pathologically 
increased Tc-99m-HMPAO labeled WBC uptake in the bowel can be de-
fined within four hours after injection, less time will be required for 
completion of the Tc-99m-HMPAO-WBC imaging protocol, compared to 
In-111 -IgG scintigraphy. 
The handling of possibly infected blood when preparing labeled WBC 
implies certain risks to the staff and patients (19). Therefore, nowadays 
many centres are reluctant to perform WBC labeling. Moreover, for the 
In-111 labeled preparation, the dose, that can safely be used, is limited due 
to dosimetric restrictions (radiation burden to the spleen) and possible 
radiation damage to lymphocytes (20). 
As indicated earlier, labeling with Tc-99m has advantages with regard 
to logistics and dosimetry. However, first clinical studies with Tc-99m 
labeled IgG, showed rather disappointing results in patients with IBD, due 
to both low sensitivity and physiological excretion in the bowel, interfering 
with image interpretation (21). In contrast, Buscombe et al. coinjected 
In-111 labeled WBC and Tc-99m-IgG and found 100% concordance 
between the two techniques in 16 patients with IBD (22). 
A different approach for labeling WBC is the use of specific 
monoclonal antigranulocyte antibodies (MAb). M Ab supposedly label 
granulocytes in vivo by binding to an epitope on the surface membrane of 
granulocytes. First results of studies with the BW 250/183 murine anti-
granulocyte antibody showed promising results with regard to detection of 
inflammatory activity. Segarra et al. reported very similar results in a study 
comparing Tc-99m-BW 250/183 and In-111 labeled WBC scintigraphy (10). 
Perkins et al. reported good concordance of immunoscintigraphy with 
conventional examinations in sixteen patients with IBD (23). However, since 
only a minor part of the administered dose is bound to circulating granulo-
cytes, one might question whether the uptake in inflammatory foci is 
granulocyte-associated activity. Moreover, the discussion on the relevance 
of development of human anti-mouse antibodies (HAMA) after injection of 
antigranulocyte antibodies of murine origin has not been finalized as yet. 
Especially in patients with benign disease, HAMA development is an un-
desirable sequel, since it may induce allergic reactions, increased liver 
uptake and interference with radioimmunoassays (24,25). 
Dawson et al. reported the use of orally administrated Tc-99m labeled 
sucralfate for diagnosing IBD and for the evaluation of disease activity (26). 
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Although it appeared to be an adequate and convenient technique, it has not 
gained great popularity. The main disadvantage of sucralfate scanning is the 
inability to detect extraluminal disease. 
In conclusion, it appears possible to assess the presence and extent of 
active fflD with In-111-IgG scintigraphy. High-quality SPECT is feasible 
and essential for accurate localization of active inflammation. In-111-IgG 
scintigraphy deserves a place in the evaluation of IBD, especially when the 
patient is severely ill, in case it is too dangerous to perform invasive 
techniques, and in those patients in whom it is mandatory to assess 
inflammatory activity proximal to stenosis (27). However, several aspects 
of this new technique need fiirther clarification. For example, it is not 
known in what chemical form In-111 is present in the inflammatory lesion 
and in the bowel content. Furthermore, as yet we do not know to what 
extent accumulation of radioactivity correlates with well-established indices 
of disease activity. 
Compared to labeled WBC, the preparation of In-111-IgG is con­
venient. Potential hazards of handling blood are avoided. However, for 
identification of significant structural abnormalities, diagnostic procedures 
- such as endoscopy and contrast radiography - are necessary. Therefore, 
we feel that In-111-IgG scintigraphy is not a replacement for these 
techniques, but a complementary diagnostic tool for noninvasive assessment 
of inflammatory lesions in patients suspected of exacerbation of disease 
activity. 
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INTRODUCTION 
Indium-Ill labeled autologous leukocyte (In-111-WBC) scintigraphy 
is widely accepted as the standard technique for the scintigraphic delineation 
of infectious and inflammatory foci. High accuracy of this imaging 
procedure has been reported, especially in acute infections (1). However, 
preparation of In-111-WBC is time-consuming, complicated and costly. 
Moreover, obtaining sufficient viable leukocytes is more difficult when the 
peripheral leukocyte count is less than 2 χ IO9 /1 and practically impossible 
when less than 0.5 χ IO9 /1. 
Several reports suggested the utility of indium-Ill labeled human 
nonspecific polyclonal immunoglobulin G (In-111-IgG) scintigraphy for the 
detection of infectious foci (2,3,4,5). In-111-IgG is a convenient 
radiopharmaceutical that is readily available as a kit and that can be 
prepared in less than 30 minutes. If the performance of In-111-IgG 
scintigraphy would be equal to or better than that of In-111-WBC 
scintigraphy, adequate imaging of focal infection and inflammation becomes 
available on a much larger scale. The present study reports the results of 
a direct comparison of In-111-IgG scintigraphy to In-111-WBC scintigraphy 
in a prospective study of patients with subacute infection. 
PATIENTS AND METHODS 
Radiopharmaceuticals 
Іп-111-WBC. Total white blood cell count and differentiation were 
determined. Forty to 50 ml of blood were drawn by venipuncture in a 
syringe containing 10 ml acid citrate dextrose (ACD). Under strictly sterile 
conditions 6 ml 6% hydroxyethyl starch were added to 50 ml ACD-blood. 
The erythrocytes were allowed to sediment for one hour. The supernatant 
was removed and centrifuged for 10 minutes at 150 g. The cell pellet was 
washed with 5 ml of a 1 % human serum albumin (HSA) solution in isotonic 
phosphate buffered saline (PBS) buffer (pH=7.4) and centrifuged once more 
for 10 minutes at 150 g. The cell pellet was resuspended in 1.5 ml of a 1 % 
HSA solution in isotonic PBS buffer. Twenty five to 30 MBq In-111-oxine 
solution (In-111-oxine DRN 4908, Mallinckrodt Diagnostica Holland, 
Petten, The Netherlands) in 0.2 M Tris(hydroxymethyl)aminomethane 
(pH = 8.0) was added to the cell suspension. Incubation at room temperature 
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continued for 30 minutes. After centrifuging a third time for 10 minutes at 
150 g, the supernatant was discarded and the cell pellet was resuspended 
in 5 ml of a 1% HSA solution in isotonic PBS buffer. Morphological 
integrity of the leukocytes was checked by light microscopic examination. 
Labeling efficiency, determined by measuring cell associated and 
supernatant activity in a sample of the labeled WBC suspension, was always 
higher than 95%. A dose of 25 to 30 MBq of In-111-WBC was injected 
intravenously. 
In-111-IgG. Diethylenetriaminepentaacetic bicyclic anhydride (bicyclic 
DTPA) was conjugated to HIV and HBsAg-negative, human, nonspecific, 
polyclonal IgG (Sandoglobulin, Sandoz AG, Nurenberg, FRG) according 
to the method described by Hnatowich and colleagues (6). Two to three 
DTPA ligands were coupled to one IgG molecule. The purified 
DTPA-conjugated IgG was diluted to 2 mg/ml with 0.15 M acetate 
(pH = 6.5) and sterilized by membrane filtration. Aliquote of 0.5 ml of the 
conjugate were radiolabeled with In-111 (Indium chloride, Amersham 
International Ltd., Buckinghamshire, UK) via citrate transchelation. Radio-
chemical purity was determined by ITLC-SG chromatography (Gelman 
Laboratories, Ann Arbor, MI) with 0.1 M citrate (pH=5) as the solvent. 
The labeling efficiency was always higher than 95%. A dose of 
approximately 1 mg of IgG labeled with 75 MBq In-111 was injected 
intravenously. 
Study design 
Since both radiopharmaceuticals were labeled with In-111, the 
investigations had to be separated in time to allow clearance of the 
radiopharmaceutical that was administered first. The maximal In-111 dose 
that can be safely injected with leukocytes is limited to 30 MBq (7,8). This 
strict limitation of the In-111 does not apply to the administration of 
In-111-IgG (9). Therefore, in this study In-111-WBC scintigraphy was 
performed first, and In-111-IgG scintigraphy one week later; in that way 
adequate images of both radiopharmaceuticals could be obtained, while 
imaging times remained reasonable. Immediately before the administration 
of In-111-IgG, the remaining activity of In-111-WBC in the liver and the 
spleen region was determined and compared to the activity in the 
In-111-IgG image that was obtained 4 hours postinjection (p.i). 
Patients 
Patients with normal or elevated peripheral leukocyte counts, in whom 
a In-111-WBC scintigraphy was indicated, because of a suspected focal 
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infection or inflammation, were eligible for the study. Patients who did not 
have a stable medical condition for the interval between the two imaging 
techniques were excluded. 
No patient had a history suggestive of IgA- or IgG-deficiency or 
adverse reaction to previous IgG administration. Pregnant and lactating 
females were excluded. Informed consent was obtained from all patients. 
The study was approved by the Institutional Review Board of the University 
Hospital Nijmegen. 
Thirty five patients were studied (17 males, 18 females; mean age 51.8 
years, range 18 - 87 years). The mean WBC count was 8.9 χ IO9 /1 (range 
3.6 - 19.0 χ 10' /1. The relative number of granulocytes was always higher 
than 60% of the total WBC count. None of the patients was immunocom­
promised. 
Three other patients were excluded from the study: one patient due to 
progressive disease, one patient due to regression of an infectious focus and 
in the third patient the scintigraphic results could not be verified. 
Imaging procedures 
Scintigraphic images were obtained with a Siemens Orbiter gamma 
camera connected to a Scintiview image processor (Siemens Inc., Hoffman 
Estate, II, USA). All images were collected in digital format in a 256 χ 256 
matrix. A medium-energy parallel-hole collimator (173 keV peak, 15% 
symmetric window; 247 keV peak, 15% symmetric window) was used. 
Both In-111-WBC and In-111-IgG images were acquired at 4, 24 and 
48 hours p.i. for a preset time of 5, 7.5, and 10 minutes, respectively. At 
least once, 24 hours p.i., spot views of the total body were obtained. 
The remaining In-111-WBC activity in the liver and spleen region, 
determined immediately before In-111-IgG injection, was always lower than 
10% of the In-111-IgG activity in the same region on the image obtained 
4 hours after In-111-IgG administration. 
All images were interpreted by three observers, blinded to the results 
of the verification procedures. An In-111-WBC scintigraphy was interpreted 
as positive, if consistent, focally increased uptake was seen during the 
study, excluding known causes for artifacts. An In-111-IgG scan was 
interpreted as positive, if focally increasing accumulation could be noted 
over time, since hyperemic noninflamed lesions initially show some uptake 
but no further accumulation of In-111-IgG over time (5). 
The results of the scintigraphic findings were verified by clinical, 
roentgenological and ultrasonographical methods and, if possible, by 
bacterial cultures. The outcome of the two imaging techniques was 
analyzed, using the x2-test. 
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RESULTS 
The clinical characteristics, scintigraphic results and verification 
procedures are summarized in the tables 1 and 2. Table 1 represents those 
patients with infections predominantly of the locomotor system, table 2 
those patients with other types of infection. All possible infections were 
either subacute - duration of illness for several weeks - or chronic - duration 
of illness for months or even years -. 
All lesions in the locomotor system (table 1) were correctly identified 
with In-Ul-IgG scintigraphy. Two cases of arthritis and two cases of 
osteomyelitis were missed with In-111-WBC scintigraphy. One rib lesion 
on In-111-WBC scintigraphy could not be proven by other diagnostic tech­
niques. Figure 1 shows the concordant In-111-IgG and In-111-WBC images 
of a soft-tissue infection, caused by hemolytic Streptococci in patient 9. 
In patient 15 (table 2), abscesses in the liver, caused by Bacteroides 
fragilis, were seen on the In-111-WBC scintigraphy, while In-111-IgG was 
distributed homogeneously in the liver. This was the only patient with 
verified infectious foci, which were correctly identified with In-111-WBC, 
but missed with In-111-IgG scintigraphy. 
Figure 1. Concordant In- i l l -IgG and In- 111 -WBC scintigraphies : soft-tissue infection 
of the upper left leg (large arrows), extending to the bladder region (small 
arrows), in patient 9, due to hemolytic Streptococci. 
(A) In-111-IgG scintigraphy, posterior view of the pelvis, 48 hours postinjection. (В) 
In-1 II WBC scintigraphy, posterior view of the pelvis, 48 hours postinjection. 
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Table 1. Clinical characteristics, scintigraphy and verification results for patients with infections 
of the locomotor system. 
Patient 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Sex/Age 
(WBCC) 
F/79 
(8.7) 
F/59 
(8.4) 
F/51 
(6.4) 
M/54 
(13.1) 
M/32 
(11.1) 
F/43 
(7.5) 
F/87 
(4.9) 
M/34 
(6.6) 
F/61 
(15.6) 
F/76 
(11.7) 
F/66 
(4.7) 
F/27 
(3.6) 
M/60 
(17.2) 
F/67 
(4.9) 
Duration 
2 mo 
2 mo 
3 mo 
10 yr 
lyr 
2 mo 
2 wk 
4wlc 
3 wk 
4 mo 
6wk 
3 wk 
3 wk 
9 mo 
Suspected focus 
Shoulder 
Knee 
Lumbar spine 
Total hip prosthesis 
Proximal femur 
Lumbar spine 
Femoral blood 
vessels 
Sternum 
Tibia 
Delayed healing of 
tibial fracture 
Toe 
Клее 
Total hip prosthesis 
Sternum 
Upper leg/pelvic 
soft-tissues 
Total hip prosthesis 
Thoracic spine 
Hip 
Shoulder 
Upper leg 
Shoulder 
Foot 
Total hip prosthesis 
Scintigraphy 
WBC IgG 
+ 
+ 
+ 
— 
+ 
— 
+ 
— 
+ 
— 
— 
— 
— 
— 
+ 
— 
+ 
— 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
— 
+ 
— 
— 
— 
+ 
— 
+ 
+ 
— 
+ 
+ 
— 
+ 
+ 
+ 
+ 
+ 
+ 
Proc. 
Ρ 
Ρ 
Ρ 
F,R 
S 
Ρ 
F 
F.R.C 
F,R 
S 
C,R 
Ρ 
F.R 
C.R.F 
Ρ 
F,R 
Ρ 
Ρ 
S 
S 
s 
Ρ 
F,R 
Verification 
Result 
\ 
— MT infection 
/ 
no evidence of infection 
nonspecific osteomyelitis 
no infection 
no evidence of infection 
or thrombosis 
no evidence of persisting 
infection 
osteomyelitis of tibia 
(productive fistula) 
noninfected osteosyn­
thesis after fracture 
SA osteomyelitis of toe 
synovitis 
no evidence of infection 
SM osteomyelitis 
HS infection 
no evidence of infection 
HS infection 
HS infection 
SA arthritis 
\ 
— SA infection 
/ 
no evidence of infection 
WBCC = white blood cell count (x lO'/liter). С = bacterial cultures; F = clinical follow-up of at least 3 
mo; Ρ = puncture/biopsy; R = roentgenologic procedures, including CT scanning and ultrasonography; S 
= surgery. HS = ^-hemolytic streptococcus; MT = mycobacterium tuberculosis; SA = staphylococcus 
aureus; SM = streptococcus mitis. 
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Figure 2 represents the images of patient 16 who had diverticulitis. 
With In-111-IgG scintigraphy inflammatory activity was adequately 
detected, while In-111-WBC scintigraphy showed no abnormalities. In a 
splenectomized patient (no. 17), In-111-WBC scintigraphy indicated left 
sided, subphrenic activity, while no elevated In-111-IgG uptake was seen. 
At surgery, neither abdominal infection nor accessory splenic tissue were 
found. 
Figure 3 shows the images of patient 32 who had renal failure due to 
polycystic kidneys and Escherichia coli infection of a renal cyst. There is 
increased In-111-IgG uptake, but no abnormal In-111-WBC accumulation. 
Two patients had malignant tumors. In patient 8, a mediastinal 
malignant non-Hodgkin lymphoma was diagnosed. Patient 23 had an 
alveolar cell carcinoma of the lung and a malignant non-Hodgkin 
lymphoma. The tumors did not show pathological In-111-WBC or 
In-111-IgG accumulation. 
When using lesions rather than patients, sensitivity and specificity in 
this group of patients were 74% and 100% for In-111-IgG scintigraphy and 
52% and 78% for In-111-WBC scintigraphy respectively. The differences 
between the two techniques are significant (χ2 = 6.50, ρ <0.01). 
Figure 2. True-positive In-111 -IgG scintigraphy and false-negative In-111 -WBC scinti­
graphy: diverticulitis of the sigmoid, proven at endoscopy, in patient 16. 
(A) In-111-IgG scintigraphy, anterior view of the pelvis, 48 hours postinjection: 
increased In-111-IgG uptake in the lower left abdomen (arrow). (B) In-111 WBC 
scintigraphy, anterior view of the pelvis, 48 hours postinjection: no abnormal 
accumulation of activity in the abdomen. 
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Table 2. Clinical characteristics, scintigraphy and verification results for patients with other types 
of infection. 
Patient 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
(Continu 
Sex/Age 
(WBCC) 
M/23 
(8.8) 
F/80 
(5.7) 
F/32 
(8.9) 
F/42 
(10.9) 
M/49 
(5.1) 
F/65 
(5.0) 
M/27 
(5.6) 
M/60 
(10.2) 
M/76 
(5.3) 
M/81 
(10.8) 
F/42 
Duration 
1 mo 
3 wk 
1 mo 
1 mo 
1 mo 
6 mo 
lyr 
4 wk 
4wk 
4wk 
6 mo 
(8-8) 
ted on next page) 
Suspected focus 
Liver 
Lower abdomen 
Abdomen.persisting 
infection after 
splenectomy 
Abdomen 
Treated EC sepsis, 
no focus 
Fever of unknown 
origin 
Fever of unknown 
origin 
Fever of unknown 
origin 
Fever of unknown 
origin 
Endocarditis 
Femoral blood 
vessels 
Rib 
Aorto-bifemoral 
vascular graft 
Scintigraphy 
WBC IgG 
+ 
— 
+ 
— 
— 
— 
— 
— 
+ 
+ 
— 
— 
+ 
— 
— 
— 
— 
— 
— 
— 
— 
Proc. 
R,C 
E 
S 
S 
F,C,R 
F.C.R 
F.C.R 
F,C,R 
F.CR 
C.R 
F 
F.R 
S 
Verification 
Result 
multiple BF liver 
abscesses 
diverticulitis of sigmoid 
no infection, no acces-
sory splenic tissue 
polycystic ovaries, no 
infection 
no evidence of persisting 
infection 
no cause identified 
no infectious focus 
identified, fever of 
hypothalamic origin 
no cause identified 
no evidence of infection, 
fever caused by malig-
nant lymphoma or lung 
carcinoma 
EA infection 
no evidence of infection 
or thrombosis 
no evidence of infection 
infected graft (intestinal 
bacteria) 
DISCUSSION 
The results of the present prospective comparative study indicate that 
In-111-IgG scintigraphy performed significantly better than In-111-WBC 
scintigraphy in this group of patients with subacute infections. The majority 
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Table 2. (continued) 
Patient 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
Sex/Age 
(WBCC) 
F/22 
(9.2) 
M/38 
(11.1) 
M/30 
(19.0) 
M/59 
(6.6) 
F/55 
(8.9) 
M/75 
(11.4) 
M/58 
(10.4) 
F/59 
(6.1) 
M/25 
(7.2) 
M/18 
(10.7) 
Duration 
6wlc 
4wk 
6wk 
6wk 
1 mo 
3 wk 
2 wk 
2 mo 
3 wk 
lyr 
Suspected focus 
Pulmonary 
tuberculosis 
Hilar lymph node 
involvement 
Pulmonary 
tuberculosis 
Pulmonary 
tuberculosis 
Pulmonary 
tuberculosis 
Eye, treated CA 
endophthalmitis 
Eye 
Shoulder 
Polycystic kidneys 
Polycystic kidneys 
Treated pyelo­
nephritis of renal 
transplant 
Positive yersinia 
serology, no focus 
Positive yersinia 
serology, no focus 
Scintigraphy 
WBC IgG 
— 
+ 
+ 
+ 
— 
— 
— 
— 
— 
— 
— 
— 
— 
+ 
+ 
— 
— 
+ 
— 
+ 
— 
— 
Proc. 
C,R 
R,F 
C,R 
C,R 
C,R 
F 
S 
Ρ 
C,F 
F,C 
F,C,P 
F,R 
F,R 
Verification 
Result 
primary MT infection 
upper lobe of left lung 
no evidence of lymph 
node involvement 
primary MT infection 
upper lobe of both lungs 
primary MT infection 
both lungs 
miliary MT infection 
of lungs 
no evidence of persisting 
infection 
SP endophthalmitis 
no evidence of infection 
EC infection of renal 
cyst 
no evidence of infection 
no evidence of persisting 
infection 
no focus identified 
no focus identified 
WBCC = white blood cell count (x lO'/liter). С = bacterial cultures; E = endoscopy, F = clinical follow-up 
of at least 3 mo; Ρ = puncture/biopsy; R = roentgenologic procedures, including CT scanning and 
ultrasonography; S = surgery. BF = bacteroides firagilis; CA = candida albicans; EA = enterobacter 
aerogenes; EC = Escherichia coli; MT = mycobacterium tuberculosis; SP = streptococcus pneumoniae. 
of the detected infections was localized in the locomotor system. In this 
group of patients, In-111-WBC performed relatively poor, while In-111-IgG 
scintigraphy showed an excellent accuracy. The usefulness of In-111-IgG 
scintigraphy for detection of infections of the locomotor system corroborates 
the results in a previous study from our group, in which no comparison was 
made with In-111-WBC scintigraphy (5). The relatively poor performance 
143 
of In-Ul-WBC scintigraphy in subacute infectious bone and joint disease 
is in agreement with the findings of other authors (1,10,11). 
The scintigraphic results in the patient with liver abscesses cannot be 
explained satisfactorily. A possible explanation for the normal In-111-IgG 
images could be, that the degree of inflammation decreased under treatment 
(a daily dose of 2 g of metronidazole intravenously). 
В 
С Figure3. True-positive In-111-IgG 
scintigraphy and false-
negative In-111 - WBC scintigraphy : 
Escherichia coli infection of a cyst in 
the left kidney of patient 32 with renal 
failure due to polycystic kidneys. The 
patient was on hemodialysis. (A) 
Tc-99m-mercaptoacetyltriglycinescin-
tigraphy, posterior view of the kid­
neys, 15 minutes postinjection: iden­
tification of residual kidney function. 
Note: no functional kidney tissue in 
the lower pole of the left kidney 
(arrow). (B) In-111-IgG scintigraphy, 
posterior view, 48 hours postinjection: 
increased uptake in the lower pole of the left kidney (arrow). (C) In-111-WBC scinti­
graphy, posterior view, 48 hours postinjection: absence of accumulation of activity in 
the renal regions. 
• ч * ^ 
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The performance of In-111-IgG scintigraphy in abdominal infections 
is in agreement with data in the literature (2). Although accessory splenic 
tissue was not found at surgery in the splenectomized patient, it could have 
been the cause for the false-positive In-111-WBC scintigraphy. Unfortu-
nately, Tc-99m sulphur colloid scintigraphy could not be performed. 
Both In-111-WBC and In-111-IgG scintigraphy missed a case of 
endocarditis. This was not surprising since In-111-IgG shows a 
physiological high blood pool activity in all patients, thereby obscuring 
possible cardiac lesions. Moreover, these small lesions show only mild 
inflammation. 
In four patients with vascular lesions, In-111-WBC scintigraphy 
showed two sites of accumulation in the femoral vein or artery. Since 
clinical examination and follow-up ruled out infection or thrombosis, the 
two lesions had to be considered false-positive. Both techniques apparently 
missed a low-grade infection of a vascular graft. However, data in the 
literature suggest that In-111-IgG scintigraphy is a good technique for 
evaluation of vascular graft infection (4). 
Both techniques showed variable results in the delineation of 
tuberculous infection. Large lesions were adequately detected, whereas 
small infectious foci were missed. One probable explanation for the negative 
WBC scintigraphies is that lymphocytes and macrophages, rather than 
granulocytes, are involved in a tuberculosis infection. 
The detection of an infected renal cyst with In-111-IgG was only 
possible because this patient had renal failure and was on hemodialysis. In 
patients with normal renal function, it will be nearly impossible to delineate 
infection in the kidneys, since the physiological In-111-IgG uptake in 
kidneys will most probably obscure pathological accumulation. The utility 
of In-111-IgG scintigraphy for detection of infectious foci in uremic patients 
is not well established. Tolkoff and Rubin suggested that under these 
circumstances In-111-IgG accumulation in infectious foci is poor (12). 
The normal scintigraphy of the two patients with active disseminated 
yersiniosis can probably be explained, according to the literature, by the 
small size of the infectious foci and the localization in mesenteric 
lymphnodes and parenchymatous organs (13). Detection of such small 
lesions with moderately increased activity is not possible due to a relatively 
poor target to nontarget ratio and to the limited resolution of the gamma 
camera, especially when localized in organs with relatively high physio-
logical activity uptake such as liver and kidneys. 
The subacute nature of the infections we studied, in many patients not 
accompanied by leukocytosis, could partially explain the relatively large 
number of false-negative In-111-WBC results. The number of WBC appears 
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not to be a major factor in In-111-IgG accumulation, since In-111-IgG 
accumulated in infectious foci in granulocytopenic patients (14). 
In-111-WBC have a half-life in circulation of approximately six hours 
(15). This fast blood clearance results in low background activity. With 
In-111-IgG scintigraphy target to background ratios were lower due to the 
relatively slower blood clearance of In-111 -IgG (t,^ approximately 24 hours) 
(5). However, this did not significantly interfere with image interpretation 
at 24 and 48 hours. 
When designing the comparative study, several options were 
considered. Random sequence of the two techniques would have been the 
best choice. This was reluctantly rejected for a number of reasons. The 
In-Ill dose that can be safely injected with leukocytes is limited to 30 
MBq, because of possible chromosomal damage to long-lived T-lympho-
cytes and the radiation burden to the spleen (7,8). Biodistribution and 
kinetic studies showed that this strict limitation of the In-111 does not apply 
to the administration of In-111-IgG (9). If one would choose to perform the 
investigations in a random sequence, it would be necessary to lower the 
injected In-111-IgG dose to approximately 15 MBq for the first 
investigation. This would lead to unacceptable long imaging times or to 
statistically inadequate images. Injection of the full dose of 75 MBq 
In-111-IgG before the In-111-WBC scintigraphy would increase the time 
span between the two studies to at least two weeks, in order to avoid 
significant In-111-IgG contribution to the In-111-WBC images. Moreover, 
the In-111-WBC scintigraphy, being the standard procedure, was considered 
to be of clinical importance and therefore was accepted in the final study 
design as the first procedure. In the current study, their was no significant 
contribution of In-111-WBC activity in the In-111-IgG images. 
When comparing In-111-WBC and In-111-IgG scintigraphy in a fixed 
sequence, the two investigations had to be separated in time. This introduces 
some inevitable bias. In-111-IgG scintigraphy was systematically placed in 
a disadvantageous position, since many patients were treated for a longer 
period of time. Only patients with disease in a relatively stable and subacute 
condition were eligible for the study. Patients with acute infections, who 
required immediate invasive therapy after completion of the In-111-WBC 
scintigraphy, were not studied in this protocol. Nevertheless, we feel that 
the patients studied are representative candidates for such imaging 
procedures, since a major indication for these scintigraphic techniques is 
localization of chronic infection. While data in the literature as well as our 
own experience suggest that acute infections can be adequately detected with 
both In-111-WBC and In-111-IgG scintigraphy, clinical examination and 
other imaging techniques are usually sufficient (2,16). 
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Alternatives for comparative studies between WBC and IgG 
scintigraphy would be to label one of the two pharmaceuticals with Tc-99m. 
Buscombe et al. found that Tc-99m-IgG and In-111-WBC scintigraphy 
showed excellent concordance (17). In this study, the authors co-injected 
both radiopharmaceuticals. They did not provide information as to whether 
In-Ill scatter in the Tc-99m window at 24 hours postinjection could have 
possibly contributed to some extent to the concordance between the two 
techniques at 24 hours postinjection. In their study protocol, In-111-WBC 
scintigraphy was the golden standard. In our study, we found thirteen 
false-negative In-111-WBC scintigraphies, mainly inpatients with low-grade 
bone and joint infections. An important question is whether Tc-99m labeled 
IgG performs equally to In-111-IgG. In an artificially induced calf muscle 
abscess in rats, we found that Tc-99m-labeled IgG shows relatively poor 
uptake when compared to In-111-IgG uptake, although target to nontarget 
ratios were similar (18). Another alternative for comparing In-111-IgG 
scintigraphy with labeled WBC could be Tc-99m labeling of WBC. 
Tc-99m-hexamethylpropyleneamine oxime (HMPAO) labeled WBC seems 
to be a useful technique for labeling leukocytes with Tc-99m and appears 
promising in chronic infectious disease in humans (19,20,21). However, 
a disadvantage of this technique is the rapid biliary excretion of 
Tc-99m-HMPAO interfering with interpretation of abdominal images 
obtained later than two to three hours postinjection. The Tc-99m colloid 
labeling of leukocytes in full blood is poorly established (22,23,24). A 
major limitation of every radiopharmaceutical labeled with Tc-99m is that 
imaging beyond 24 hours after injection is impossible. 
Although gallium-67 has been used successfully in the evaluation of 
patients with subacute and chronic illness, the multipeak high-energy gamma 
rays, the physiological bowel excretion and the nonspecific uptake in tumors 
and in areas of increased bone turn-over, make gallium-67 citrate a less 
optimal radiopharmaceutical for delineating infection (17,21). 
The mechanism of In-111-IgG accumulation is not fully elucidated as 
yet. Increased vascular permeability and nonspecific macromolecular 
entrapment in inflammatory foci is the most probable hypothesis (14,25). 
Notwithstanding the unclarity with regard to the mechanism of accumulation 
of IgG, the present study shows that In-111-IgG scintigraphy performs 
significantly better in patients with subacute infections than In-111-WBC 
scintigraphy. In addition, In-111-IgG is a more convenient radiopharma-
ceutical, that is readily available as a sterile, pyrogen free kit for fast 
labeling obviating the need for handling patients' blood and a three hours 
labeling procedure. Moreover, since IgG is a human protein, there is no 
risk for the development of human anti-mouse antibodies which may cause 
side effects (26,27). 
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CONCLUSIONS AND FUTURE PROSPECTS 
Infection and inflammation are common clinical problems. Improve-
ment of techniques for delineating active disease are still necessary. 
Ultrasonography, X-ray computed tomography and magnetic resonance 
imaging are especially helpful in depicting structural abnormalities. 
However, using these techniques, it is often not possible to differentiate 
active disease from persisting abnormalities after subsidence of infection. 
In contrast, scintigraphic techniques do not depend on structural changes, 
but exhibit physiochemical properties. Increased or decreased accumulation 
of radiopharmaceuticals represent local changes in handling of these 
compounds under pathological conditions. Therefore, scintigraphic images 
portray pathophysiological processes rather than changes in structure and 
anatomy. The ability to perform whole body imaging without inconvenience 
to the patient is an important additional option of nuclear medicine 
techniques. 
Disadvantages and limitations of the radiopharmaceuticals, currently 
used for imaging infection and inflammation, warrant continuing research 
efforts to improve scintigraphy of infectious and inflammatory lesions. 
As indicated in chapter 1, gallium-67 (Ga-67) citrate is a well-known 
and frequently used radiopharmaceutical. Although the characteristics of Ga-
67 are by far not ideal, favorable results were reported, especially in 
delineating chest infections and infections of the locomotor system. Under 
these conditions, In-111-IgG scintigraphy shows at least equal results 
(chapter 3, 4, 6, and 8). Physiological excretion in bowel does severely 
hamper diagnostic accuracy of Ga-67 in the abdomen. In contrast, 
physiological bowel uptake of In-111-IgG is only minimal and does not 
interfere with assessment of bowel inflammation (chapter 7). Avid 
accumulation of Ga-67 in lymphoma and in noninfected areas of increased 
bone turn-over may cause diagnostic problems. Although it has been 
reported that In-111-IgG accumulates in inflamed tumors, there is no 
significant uptake in lymphoma (chapter 6). The multipeak, high-energy 
photons of Ga-67 are not ideal for scintigraphic imaging, because most 
gamma cameras are designed for lower energy photons. Moreover, the 
radiation burden after administration of recommended doses Ga-67 is 
relatively high. The radiation burden after In-111-IgG injection appears to 
be significantly lower. 
Labeled autologous white blood cell (WBC) scintigraphy shows 
excellent results, especially in acute infection. However, as indicated in 
chapter 8, In-111-IgG scintigraphy shows a better sensitivity in subacute 
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and chronic infection. Another advantage of In-111-IgG is its suitability in 
febrile granulocytopenic patients (chapter 6). Major drawbacks of labeled 
WBC scintigraphy are the time-consuming and relatively complicated 
labeling procedure as well as the fact that quality control is far from easy. 
Furthermore, there are two major concerns: the handling of possibly 
infected blood with the inherent risk of contamination of personnel and the 
ever existing chance of administering blood cells to the wrong patient. 
These problems require meticulous care by the staff. In contrast, IgG-DTPA 
conjugate is readily available as a sterile, pyrogen-free kit for convenient, 
one step In-111 labeling. After preparation, the quality of the labeled IgG 
can easily be assured before administration to the patient. 
The discussion on whether to prefer In-111 or Tc-99m labeling of IgG 
has not been finalized. In favor of Tc-99m labeling are both physical (better 
photon flux, lower radiation burden) and logistic (continuous availability) 
properties. However, in view of the relatively high background activity of 
labeled IgG, In-111-IgG appears better suited for delineating subacute 
infection, because imaging beyond 24 hours postinjection is possible. 
Moreover, In-111-IgG scintigraphy appears to give better results in 
evaluation of bowel infection and inflammation, due to both greater 
accumulation in lesions and insignificant nonspecific bowel uptake. 
In-111-IgG has clear advantages over the currently available labeled 
monoclonal antigranulocyte antibodies. Human IgG in an unlabeled form 
has proven for many years to be a safe agent both for prophylaxis and 
therapy. In contrast, most currently used monoclonal antibodies are of 
murine origin and induce immune responses. The development of human 
antimouse antibodies (HAMA) is unwanted, especially in patients with 
benign disease. After repeat administration, HAMA may cause allergic 
reactions and increased liver uptake of the radiopharmaceutical. Moreover, 
HAMA may interfere with the results of radioimmunoassays as used in 
routine clinical chemistry. 
Overall it can be concluded that In-111-IgG scintigraphy provides an 
accurate technique to evaluate infection and inflammation. It overcomes a 
number of problems associated with currently available techniques. 
However, delineation of infectious foci is relatively slow and accumulation 
in organs such as liver and kidneys and slow clearance from blood and 
background clearance constitute limitations. In the future, research should 
be directed towards nontoxic and nonimmunogenic imaging agents, that 
show fast delineation of infectious foci with low background and organ 
activity. Furthermore, convenient Tc-99m labeling without loss of affinity 
is mandatory for widespread use of such agents. 
A first step in this direction may be the use of chemotactic peptides, 
that show high specific affinity to receptors in an infectious focus. In 
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animals, infectious foci were depicted within minutes, while organ uptake 
and background activity remained relatively low. However, the possible 
induction of neutropenia by these radiopharmaceuticals makes it difficult 
to progress to human studies, since absence of toxicity is one of the major 
requirements for a new imaging agent. 
Another approach is the use of unlabeled avidin or streptavidin, being 
xenoproteins that accumulate in inflammatory foci by a similar mechanism 
as human nonspecific IgG. A few hours after injection with unlabeled avidin 
or streptavidin, these proteins can be specifically targeted with radiolabeled 
biotin. Biotin is a relatively small molecule with high affinity for both 
avidin and streptavidin, that demonstrates rapid blood clearance. As early 
as 5 hours postinjection, significantly higher target to nontarget ratios were 
observed in an animal model, utilizing this system, compared to In-111-IgG. 
So far, there is no evidence of toxicity of avidin or streptavidin in humans. 
However, there is evidence that avidin and streptavidin are immunogenic 
in humans, even in low doses. 
The use of high-affinity human(ized) monoclonal antibodies or antibody 
fragments, directed against epitopes present in infectious and inflammatory 
foci, will be another option worthwhile to consider. Still, it appears that the 
development of molecules with high affinity binding in both acute and 
chronic lesions and fast clearance from both blood and organs, is the way 
to go. Whether small molecules, a pretargeting approach or improved 
monoclonal antibodies will prove to be the best new option in the expanding 
array of radiopharmaceuticals, available for evaluation of infection and 
inflammation, remains to be studied and elucidated. 
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SUMMARY 
Localization of acute, subacute, and chronic infection remains a vexing 
clinical problem. Adequate detection of active infectious and inflammatory 
lesions contributes to both elucidation of the cause of the disease and 
installation of appropriate therapy. With techniques based on detection of 
changes of structure, density and proton content - such as ultrasonography, 
X-ray CT, and MRI - it is often difficult to differentiate active disease from 
either residual abnormalities after cure or from local, postoperative changes. 
In contrast, scintigraphic techniques do not depend upon the local 
anatomic situation. They are based on physiochemical processes in tissue 
and changes therein. Since all currently available and commonly used 
radiopharmaceuticals have various limitations, the need for new, more 
suitable compounds still exists. 
The aim of the studies, described in this thesis, was the evaluation of 
indium-Ill labeled human nonspecific polyclonal immunoglobulin G (In-
111-IgG) as a new radiopharmaceutical for scintigraphic detection and 
localization of infection and inflammation. 
In chapter 1, an overview of the literature, dealing with current 
scintigraphic techniques and new developments is presented. Both results 
of clinical studies and indications and limitations are discussed. 
In an animal model, both the impact of the radionuclide and that of the 
protein were studied, as reported in chapter 2. The radionuclide appears to 
be the most pertinent factor for accumulation of a radiolabeled protein in 
infectious foci. Especially the very similar abscess to background ratios of 
In-111-IgG, In-111-IgA and In-111 human serum albumin indicate, that 
specific interaction between the Fc-part of the IgG molecule and Fc-γ 
receptors are of minor, if any, importance. The nature of the protein was 
relevant for the biodistribution of radiolabeled proteins in organs. The 
molecular size of the protein plays a role in background activity, such as 
in normal muscle. 
With In-111-IgG scintigraphy, adequate results were obtained in 
various patient groups. In the three parts of chapter 3, the diagnostic 
accuracy of In-111-IgG scintigraphy for evaluation of possible infectious 
bone and joint disease are reported. In a series of 113 patients with 120 
lesions, a sensitivity of 97 percent and a specificity for infection of 85 
percent was observed. These studies also show that differentiation between 
infection and sterile inflammation is not possible with this technique. In the 
addendum to chapter 3, the ability to discriminate septic from aseptic joint 
prosthesis loosening is discussed. 
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In chapter 4, a study in patients with complications of diabetes mellitus 
is reported. All patients were suspected of osteomyelitis of the foot after 
infection of ulcers or gangrenous lesions. Using In-111-IgG scintigraphy, 
a sensitivity of 86 percent and a specificity of 84 percent was observed with 
regard to differentiation between osteomyelitis and noninfectious bone 
abnormalities. In this study, In-111-IgG scintigraphy proved to be more 
specific than standard bone scintigraphy with technetium-99m methylene 
diphosphonate, and more sensitive and more specific compared to plain 
radiographs. 
In the past decades, many theories on the etiology of reflex sympathetic 
dystrophy were presented. This condition is generally considered to be an 
inappropriate response of the sympathetic nervous system to injury, 
although all classical signs of inflammation are present in the acute phase 
of reflex sympathetic dystrophy. In a group of patients with reflex 
sympathetic dystrophy, In-111-IgG scintigraphy was performed to verify 
the hypothesis that inflammation plays a role in this condition (chapter 5). 
In 14 of 17 patients with early dystrophy, a steadily increasing In-111-IgG 
accumulation was observed in the affected hand, thus demonstrating an 
important characteristic of inflammation: extravasation of large proteins. 
Since extravasation was independent of altered blood flow, these findings 
strongly suggest that inflammation does play a role in the development of 
reflex sympathetic dystrophy. 
Increased In-111-IgG accumulation was observed in artificially induced 
muscle infection in granulocytopenic rats (chapter 6). In twenty febrile 
granulocytopenic patients, both bacterial and fungal infections were 
adequately delineated with In-111-IgG, quite often in the early stages of 
disease (chapter 6). In this group of patients, other scintigraphic techniques, 
such as labeled autologous leukocyte and gallium-67 scintigraphy, are either 
impossible or do have low sensitivity. 
In chapter 7, initial results in patients with active inflammatory bowel 
disease are reported. In ten patients, it was possible to adequately depict 
the localization and extent of inflammatory activity, especially when using 
SPECT. In this study, all small and large bowel lesions, that were detected 
at endoscopy and contrast radiography, showed increased In-111-IgG 
accumulation. 
In 35 patients with predominantly subacute infection, In-111-IgG 
scintigraphy was compared to In-111 labeled leukocyte scintigraphy, which 
is a nowadays commonly used technique. In-111-IgG scintigraphy showed 
significantly better results (chapter 8). The relatively high accuracy of In-
111-IgG scintigraphy is especially important, since preparation of In-111-
IgG is convenient and fast. In contrast, isolation and In-111 labeling of 
autologous leukocytes is relatively complicated and time-consuming. 
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Moreover, labeling of leukocytes is unattractive, due to possible exposure 
of patients and personnel to infected blood. 
Overall, it can be concluded that In-111-IgG deserves an prominent 
position on the ranking list of radiopharmaceuticals, available for imaging 
infection and inflammation. This new imaging modality overcomes, at least 
in part, many of the disadvantages of other procedures. Further clinical 
studies, including comparison with other imaging modalities, are needed 
to fully appreciate the diagnostic potential of In-111-IgG scintigraphy. 
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SAMENVATTING 
De lokalisatie van acute, subacute en chronische infectiehaarden is 
nog steeds een veelvoorkomend klinisch probleem. Adequate detectie 
van de actieve infectie- en ontstekingshaarden draagt zowel bij tot 
opheldering van de oorzaak van de ziekte als tot het instellen van een 
adequate behandeling. Met technieken gebaseerd op afbeelding van 
veranderingen van weefselstructuren, dichtheid en protonengehalte -
zoals echografie, CT scanning en MRI - is het vaak niet goed mogelijk 
een actief proces te onderscheiden van restafwijkingen na een door-
gemaakte infectie of een veranderde anatomische situatie na bijvoorbeeld 
operatie. 
De resultaten van scintigrafische technieken worden daarentegen 
niet bepaald door de morfologische situatie. Deze modaliteiten zijn 
gebaseerd op fysio-chemische processen in weefsels en de veranderingen 
daarin. Aangezien alle tot op heden gebruikte radiofarmaca nadelen 
vertonen die brede toepassing bemoeilijken, blijft er behoefte aan 
ontwikkeling van nieuwe, beter geschikte technieken. 
De doelstelling van de in dit proefschrift beschreven studies was de 
evaluatie van indium-111 gelabeld humaan niet-specifiek polyclonaal 
gammaglobuline (In-111-IgG), een nieuw ontwikkeld radiofarmacon 
voor de scintigrafische detectie en lokalisatie van infectie- en ontste-
kingshaarden. 
In hoofdstuk 1 wordt een overzicht gegeven van de literatuur 
betreffende de gangbare radiofarmaca alsmede enkele nieuwe ontwikke-
lingen. Hierbij wordt aandacht besteed aan zowel de resultaten van 
klinische studies als de voor- en nadelen van diverse radiofarmaca. 
In een diermodel werd aangetoond dat het radionuclide waarmee 
een eiwit gelabeld wordt, de meest bepalende factor is voor de stapeling 
in infectiehaarden (hoofdstuk 2). Met name de zeer vergelijkbare 
abces/achtergrond verhoudingen van In-111-IgG, In-111-IgA en In-111 
humaan serum albumine wijzen erop, dat specifieke interactie tussen het 
Fc-deel van het IgG-molecule en Fc-7 receptoren, geen rol van bete-
kenis speelt bij de stapeling in infectiehaarden. Het eiwit bleek met 
name van belang voor de biodistributie in organen. Ook speelt de 
molecuulgrootte van het eiwit een rol in de hoogte van achtergrond-
activiteit zoals bijvoorbeeld in normaal spierweefsel. 
In-111-IgG scintigrafie bleek een adequate techniek om infecties en 
ontstekingen te onderzoeken bij diverse patiëntengroepen. In de drie 
onderdelen van hoofdstuk 3 wordt de bruikbaarheid van In-111-IgG 
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scintigrafie voor de evaluatie van mogelijke infecties van het bewegings-
apparaat beschreven. In een serie van 113 patiënten met 120 mogelijke 
infectiehaarden werd een sensitiviteit van 97 procent en een specificiteit 
voor infectie van 85 procent gevonden. In deze studie werd ook aange-
toond dat het middels In-111-IgG scintigrafie niet mogelijk is onder-
scheid te maken tussen infectieuze processen en steriele ontstekingen. In 
het addendum bij hoofdstuk 3 wordt de toepassing van In-111-IgG 
scintigrafìe voor differentiatie tussen aseptische en infectieuze loslating 
van gewrichtsprotheses nader toegelicht. 
In hoofdstuk 4 wordt een studie bij patiënten met complicaties van 
diabetes mellitus beschreven. Deze patiënten waren verdacht van osteo-
myelitis van de voet ten gevolge van secundaire infectie van ulcera en 
gangreneuze afwijkingen. Wat betreft differentiatie tussen osteomyelitis 
en niet-infectieuze botafwij kingen, werd met In-111-IgG scintigrafie een 
sensitiviteit van 86 procent en een specificiteit van 84 procent gevonden. 
In-111-IgG scintigrafìe bleek specifieker dan de standaard skeletscinti-
grafie met technetium-99m methyleen difosfonaat en zowel sensitiever 
als specifieker dan conventionele röntgenfoto's. 
Over de etiologie van posttraumatische sympathische reflex 
dystrofie bestaan vele theorieën. In de literatuur wordt deze aandoening 
in het algemeen beschouwd als een verhoogde activiteit van het sympa-
tische zenuwstelsel. Echter in het acute stadium zijn alle klassieke 
symptomen van ontsteking - rubor, calor, dolor, tumor en functio laesa -
aanwezig. Bij een groep patiënten met posttraumatische dystrofie werd 
In-111-IgG scintigrafie verricht ter toetsing van de hypothese, dat 
ontsteking een rol speelt (hoofdstuk 5). Bij 14 van de 17 patiënten met 
dystrofie in een vroeg stadium, werd een in de tijd toenemende In-111-
IgG stapeling in de aangedane hand waargenomen. Dit wijst op een 
belangrijk kenmerk van ontsteking: extravasatie van grote eiwitten. 
Aangezien de extravasatie onafhankelijk was van de mate van door-
bloeding, pleitten deze bevindingen ervoor, dat ontsteking een rol speelt 
in het ontstaan van posttraumatische sympathische reflex dystrofie. 
Bij ratten met middels cyclofosfamide geïnduceerde granulocyto-
penie werd In-111-IgG stapeling waargenomen in infectiehaarden, 
opgewekt door intramusculaire injectie van Staphylococcus aureus 
(hoofdstuk 6). Ook bij twintig granulocytopenische patiënten met koorts 
werden met behulp van In-111-IgG scintigrafie zowel bacteriële als 
schimmelinfecties, vaak in vroege stadia, opgespoord (hoofdstuk 6). 
Andere scintigrafische technieken, zoals gelabelde autologe leucocyten 
en gallium-67 scintigrafie, zijn bij deze patiënten niet mogelijk of 
vertonen een lage sensitiviteit. 
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In een groep van tien patiënten met actieve inflammatoire darm-
ziekten was het, met name middels SPECT, mogelijk om de lokalisatie 
en uitbreiding van de ontstekingsactiviteit adequaat af te beelden (hoofd-
stuk 7). In deze studie vertoonden alle, middels endoscopie en röntgen-
contrast onderzoek gevonden dunne darm en colonlesies ook verhoogde 
In-111-IgG stapeling. 
Bij vergelijking van In-111-IgG scintigrafie met In-111 gelabelde 
leucocyten scintigrafie - een op dit moment op grote schaal toegepast 
onderzoek - werd bij 35 patiënten met voornamelijk subacute infecties 
aangetoond, dat de resultaten van In-111-IgG scintigrafie significant 
beter waren (hoofdstuk 8). De relatief goede resultaten van In-111-IgG 
scintigrafie zijn met name ook daarom van belang, omdat In-111-IgG 
zeer eenvoudig bereid kan worden, terwijl de labelling van autologe 
leucocyten met In-111 relatief gecompliceerd en tijdrovend is. Bereiding 
van gelabelde leucocyten is bovendien niet aantrekkelijk, omdat met 
potentieel geïnfecteerd bloed gewerkt moet worden, hetgeen risico's 
voor patiënt en personeel kan inhouden. 
In het algemeen kan geconcludeerd worden, dat In-111-IgG scinti-
grafìe een belangrijke plaats verdient bij de evaluatie van infectie- en 
ontstekingshaarden. Vele van de nadelen van andere, thans in kliniek 
toegepaste scintigrafische technieken, gelden niet of in veel mindere 
mate voor In-111-IgG scintigrafie. Verdere klinische studies, inclusief 
vergelijking met andere beeldvormende technieken, zijn nodig om de 
diagnostische mogelijkheden van In-111-IgG scintigrafie op hun volle 
waarde te kunnen schatten. 
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STELLINGEN 
behorende bij het proefschrift 
DETECTION OF INFECTION AND INFLAMMATION 
WITH INDIUM-111 LABELED 
HUMAN NONSPECIFIC IMMUNOGLOBULIN G 
W.J.G. Oyen 
18 maart 1992 
1. Indium-lll humaan gelabeld niet-specifiek gammaglobuline is beter 
bruikbaar voor scintigrafische evaluatie van subacute en chronische 
infecties dan indium-lll gelabelde autologe leucocyten. 
(dit proefschrift) 
2. Met de huidige scintigrafische technieken is differentiatie tussen 
steriele ontsteking en infectie niet betrouwbaar mogelijk. 
(dit proefschrift) 
3. De stapeling van indium-lll gelabeld humaan niet-specifiek 
gammaglobuline in ontstekingshaarden is niet het gevolg van specifieke 
binding van het radiofarmacon aan Fc-7 receptoren van cellen in een 
ontstekingsinfiltraat. 
(dit proefschrift) 
4. De chemische karakteristieken van een radionuclide waarmee het 
proteïne gelabeld wordt, zijn evenzeer bepalend voor biodistributie en 
kinetiek van een radiofarmacon als het eiwit zelf. 
(dit proefschrift) 
5. Scintigrafisch onderzoek dient niet als sluitpost van de diagnostiek van 
infectieziekten gebruikt te worden. 
6. Het ontstaan van humane antistoffen tegen in muizen opgewekte 
monoclonale antilichamen bij een deel van de patiënten maakt 
dergelijke monoclonale antilichamen ongeschikt voor herhaald gebruik 
bij patiënten met benigne aandoeningen. 
7. "Correlative imaging" levert meer op dan de som van de delen. 
8. Nuclear magnetic resonance imaging mag met recht "nucleaire" 
geneeskunde genoemd worden. 
9. Het routinematig gebruik van antibiotica met een ultra-breed 
therapeutisch spectrum kan een verlaging van het niveau van de 
geneeskunst tot gevolg hebben, doordat de toepassing van deze 
middelen de noodzaak tot het stellen van een precieze diagnose en tot 
optimaal klinisch handelen vermindert. 
B.E. de Pauw, J.P. Donnelly, A. Elves, С. Verhagen, LR.О. Nováková en J.W.M, van 
der Meer. Neth J Med 1990; 37: 111-119. 
10. Opheffing van de anonimiteit van donoren ten behoeve van donor-
inseminatie leidt tot sociale ongelijkheid. 
J. Kremer en H.J.J. Leenen. Ned Tijdschr Geneeskd 1991; 135: 1476-1478. 
11. Met het oog op zowel patiëntvriendelijke bejegening als collegiale 
verhoudingen verdient het aanbeveling, dat ziekenhuisrestaurants geen 
knoflook gebruiken. 
12. De hoogte van het wetenschappelijk niveau van sommige sprekers 
spoort niet altijd met het peil van beschaving tijdens een bij een groot 
internationaal congres aangeboden buffet. 
13. Niet alles in de geneeskunde wat kan moet, maar moet wel kunnen. 
14. De particulier verzekerde dreigt in het nieuwe stelsel van ziekten-
kostenverzekering met recht de "KLOZ" te worden. 
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